id	sid	tid	token	lemma	pos
cord-266455-rbblg4pu	1	1	key	key	NN
cord-266455-rbblg4pu	1	2	:	:	:
cord-266455-rbblg4pu	1	3	cord-266455-rbblg4pu	cord-266455-rbblg4pu	.
cord-266455-rbblg4pu	2	1	authors	author	NNS
cord-266455-rbblg4pu	2	2	:	:	:
cord-266455-rbblg4pu	2	3	Poole	Poole	NNP
cord-266455-rbblg4pu	2	4	,	,	,
cord-266455-rbblg4pu	2	5	Stephen	Stephen	NNP
cord-266455-rbblg4pu	2	6	;	;	:
cord-266455-rbblg4pu	2	7	Clark	Clark	NNP
cord-266455-rbblg4pu	2	8	,	,	,
cord-266455-rbblg4pu	2	9	Tristan	Tristan	NNP
cord-266455-rbblg4pu	2	10	W.	W.	NNP
cord-266455-rbblg4pu	2	11	title	title	NN
cord-266455-rbblg4pu	2	12	:	:	:
cord-266455-rbblg4pu	2	13	Rapid	Rapid	NNP
cord-266455-rbblg4pu	2	14	syndromic	syndromic	JJ
cord-266455-rbblg4pu	2	15	molecular	molecular	JJ
cord-266455-rbblg4pu	2	16	testing	testing	NN
cord-266455-rbblg4pu	2	17	in	in	IN
cord-266455-rbblg4pu	2	18	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	2	19	:	:	:
cord-266455-rbblg4pu	3	1	The	the	DT
cord-266455-rbblg4pu	3	2	current	current	JJ
cord-266455-rbblg4pu	3	3	landscape	landscape	NN
cord-266455-rbblg4pu	3	4	and	and	CC
cord-266455-rbblg4pu	3	5	future	future	JJ
cord-266455-rbblg4pu	3	6	potential	potential	JJ
cord-266455-rbblg4pu	3	7	date	date	NN
cord-266455-rbblg4pu	3	8	:	:	:
cord-266455-rbblg4pu	3	9	2019	2019	CD
cord-266455-rbblg4pu	3	10	-	-	HYPH
cord-266455-rbblg4pu	3	11	12	12	CD
cord-266455-rbblg4pu	3	12	-	-	HYPH
cord-266455-rbblg4pu	3	13	03	03	CD
cord-266455-rbblg4pu	3	14	journal	journal	NN
cord-266455-rbblg4pu	3	15	:	:	:
cord-266455-rbblg4pu	3	16	J	J	NNP
cord-266455-rbblg4pu	3	17	Infect	infect	VB
cord-266455-rbblg4pu	3	18	DOI	DOI	NNP
cord-266455-rbblg4pu	3	19	:	:	:
cord-266455-rbblg4pu	3	20	10.1016	10.1016	CD
cord-266455-rbblg4pu	3	21	/	/	SYM
cord-266455-rbblg4pu	3	22	j.jinf.2019.11.021	j.jinf.2019.11.021	NNP
cord-266455-rbblg4pu	3	23	sha	sha	NNP
cord-266455-rbblg4pu	3	24	:	:	:
cord-266455-rbblg4pu	4	1	b05a28a43ac960b7bbab0ecceae768874efcb7e5	b05a28a43ac960b7bbab0ecceae768874efcb7e5	CC
cord-266455-rbblg4pu	4	2	doc_id	doc_id	CD
cord-266455-rbblg4pu	4	3	:	:	:
cord-266455-rbblg4pu	4	4	266455	266455	CD
cord-266455-rbblg4pu	4	5	cord_uid	cord_uid	NNS
cord-266455-rbblg4pu	4	6	:	:	:
cord-266455-rbblg4pu	5	1	rbblg4pu	rbblg4pu	NNP
cord-266455-rbblg4pu	5	2	Community	Community	NNP
cord-266455-rbblg4pu	5	3	acquired	acquire	VBD
cord-266455-rbblg4pu	5	4	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	5	5	(	(	-LRB-
cord-266455-rbblg4pu	5	6	CAP	CAP	NNP
cord-266455-rbblg4pu	5	7	)	)	-RRB-
cord-266455-rbblg4pu	5	8	,	,	,
cord-266455-rbblg4pu	5	9	hospital	hospital	NN
cord-266455-rbblg4pu	5	10	-	-	HYPH
cord-266455-rbblg4pu	5	11	acquired	acquire	VBN
cord-266455-rbblg4pu	5	12	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	5	13	(	(	-LRB-
cord-266455-rbblg4pu	5	14	HAP	HAP	NNP
cord-266455-rbblg4pu	5	15	)	)	-RRB-
cord-266455-rbblg4pu	5	16	and	and	CC
cord-266455-rbblg4pu	5	17	ventilator	ventilator	NN
cord-266455-rbblg4pu	5	18	associated	associate	VBN
cord-266455-rbblg4pu	5	19	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	5	20	(	(	-LRB-
cord-266455-rbblg4pu	5	21	VAP	VAP	NNP
cord-266455-rbblg4pu	5	22	)	)	-RRB-
cord-266455-rbblg4pu	5	23	are	be	VBP
cord-266455-rbblg4pu	5	24	all	all	DT
cord-266455-rbblg4pu	5	25	associated	associate	VBN
cord-266455-rbblg4pu	5	26	with	with	IN
cord-266455-rbblg4pu	5	27	significant	significant	JJ
cord-266455-rbblg4pu	5	28	mortality	mortality	NN
cord-266455-rbblg4pu	5	29	and	and	CC
cord-266455-rbblg4pu	5	30	cause	cause	VB
cord-266455-rbblg4pu	5	31	huge	huge	JJ
cord-266455-rbblg4pu	5	32	expense	expense	NN
cord-266455-rbblg4pu	5	33	to	to	IN
cord-266455-rbblg4pu	5	34	health	health	NN
cord-266455-rbblg4pu	5	35	care	care	NN
cord-266455-rbblg4pu	5	36	services	service	NNS
cord-266455-rbblg4pu	5	37	around	around	IN
cord-266455-rbblg4pu	5	38	the	the	DT
cord-266455-rbblg4pu	5	39	world	world	NN
cord-266455-rbblg4pu	5	40	.	.	.
cord-266455-rbblg4pu	6	1	Early	early	RB
cord-266455-rbblg4pu	6	2	,	,	,
cord-266455-rbblg4pu	6	3	appropriate	appropriate	JJ
cord-266455-rbblg4pu	6	4	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	6	5	therapy	therapy	NN
cord-266455-rbblg4pu	6	6	is	be	VBZ
cord-266455-rbblg4pu	6	7	crucial	crucial	JJ
cord-266455-rbblg4pu	6	8	for	for	IN
cord-266455-rbblg4pu	6	9	effective	effective	JJ
cord-266455-rbblg4pu	6	10	treatment	treatment	NN
cord-266455-rbblg4pu	6	11	.	.	.
cord-266455-rbblg4pu	7	1	Syndromic	Syndromic	NNP
cord-266455-rbblg4pu	7	2	diagnostic	diagnostic	JJ
cord-266455-rbblg4pu	7	3	testing	testing	NN
cord-266455-rbblg4pu	7	4	using	use	VBG
cord-266455-rbblg4pu	7	5	novel	novel	NN
cord-266455-rbblg4pu	7	6	,	,	,
cord-266455-rbblg4pu	7	7	rapid	rapid	JJ
cord-266455-rbblg4pu	7	8	multiplexed	multiplexed	JJ
cord-266455-rbblg4pu	7	9	molecular	molecular	JJ
cord-266455-rbblg4pu	7	10	platforms	platform	NNS
cord-266455-rbblg4pu	7	11	represents	represent	VBZ
cord-266455-rbblg4pu	7	12	a	a	DT
cord-266455-rbblg4pu	7	13	new	new	JJ
cord-266455-rbblg4pu	7	14	opportunity	opportunity	NN
cord-266455-rbblg4pu	7	15	for	for	IN
cord-266455-rbblg4pu	7	16	rapidly	rapidly	RB
cord-266455-rbblg4pu	7	17	targeted	target	VBN
cord-266455-rbblg4pu	7	18	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	7	19	therapy	therapy	NN
cord-266455-rbblg4pu	7	20	to	to	TO
cord-266455-rbblg4pu	7	21	improve	improve	VB
cord-266455-rbblg4pu	7	22	patient	patient	JJ
cord-266455-rbblg4pu	7	23	outcomes	outcome	NNS
cord-266455-rbblg4pu	7	24	and	and	CC
cord-266455-rbblg4pu	7	25	facilitate	facilitate	VB
cord-266455-rbblg4pu	7	26	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	7	27	stewardship	stewardship	NN
cord-266455-rbblg4pu	7	28	.	.	.
cord-266455-rbblg4pu	8	1	In	in	IN
cord-266455-rbblg4pu	8	2	this	this	DT
cord-266455-rbblg4pu	8	3	article	article	NN
cord-266455-rbblg4pu	8	4	we	-PRON-	PRP
cord-266455-rbblg4pu	8	5	review	review	VBP
cord-266455-rbblg4pu	8	6	the	the	DT
cord-266455-rbblg4pu	8	7	currently	currently	RB
cord-266455-rbblg4pu	8	8	available	available	JJ
cord-266455-rbblg4pu	8	9	testing	testing	NN
cord-266455-rbblg4pu	8	10	platforms	platform	NNS
cord-266455-rbblg4pu	8	11	and	and	CC
cord-266455-rbblg4pu	8	12	discuss	discuss	VB
cord-266455-rbblg4pu	8	13	the	the	DT
cord-266455-rbblg4pu	8	14	potential	potential	JJ
cord-266455-rbblg4pu	8	15	benefits	benefit	NNS
cord-266455-rbblg4pu	8	16	and	and	CC
cord-266455-rbblg4pu	8	17	pitfalls	pitfall	NNS
cord-266455-rbblg4pu	8	18	of	of	IN
cord-266455-rbblg4pu	8	19	rapid	rapid	JJ
cord-266455-rbblg4pu	8	20	testing	testing	NN
cord-266455-rbblg4pu	8	21	in	in	IN
cord-266455-rbblg4pu	8	22	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	8	23	.	.	.
cord-266455-rbblg4pu	9	1	Lower	low	JJR
cord-266455-rbblg4pu	9	2	respiratory	respiratory	JJ
cord-266455-rbblg4pu	9	3	tract	tract	NN
cord-266455-rbblg4pu	9	4	infections	infection	NNS
cord-266455-rbblg4pu	9	5	were	be	VBD
cord-266455-rbblg4pu	9	6	accountable	accountable	JJ
cord-266455-rbblg4pu	9	7	for	for	IN
cord-266455-rbblg4pu	9	8	an	an	DT
cord-266455-rbblg4pu	9	9	estimated	estimate	VBN
cord-266455-rbblg4pu	9	10	2.7	2.7	CD
cord-266455-rbblg4pu	9	11	million	million	CD
cord-266455-rbblg4pu	9	12	deaths	death	NNS
cord-266455-rbblg4pu	9	13	in	in	IN
cord-266455-rbblg4pu	9	14	2015	2015	CD
cord-266455-rbblg4pu	9	15	,	,	,
cord-266455-rbblg4pu	9	16	making	make	VBG
cord-266455-rbblg4pu	9	17	them	-PRON-	PRP
cord-266455-rbblg4pu	9	18	the	the	DT
cord-266455-rbblg4pu	9	19	third	third	JJ
cord-266455-rbblg4pu	9	20	most	most	RBS
cord-266455-rbblg4pu	9	21	common	common	JJ
cord-266455-rbblg4pu	9	22	cause	cause	NN
cord-266455-rbblg4pu	9	23	of	of	IN
cord-266455-rbblg4pu	9	24	death	death	NN
cord-266455-rbblg4pu	9	25	worldwide	worldwide	RB
cord-266455-rbblg4pu	9	26	1	1	CD
cord-266455-rbblg4pu	9	27	.	.	.
cord-266455-rbblg4pu	10	1	Community	community	NN
cord-266455-rbblg4pu	10	2	acquired	acquire	VBD
cord-266455-rbblg4pu	10	3	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	10	4	(	(	-LRB-
cord-266455-rbblg4pu	10	5	CAP	CAP	NNP
cord-266455-rbblg4pu	10	6	)	)	-RRB-
cord-266455-rbblg4pu	10	7	caused	cause	VBD
cord-266455-rbblg4pu	10	8	nearly	nearly	RB
cord-266455-rbblg4pu	10	9	30,0	30,0	CD
cord-266455-rbblg4pu	10	10	0	0	CD
cord-266455-rbblg4pu	10	11	0	0	CD
cord-266455-rbblg4pu	10	12	deaths	death	NNS
cord-266455-rbblg4pu	10	13	in	in	IN
cord-266455-rbblg4pu	10	14	England	England	NNP
cord-266455-rbblg4pu	10	15	and	and	CC
cord-266455-rbblg4pu	10	16	Wales	Wales	NNP
cord-266455-rbblg4pu	10	17	in	in	IN
cord-266455-rbblg4pu	10	18	2015	2015	CD
cord-266455-rbblg4pu	10	19	2	2	CD
cord-266455-rbblg4pu	10	20	and	and	CC
cord-266455-rbblg4pu	10	21	costs	cost	VBZ
cord-266455-rbblg4pu	10	22	Europe	Europe	NNP
cord-266455-rbblg4pu	10	23	around	around	IN
cord-266455-rbblg4pu	10	24	€	€	$
cord-266455-rbblg4pu	10	25	10	10	CD
cord-266455-rbblg4pu	10	26	million	million	CD
cord-266455-rbblg4pu	10	27	annually	annually	RB
cord-266455-rbblg4pu	10	28	3	3	CD
cord-266455-rbblg4pu	10	29	.	.	.
cord-266455-rbblg4pu	11	1	It	-PRON-	PRP
cord-266455-rbblg4pu	11	2	is	be	VBZ
cord-266455-rbblg4pu	11	3	estimated	estimate	VBN
cord-266455-rbblg4pu	11	4	that	that	IN
cord-266455-rbblg4pu	11	5	25	25	CD
cord-266455-rbblg4pu	11	6	per	per	IN
cord-266455-rbblg4pu	11	7	10,0	10,0	CD
cord-266455-rbblg4pu	11	8	0	0	CD
cord-266455-rbblg4pu	11	9	0	0	CD
cord-266455-rbblg4pu	11	10	adults	adult	NNS
cord-266455-rbblg4pu	11	11	are	be	VBP
cord-266455-rbblg4pu	11	12	hospitalised	hospitalise	VBN
cord-266455-rbblg4pu	11	13	with	with	IN
cord-266455-rbblg4pu	11	14	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	11	15	each	each	DT
cord-266455-rbblg4pu	11	16	year	year	NN
cord-266455-rbblg4pu	11	17	4	4	CD
cord-266455-rbblg4pu	11	18	.	.	.
cord-266455-rbblg4pu	12	1	Hospital	hospital	NN
cord-266455-rbblg4pu	12	2	acquired	acquire	VBD
cord-266455-rbblg4pu	12	3	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	12	4	(	(	-LRB-
cord-266455-rbblg4pu	12	5	HAP	HAP	NNP
cord-266455-rbblg4pu	12	6	)	)	-RRB-
cord-266455-rbblg4pu	12	7	is	be	VBZ
cord-266455-rbblg4pu	12	8	defined	define	VBN
cord-266455-rbblg4pu	12	9	as	as	IN
cord-266455-rbblg4pu	12	10	occurring	occur	VBG
cord-266455-rbblg4pu	12	11	>	>	XX
cord-266455-rbblg4pu	13	1	48	48	CD
cord-266455-rbblg4pu	13	2	h	h	NN
cord-266455-rbblg4pu	13	3	after	after	IN
cord-266455-rbblg4pu	13	4	admission	admission	NN
cord-266455-rbblg4pu	13	5	to	to	IN
cord-266455-rbblg4pu	13	6	a	a	DT
cord-266455-rbblg4pu	13	7	healthcare	healthcare	NN
cord-266455-rbblg4pu	13	8	facility	facility	NN
cord-266455-rbblg4pu	13	9	.	.	.
cord-266455-rbblg4pu	14	1	It	-PRON-	PRP
cord-266455-rbblg4pu	14	2	is	be	VBZ
cord-266455-rbblg4pu	14	3	caused	cause	VBN
cord-266455-rbblg4pu	14	4	by	by	IN
cord-266455-rbblg4pu	14	5	a	a	DT
cord-266455-rbblg4pu	14	6	different	different	JJ
cord-266455-rbblg4pu	14	7	spectrum	spectrum	NN
cord-266455-rbblg4pu	14	8	of	of	IN
cord-266455-rbblg4pu	14	9	more	more	RBR
cord-266455-rbblg4pu	14	10	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	14	11	resistant	resistant	JJ
cord-266455-rbblg4pu	14	12	bacterial	bacterial	JJ
cord-266455-rbblg4pu	14	13	pathogens	pathogen	NNS
cord-266455-rbblg4pu	14	14	than	than	IN
cord-266455-rbblg4pu	14	15	those	those	DT
cord-266455-rbblg4pu	14	16	occurring	occur	VBG
cord-266455-rbblg4pu	14	17	in	in	IN
cord-266455-rbblg4pu	14	18	the	the	DT
cord-266455-rbblg4pu	14	19	community	community	NN
cord-266455-rbblg4pu	14	20	.	.	.
cord-266455-rbblg4pu	15	1	Ventilator	ventilator	NN
cord-266455-rbblg4pu	15	2	associated	associate	VBD
cord-266455-rbblg4pu	15	3	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	15	4	(	(	-LRB-
cord-266455-rbblg4pu	15	5	VAP	VAP	NNP
cord-266455-rbblg4pu	15	6	)	)	-RRB-
cord-266455-rbblg4pu	15	7	is	be	VBZ
cord-266455-rbblg4pu	15	8	defined	define	VBN
cord-266455-rbblg4pu	15	9	as	as	IN
cord-266455-rbblg4pu	15	10	occurring	occur	VBG
cord-266455-rbblg4pu	16	1	>	>	XX
cord-266455-rbblg4pu	17	1	48	48	CD
cord-266455-rbblg4pu	17	2	h	h	NN
cord-266455-rbblg4pu	17	3	after	after	IN
cord-266455-rbblg4pu	17	4	intubation	intubation	NN
cord-266455-rbblg4pu	17	5	for	for	IN
cord-266455-rbblg4pu	17	6	invasive	invasive	JJ
cord-266455-rbblg4pu	17	7	artificial	artificial	JJ
cord-266455-rbblg4pu	17	8	ventilation	ventilation	NN
cord-266455-rbblg4pu	17	9	.	.	.
cord-266455-rbblg4pu	18	1	The	the	DT
cord-266455-rbblg4pu	18	2	two	two	CD
cord-266455-rbblg4pu	18	3	entities	entity	NNS
cord-266455-rbblg4pu	18	4	combined	combine	VBN
cord-266455-rbblg4pu	18	5	(	(	-LRB-
cord-266455-rbblg4pu	18	6	HAP	HAP	NNP
cord-266455-rbblg4pu	18	7	and	and	CC
cord-266455-rbblg4pu	18	8	VAP	VAP	NNP
cord-266455-rbblg4pu	18	9	)	)	-RRB-
cord-266455-rbblg4pu	18	10	are	be	VBP
cord-266455-rbblg4pu	18	11	the	the	DT
cord-266455-rbblg4pu	18	12	most	most	RBS
cord-266455-rbblg4pu	18	13	common	common	JJ
cord-266455-rbblg4pu	18	14	nosocomial	nosocomial	JJ
cord-266455-rbblg4pu	18	15	infection	infection	NN
cord-266455-rbblg4pu	18	16	in	in	IN
cord-266455-rbblg4pu	18	17	the	the	DT
cord-266455-rbblg4pu	18	18	developed	developed	JJ
cord-266455-rbblg4pu	18	19	world	world	NN
cord-266455-rbblg4pu	18	20	5	5	CD
cord-266455-rbblg4pu	18	21	with	with	IN
cord-266455-rbblg4pu	18	22	HAP	HAP	NNP
cord-266455-rbblg4pu	18	23	complicating	complicate	VBG
cord-266455-rbblg4pu	18	24	around	around	IN
cord-266455-rbblg4pu	18	25	2	2	CD
cord-266455-rbblg4pu	18	26	%	%	NN
cord-266455-rbblg4pu	18	27	of	of	IN
cord-266455-rbblg4pu	18	28	hospital	hospital	NN
cord-266455-rbblg4pu	18	29	admissions	admission	NNS
cord-266455-rbblg4pu	18	30	6	6	CD
cord-266455-rbblg4pu	18	31	.	.	.
cord-266455-rbblg4pu	19	1	The	the	DT
cord-266455-rbblg4pu	19	2	incidence	incidence	NN
cord-266455-rbblg4pu	19	3	of	of	IN
cord-266455-rbblg4pu	19	4	VAP	VAP	NNP
cord-266455-rbblg4pu	19	5	in	in	IN
cord-266455-rbblg4pu	19	6	intubated	intubate	VBN
cord-266455-rbblg4pu	19	7	patients	patient	NNS
cord-266455-rbblg4pu	19	8	is	be	VBZ
cord-266455-rbblg4pu	19	9	around	around	IN
cord-266455-rbblg4pu	19	10	10	10	CD
cord-266455-rbblg4pu	19	11	%	%	NN
cord-266455-rbblg4pu	19	12	7	7	CD
cord-266455-rbblg4pu	19	13	and	and	CC
cord-266455-rbblg4pu	19	14	is	be	VBZ
cord-266455-rbblg4pu	19	15	associated	associate	VBN
cord-266455-rbblg4pu	19	16	with	with	IN
cord-266455-rbblg4pu	19	17	mortality	mortality	NN
cord-266455-rbblg4pu	19	18	of	of	IN
cord-266455-rbblg4pu	19	19	around	around	IN
cord-266455-rbblg4pu	19	20	10	10	CD
cord-266455-rbblg4pu	19	21	%	%	NN
cord-266455-rbblg4pu	19	22	8	8	CD
cord-266455-rbblg4pu	19	23	.	.	.
cord-266455-rbblg4pu	20	1	A	a	DT
cord-266455-rbblg4pu	20	2	retrospective	retrospective	JJ
cord-266455-rbblg4pu	20	3	matched	match	VBN
cord-266455-rbblg4pu	20	4	cohort	cohort	NN
cord-266455-rbblg4pu	20	5	study	study	NN
cord-266455-rbblg4pu	20	6	by	by	IN
cord-266455-rbblg4pu	20	7	Kollef	Kollef	NNP
cord-266455-rbblg4pu	20	8	et	et	NNP
cord-266455-rbblg4pu	20	9	al	al	NNP
cord-266455-rbblg4pu	20	10	.	.	.
cord-266455-rbblg4pu	21	1	9	9	CD
cord-266455-rbblg4pu	21	2	found	find	VBD
cord-266455-rbblg4pu	21	3	patients	patient	NNS
cord-266455-rbblg4pu	21	4	who	who	WP
cord-266455-rbblg4pu	21	5	developed	develop	VBD
cord-266455-rbblg4pu	21	6	VAP	VAP	NNP
cord-266455-rbblg4pu	21	7	were	be	VBD
cord-266455-rbblg4pu	21	8	intubated	intubate	VBN
cord-266455-rbblg4pu	21	9	for	for	IN
cord-266455-rbblg4pu	21	10	longer	long	RBR
cord-266455-rbblg4pu	21	11	,	,	,
cord-266455-rbblg4pu	21	12	spent	spend	VBN
cord-266455-rbblg4pu	21	13	longer	long	RBR
cord-266455-rbblg4pu	21	14	on	on	IN
cord-266455-rbblg4pu	21	15	ICU	ICU	NNP
cord-266455-rbblg4pu	21	16	,	,	,
cord-266455-rbblg4pu	21	17	and	and	CC
cord-266455-rbblg4pu	21	18	were	be	VBD
cord-266455-rbblg4pu	21	19	in	in	IN
cord-266455-rbblg4pu	21	20	hospital	hospital	NN
cord-266455-rbblg4pu	21	21	for	for	IN
cord-266455-rbblg4pu	21	22	a	a	DT
cord-266455-rbblg4pu	21	23	greater	great	JJR
cord-266455-rbblg4pu	21	24	period	period	NN
cord-266455-rbblg4pu	21	25	of	of	IN
cord-266455-rbblg4pu	21	26	time	time	NN
cord-266455-rbblg4pu	21	27	.	.	.
cord-266455-rbblg4pu	22	1	They	-PRON-	PRP
cord-266455-rbblg4pu	22	2	estimated	estimate	VBD
cord-266455-rbblg4pu	22	3	the	the	DT
cord-266455-rbblg4pu	22	4	additional	additional	JJ
cord-266455-rbblg4pu	22	5	cost	cost	NN
cord-266455-rbblg4pu	22	6	of	of	IN
cord-266455-rbblg4pu	22	7	VAP	VAP	NNP
cord-266455-rbblg4pu	22	8	from	from	IN
cord-266455-rbblg4pu	22	9	to	to	TO
cord-266455-rbblg4pu	22	10	be	be	VB
cord-266455-rbblg4pu	22	11	$	$	$
cord-266455-rbblg4pu	22	12	40,0	40,0	CD
cord-266455-rbblg4pu	22	13	0	0	CD
cord-266455-rbblg4pu	22	14	0	0	CD
cord-266455-rbblg4pu	22	15	per	per	IN
cord-266455-rbblg4pu	22	16	patient	patient	NN
cord-266455-rbblg4pu	22	17	.	.	.
cord-266455-rbblg4pu	23	1	Large	large	JJ
cord-266455-rbblg4pu	23	2	amounts	amount	NNS
cord-266455-rbblg4pu	23	3	of	of	IN
cord-266455-rbblg4pu	23	4	empirical	empirical	JJ
cord-266455-rbblg4pu	23	5	'	'	``
cord-266455-rbblg4pu	23	6	broad	broad	JJ
cord-266455-rbblg4pu	23	7	spectrum	spectrum	NN
cord-266455-rbblg4pu	23	8	'	'	POS
cord-266455-rbblg4pu	23	9	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	23	10	are	be	VBP
cord-266455-rbblg4pu	23	11	used	use	VBN
cord-266455-rbblg4pu	23	12	to	to	TO
cord-266455-rbblg4pu	23	13	treat	treat	VB
cord-266455-rbblg4pu	23	14	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	23	15	which	which	WDT
cord-266455-rbblg4pu	23	16	inadvertently	inadvertently	RB
cord-266455-rbblg4pu	23	17	promote	promote	VBP
cord-266455-rbblg4pu	23	18	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	23	19	resistance	resistance	NN
cord-266455-rbblg4pu	23	20	(	(	-LRB-
cord-266455-rbblg4pu	23	21	AMR	AMR	NNP
cord-266455-rbblg4pu	23	22	)	)	-RRB-
cord-266455-rbblg4pu	23	23	:	:	:
cord-266455-rbblg4pu	23	24	a	a	DT
cord-266455-rbblg4pu	23	25	problem	problem	NN
cord-266455-rbblg4pu	23	26	identified	identify	VBN
cord-266455-rbblg4pu	23	27	by	by	IN
cord-266455-rbblg4pu	23	28	the	the	DT
cord-266455-rbblg4pu	23	29	WHO	WHO	NNP
cord-266455-rbblg4pu	23	30	as	as	IN
cord-266455-rbblg4pu	23	31	one	one	CD
cord-266455-rbblg4pu	23	32	of	of	IN
cord-266455-rbblg4pu	23	33	the	the	DT
cord-266455-rbblg4pu	23	34	leading	lead	VBG
cord-266455-rbblg4pu	23	35	threats	threat	NNS
cord-266455-rbblg4pu	23	36	to	to	IN
cord-266455-rbblg4pu	23	37	global	global	JJ
cord-266455-rbblg4pu	23	38	health	health	NN
cord-266455-rbblg4pu	23	39	today	today	NN
cord-266455-rbblg4pu	23	40	.	.	.
cord-266455-rbblg4pu	24	1	The	the	DT
cord-266455-rbblg4pu	24	2	O'Neill	O'Neill	NNP
cord-266455-rbblg4pu	24	3	report	report	NN
cord-266455-rbblg4pu	24	4	,	,	,
cord-266455-rbblg4pu	24	5	commissioned	commission	VBN
cord-266455-rbblg4pu	24	6	by	by	IN
cord-266455-rbblg4pu	24	7	the	the	DT
cord-266455-rbblg4pu	24	8	UK	UK	NNP
cord-266455-rbblg4pu	24	9	government	government	NN
cord-266455-rbblg4pu	24	10	in	in	IN
cord-266455-rbblg4pu	24	11	2014	2014	CD
cord-266455-rbblg4pu	24	12	,	,	,
cord-266455-rbblg4pu	24	13	has	have	VBZ
cord-266455-rbblg4pu	24	14	highlighted	highlight	VBN
cord-266455-rbblg4pu	24	15	the	the	DT
cord-266455-rbblg4pu	24	16	need	need	NN
cord-266455-rbblg4pu	24	17	for	for	IN
cord-266455-rbblg4pu	24	18	developed	develop	VBN
cord-266455-rbblg4pu	24	19	nations	nation	NNS
cord-266455-rbblg4pu	24	20	to	to	TO
cord-266455-rbblg4pu	24	21	take	take	VB
cord-266455-rbblg4pu	24	22	a	a	DT
cord-266455-rbblg4pu	24	23	lead	lead	NN
cord-266455-rbblg4pu	24	24	in	in	IN
cord-266455-rbblg4pu	24	25	tackling	tackle	VBG
cord-266455-rbblg4pu	24	26	AMR	AMR	NNP
cord-266455-rbblg4pu	24	27	.	.	.
cord-266455-rbblg4pu	25	1	As	as	IN
cord-266455-rbblg4pu	25	2	part	part	NN
cord-266455-rbblg4pu	25	3	of	of	IN
cord-266455-rbblg4pu	25	4	this	this	DT
cord-266455-rbblg4pu	25	5	there	there	EX
cord-266455-rbblg4pu	25	6	is	be	VBZ
cord-266455-rbblg4pu	25	7	a	a	DT
cord-266455-rbblg4pu	25	8	specific	specific	JJ
cord-266455-rbblg4pu	25	9	recommendation	recommendation	NN
cord-266455-rbblg4pu	25	10	that	that	WDT
cord-266455-rbblg4pu	25	11	all	all	DT
cord-266455-rbblg4pu	25	12	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	25	13	prescriptions	prescription	NNS
cord-266455-rbblg4pu	25	14	should	should	MD
cord-266455-rbblg4pu	25	15	be	be	VB
cord-266455-rbblg4pu	25	16	supported	support	VBN
cord-266455-rbblg4pu	25	17	by	by	IN
cord-266455-rbblg4pu	25	18	diagnostic	diagnostic	JJ
cord-266455-rbblg4pu	25	19	tests	test	NNS
cord-266455-rbblg4pu	25	20	where	where	WRB
cord-266455-rbblg4pu	25	21	available	available	JJ
cord-266455-rbblg4pu	25	22	by	by	IN
cord-266455-rbblg4pu	25	23	2020	2020	CD
cord-266455-rbblg4pu	25	24	10	10	CD
cord-266455-rbblg4pu	25	25	.	.	.
cord-266455-rbblg4pu	26	1	The	the	DT
cord-266455-rbblg4pu	26	2	UK	UK	NNP
cord-266455-rbblg4pu	26	3	government	government	NN
cord-266455-rbblg4pu	26	4	recently	recently	RB
cord-266455-rbblg4pu	26	5	published	publish	VBD
cord-266455-rbblg4pu	26	6	a	a	DT
cord-266455-rbblg4pu	26	7	five	five	CD
cord-266455-rbblg4pu	26	8	-	-	HYPH
cord-266455-rbblg4pu	26	9	year	year	NN
cord-266455-rbblg4pu	26	10	action	action	NN
cord-266455-rbblg4pu	26	11	plan	plan	NN
cord-266455-rbblg4pu	26	12	for	for	IN
cord-266455-rbblg4pu	26	13	tackling	tackle	VBG
cord-266455-rbblg4pu	26	14	AMR	AMR	NNP
cord-266455-rbblg4pu	26	15	,	,	,
cord-266455-rbblg4pu	26	16	which	which	WDT
cord-266455-rbblg4pu	26	17	emphasised	emphasise	VBD
cord-266455-rbblg4pu	26	18	the	the	DT
cord-266455-rbblg4pu	26	19	need	need	NN
cord-266455-rbblg4pu	26	20	for	for	IN
cord-266455-rbblg4pu	26	21	improved	improved	JJ
cord-266455-rbblg4pu	26	22	diagnostics	diagnostic	NNS
cord-266455-rbblg4pu	26	23	to	to	TO
cord-266455-rbblg4pu	26	24	support	support	VB
cord-266455-rbblg4pu	26	25	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	26	26	prescribing	prescribing	NN
cord-266455-rbblg4pu	26	27	.	.	.
cord-266455-rbblg4pu	27	1	This	this	DT
cord-266455-rbblg4pu	27	2	included	include	VBD
cord-266455-rbblg4pu	27	3	a	a	DT
cord-266455-rbblg4pu	27	4	target	target	NN
cord-266455-rbblg4pu	27	5	to	to	TO
cord-266455-rbblg4pu	27	6	be	be	VB
cord-266455-rbblg4pu	27	7	able	able	JJ
cord-266455-rbblg4pu	27	8	to	to	TO
cord-266455-rbblg4pu	27	9	report	report	VB
cord-266455-rbblg4pu	27	10	the	the	DT
cord-266455-rbblg4pu	27	11	percentage	percentage	NN
cord-266455-rbblg4pu	27	12	of	of	IN
cord-266455-rbblg4pu	27	13	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	27	14	prescriptions	prescription	NNS
cord-266455-rbblg4pu	27	15	which	which	WDT
cord-266455-rbblg4pu	27	16	are	be	VBP
cord-266455-rbblg4pu	27	17	supported	support	VBN
cord-266455-rbblg4pu	27	18	by	by	IN
cord-266455-rbblg4pu	27	19	a	a	DT
cord-266455-rbblg4pu	27	20	diagnostic	diagnostic	JJ
cord-266455-rbblg4pu	27	21	test	test	NN
cord-266455-rbblg4pu	27	22	or	or	CC
cord-266455-rbblg4pu	27	23	decision	decision	NN
cord-266455-rbblg4pu	27	24	making	make	VBG
cord-266455-rbblg4pu	27	25	tool	tool	NN
cord-266455-rbblg4pu	27	26	by	by	IN
cord-266455-rbblg4pu	27	27	2024	2024	CD
cord-266455-rbblg4pu	27	28	11	11	CD
cord-266455-rbblg4pu	27	29	.	.	.
cord-266455-rbblg4pu	28	1	Timely	Timely	NNP
cord-266455-rbblg4pu	28	2	administration	administration	NN
cord-266455-rbblg4pu	28	3	of	of	IN
cord-266455-rbblg4pu	28	4	appropriate	appropriate	JJ
cord-266455-rbblg4pu	28	5	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	28	6	is	be	VBZ
cord-266455-rbblg4pu	28	7	a	a	DT
cord-266455-rbblg4pu	28	8	central	central	JJ
cord-266455-rbblg4pu	28	9	tenant	tenant	NN
cord-266455-rbblg4pu	28	10	of	of	IN
cord-266455-rbblg4pu	28	11	care	care	NN
cord-266455-rbblg4pu	28	12	for	for	IN
cord-266455-rbblg4pu	28	13	patients	patient	NNS
cord-266455-rbblg4pu	28	14	with	with	IN
cord-266455-rbblg4pu	28	15	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	28	16	12	12	CD
cord-266455-rbblg4pu	28	17	,	,	,
cord-266455-rbblg4pu	28	18	13	13	CD
cord-266455-rbblg4pu	28	19	and	and	CC
cord-266455-rbblg4pu	29	1	yet	yet	RB
cord-266455-rbblg4pu	29	2	the	the	DT
cord-266455-rbblg4pu	29	3	goldstandard	goldstandard	NN
cord-266455-rbblg4pu	29	4	for	for	IN
cord-266455-rbblg4pu	29	5	microbiological	microbiological	JJ
cord-266455-rbblg4pu	29	6	diagnosis	diagnosis	NN
cord-266455-rbblg4pu	29	7	remains	remain	VBZ
cord-266455-rbblg4pu	29	8	traditional	traditional	JJ
cord-266455-rbblg4pu	29	9	,	,	,
cord-266455-rbblg4pu	29	10	slow	slow	JJ
cord-266455-rbblg4pu	29	11	,	,	,
cord-266455-rbblg4pu	29	12	culture	culture	NN
cord-266455-rbblg4pu	29	13	based	base	VBN
cord-266455-rbblg4pu	29	14	methods	method	NNS
cord-266455-rbblg4pu	29	15	.	.	.
cord-266455-rbblg4pu	30	1	These	these	DT
cord-266455-rbblg4pu	30	2	take	take	VBP
cord-266455-rbblg4pu	30	3	greater	great	JJR
cord-266455-rbblg4pu	30	4	than	than	IN
cord-266455-rbblg4pu	30	5	24	24	CD
cord-266455-rbblg4pu	30	6	h	h	NN
cord-266455-rbblg4pu	30	7	to	to	TO
cord-266455-rbblg4pu	30	8	identify	identify	VB
cord-266455-rbblg4pu	30	9	an	an	DT
cord-266455-rbblg4pu	30	10	organism	organism	NN
cord-266455-rbblg4pu	30	11	and	and	CC
cord-266455-rbblg4pu	30	12	often	often	RB
cord-266455-rbblg4pu	30	13	greater	great	JJR
cord-266455-rbblg4pu	30	14	than	than	IN
cord-266455-rbblg4pu	30	15	72	72	CD
cord-266455-rbblg4pu	30	16	h	h	NN
cord-266455-rbblg4pu	30	17	to	to	TO
cord-266455-rbblg4pu	30	18	provide	provide	VB
cord-266455-rbblg4pu	30	19	phenotypic	phenotypic	JJ
cord-266455-rbblg4pu	30	20	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	30	21	sensitivity	sensitivity	NN
cord-266455-rbblg4pu	30	22	data	datum	NNS
cord-266455-rbblg4pu	30	23	.	.	.
cord-266455-rbblg4pu	31	1	Culture	culture	NN
cord-266455-rbblg4pu	31	2	is	be	VBZ
cord-266455-rbblg4pu	31	3	insensitive	insensitive	JJ
cord-266455-rbblg4pu	31	4	,	,	,
cord-266455-rbblg4pu	31	5	only	only	RB
cord-266455-rbblg4pu	31	6	detecting	detect	VBG
cord-266455-rbblg4pu	31	7	a	a	DT
cord-266455-rbblg4pu	31	8	pathogen	pathogen	NN
cord-266455-rbblg4pu	31	9	in	in	IN
cord-266455-rbblg4pu	31	10	23	23	CD
cord-266455-rbblg4pu	31	11	-	-	SYM
cord-266455-rbblg4pu	31	12	40	40	CD
cord-266455-rbblg4pu	31	13	%	%	NN
cord-266455-rbblg4pu	31	14	of	of	IN
cord-266455-rbblg4pu	31	15	patients	patient	NNS
cord-266455-rbblg4pu	31	16	with	with	IN
cord-266455-rbblg4pu	31	17	clinically	clinically	RB
cord-266455-rbblg4pu	31	18	diagnosed	diagnosed	JJ
cord-266455-rbblg4pu	31	19	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	31	20	4	4	CD
cord-266455-rbblg4pu	31	21	,	,	,
cord-266455-rbblg4pu	31	22	14	14	CD
cord-266455-rbblg4pu	31	23	-	-	SYM
cord-266455-rbblg4pu	31	24	16	16	CD
cord-266455-rbblg4pu	31	25	and	and	CC
cord-266455-rbblg4pu	31	26	an	an	DT
cord-266455-rbblg4pu	31	27	even	even	RB
cord-266455-rbblg4pu	31	28	smaller	small	JJR
cord-266455-rbblg4pu	31	29	proportion	proportion	NN
cord-266455-rbblg4pu	31	30	after	after	IN
cord-266455-rbblg4pu	31	31	the	the	DT
cord-266455-rbblg4pu	31	32	administration	administration	NN
cord-266455-rbblg4pu	31	33	of	of	IN
cord-266455-rbblg4pu	31	34	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	31	35	.	.	.
cord-266455-rbblg4pu	32	1	In	in	IN
cord-266455-rbblg4pu	32	2	recent	recent	JJ
cord-266455-rbblg4pu	32	3	years	year	NNS
cord-266455-rbblg4pu	32	4	several	several	JJ
cord-266455-rbblg4pu	32	5	rapid	rapid	JJ
cord-266455-rbblg4pu	32	6	syndromic	syndromic	JJ
cord-266455-rbblg4pu	32	7	molecular	molecular	JJ
cord-266455-rbblg4pu	32	8	tests	test	NNS
cord-266455-rbblg4pu	32	9	for	for	IN
cord-266455-rbblg4pu	32	10	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	32	11	have	have	VBP
cord-266455-rbblg4pu	32	12	been	be	VBN
cord-266455-rbblg4pu	32	13	developed	develop	VBN
cord-266455-rbblg4pu	32	14	.	.	.
cord-266455-rbblg4pu	33	1	These	these	DT
cord-266455-rbblg4pu	33	2	offer	offer	VBP
cord-266455-rbblg4pu	33	3	the	the	DT
cord-266455-rbblg4pu	33	4	potential	potential	NN
cord-266455-rbblg4pu	33	5	to	to	TO
cord-266455-rbblg4pu	33	6	revolutionise	revolutionise	VB
cord-266455-rbblg4pu	33	7	treatment	treatment	NN
cord-266455-rbblg4pu	33	8	by	by	IN
cord-266455-rbblg4pu	33	9	providing	provide	VBG
cord-266455-rbblg4pu	33	10	information	information	NN
cord-266455-rbblg4pu	33	11	to	to	IN
cord-266455-rbblg4pu	33	12	clinicians	clinician	NNS
cord-266455-rbblg4pu	33	13	in	in	IN
cord-266455-rbblg4pu	33	14	'	'	``
cord-266455-rbblg4pu	33	15	real	real	JJ
cord-266455-rbblg4pu	33	16	-	-	HYPH
cord-266455-rbblg4pu	33	17	time	time	NN
cord-266455-rbblg4pu	33	18	'	'	''
cord-266455-rbblg4pu	33	19	on	on	IN
cord-266455-rbblg4pu	33	20	the	the	DT
cord-266455-rbblg4pu	33	21	pathogens	pathogen	NNS
cord-266455-rbblg4pu	33	22	present	present	JJ
cord-266455-rbblg4pu	33	23	and	and	CC
cord-266455-rbblg4pu	33	24	their	-PRON-	PRP$
cord-266455-rbblg4pu	33	25	likely	likely	JJ
cord-266455-rbblg4pu	33	26	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	33	27	sensitivity	sensitivity	NN
cord-266455-rbblg4pu	33	28	by	by	IN
cord-266455-rbblg4pu	33	29	also	also	RB
cord-266455-rbblg4pu	33	30	detecting	detect	VBG
cord-266455-rbblg4pu	33	31	genotypic	genotypic	JJ
cord-266455-rbblg4pu	33	32	markers	marker	NNS
cord-266455-rbblg4pu	33	33	of	of	IN
cord-266455-rbblg4pu	33	34	resistance	resistance	NN
cord-266455-rbblg4pu	33	35	.	.	.
cord-266455-rbblg4pu	34	1	Multiple	multiple	JJ
cord-266455-rbblg4pu	34	2	studies	study	NNS
cord-266455-rbblg4pu	34	3	have	have	VBP
cord-266455-rbblg4pu	34	4	demonstrated	demonstrate	VBN
cord-266455-rbblg4pu	34	5	the	the	DT
cord-266455-rbblg4pu	34	6	superior	superior	JJ
cord-266455-rbblg4pu	34	7	diagnostic	diagnostic	JJ
cord-266455-rbblg4pu	34	8	accuracy	accuracy	NN
cord-266455-rbblg4pu	34	9	of	of	IN
cord-266455-rbblg4pu	34	10	PCR	PCR	NNP
cord-266455-rbblg4pu	34	11	based	base	VBN
cord-266455-rbblg4pu	34	12	platforms	platform	NNS
cord-266455-rbblg4pu	34	13	for	for	IN
cord-266455-rbblg4pu	34	14	detecting	detect	VBG
cord-266455-rbblg4pu	34	15	bacterial	bacterial	JJ
cord-266455-rbblg4pu	34	16	pathogens	pathogen	NNS
cord-266455-rbblg4pu	34	17	in	in	IN
cord-266455-rbblg4pu	34	18	the	the	DT
cord-266455-rbblg4pu	34	19	sputum	sputum	NN
cord-266455-rbblg4pu	34	20	compared	compare	VBN
cord-266455-rbblg4pu	34	21	with	with	IN
cord-266455-rbblg4pu	34	22	standard	standard	JJ
cord-266455-rbblg4pu	34	23	culture	culture	NN
cord-266455-rbblg4pu	34	24	[	[	-LRB-
cord-266455-rbblg4pu	34	25	16	16	CD
cord-266455-rbblg4pu	34	26	]	]	-RRB-
cord-266455-rbblg4pu	34	27	[	[	-LRB-
cord-266455-rbblg4pu	34	28	17	17	CD
cord-266455-rbblg4pu	34	29	]	]	-RRB-
cord-266455-rbblg4pu	34	30	[	[	-LRB-
cord-266455-rbblg4pu	34	31	18	18	CD
cord-266455-rbblg4pu	34	32	]	]	-RRB-
cord-266455-rbblg4pu	34	33	[	[	-LRB-
cord-266455-rbblg4pu	34	34	19	19	CD
cord-266455-rbblg4pu	34	35	]	]	-RRB-
cord-266455-rbblg4pu	34	36	.	.	.
cord-266455-rbblg4pu	35	1	This	this	DT
cord-266455-rbblg4pu	35	2	review	review	NN
cord-266455-rbblg4pu	35	3	will	will	MD
cord-266455-rbblg4pu	35	4	discuss	discuss	VB
cord-266455-rbblg4pu	35	5	the	the	DT
cord-266455-rbblg4pu	35	6	commercially	commercially	RB
cord-266455-rbblg4pu	35	7	available	available	JJ
cord-266455-rbblg4pu	35	8	syndromic	syndromic	JJ
cord-266455-rbblg4pu	35	9	molecular	molecular	JJ
cord-266455-rbblg4pu	35	10	panels	panel	NNS
cord-266455-rbblg4pu	35	11	for	for	IN
cord-266455-rbblg4pu	35	12	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	35	13	,	,	,
cord-266455-rbblg4pu	35	14	their	-PRON-	PRP$
cord-266455-rbblg4pu	35	15	potential	potential	JJ
cord-266455-rbblg4pu	35	16	clinical	clinical	JJ
cord-266455-rbblg4pu	35	17	impact	impact	NN
cord-266455-rbblg4pu	35	18	and	and	CC
cord-266455-rbblg4pu	35	19	the	the	DT
cord-266455-rbblg4pu	35	20	challenges	challenge	NNS
cord-266455-rbblg4pu	35	21	to	to	IN
cord-266455-rbblg4pu	35	22	implementing	implement	VBG
cord-266455-rbblg4pu	35	23	them	-PRON-	PRP
cord-266455-rbblg4pu	35	24	as	as	IN
cord-266455-rbblg4pu	35	25	a	a	DT
cord-266455-rbblg4pu	35	26	'	'	``
cord-266455-rbblg4pu	35	27	front	front	JJ
cord-266455-rbblg4pu	35	28	line	line	NN
cord-266455-rbblg4pu	35	29	'	'	''
cord-266455-rbblg4pu	35	30	diagnostic	diagnostic	JJ
cord-266455-rbblg4pu	35	31	test	test	NN
cord-266455-rbblg4pu	35	32	.	.	.
cord-266455-rbblg4pu	36	1	The	the	DT
cord-266455-rbblg4pu	36	2	greatest	great	JJS
cord-266455-rbblg4pu	36	3	potential	potential	JJ
cord-266455-rbblg4pu	36	4	clinical	clinical	JJ
cord-266455-rbblg4pu	36	5	benefit	benefit	NN
cord-266455-rbblg4pu	36	6	of	of	IN
cord-266455-rbblg4pu	36	7	a	a	DT
cord-266455-rbblg4pu	36	8	rapid	rapid	JJ
cord-266455-rbblg4pu	36	9	syndromic	syndromic	JJ
cord-266455-rbblg4pu	36	10	test	test	NN
cord-266455-rbblg4pu	36	11	for	for	IN
cord-266455-rbblg4pu	36	12	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	36	13	is	be	VBZ
cord-266455-rbblg4pu	36	14	being	be	VBG
cord-266455-rbblg4pu	36	15	able	able	JJ
cord-266455-rbblg4pu	36	16	to	to	TO
cord-266455-rbblg4pu	36	17	better	better	RB
cord-266455-rbblg4pu	36	18	utilise	utilise	VB
cord-266455-rbblg4pu	36	19	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	36	20	.	.	.
cord-266455-rbblg4pu	37	1	The	the	DT
cord-266455-rbblg4pu	37	2	superior	superior	JJ
cord-266455-rbblg4pu	37	3	diagnostic	diagnostic	JJ
cord-266455-rbblg4pu	37	4	yield	yield	NN
cord-266455-rbblg4pu	37	5	of	of	IN
cord-266455-rbblg4pu	37	6	multiplex	multiplex	NN
cord-266455-rbblg4pu	37	7	PCR	PCR	NNP
cord-266455-rbblg4pu	37	8	means	mean	VBZ
cord-266455-rbblg4pu	37	9	that	that	IN
cord-266455-rbblg4pu	37	10	a	a	DT
cord-266455-rbblg4pu	37	11	pathogen	pathogen	NN
cord-266455-rbblg4pu	37	12	is	be	VBZ
cord-266455-rbblg4pu	37	13	detected	detect	VBN
cord-266455-rbblg4pu	37	14	rapidly	rapidly	RB
cord-266455-rbblg4pu	37	15	in	in	IN
cord-266455-rbblg4pu	37	16	a	a	DT
cord-266455-rbblg4pu	37	17	much	much	RB
cord-266455-rbblg4pu	37	18	greater	great	JJR
cord-266455-rbblg4pu	37	19	proportion	proportion	NN
cord-266455-rbblg4pu	37	20	of	of	IN
cord-266455-rbblg4pu	37	21	patients	patient	NNS
cord-266455-rbblg4pu	37	22	,	,	,
cord-266455-rbblg4pu	37	23	so	so	IN
cord-266455-rbblg4pu	37	24	therapy	therapy	NN
cord-266455-rbblg4pu	37	25	can	can	MD
cord-266455-rbblg4pu	37	26	be	be	VB
cord-266455-rbblg4pu	37	27	quickly	quickly	RB
cord-266455-rbblg4pu	37	28	tailored	tailor	VBN
cord-266455-rbblg4pu	37	29	to	to	IN
cord-266455-rbblg4pu	37	30	the	the	DT
cord-266455-rbblg4pu	37	31	responsible	responsible	JJ
cord-266455-rbblg4pu	37	32	organism	organism	NN
cord-266455-rbblg4pu	37	33	.	.	.
cord-266455-rbblg4pu	38	1	In	in	IN
cord-266455-rbblg4pu	38	2	some	some	DT
cord-266455-rbblg4pu	38	3	situations	situation	NNS
cord-266455-rbblg4pu	38	4	,	,	,
cord-266455-rbblg4pu	38	5	this	this	DT
cord-266455-rbblg4pu	38	6	will	will	MD
cord-266455-rbblg4pu	38	7	allow	allow	VB
cord-266455-rbblg4pu	38	8	narrowing	narrowing	NN
cord-266455-rbblg4pu	38	9	of	of	IN
cord-266455-rbblg4pu	38	10	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	38	11	therapy	therapy	NN
cord-266455-rbblg4pu	38	12	:	:	:
cord-266455-rbblg4pu	38	13	for	for	IN
cord-266455-rbblg4pu	38	14	example	example	NN
cord-266455-rbblg4pu	38	15	,	,	,
cord-266455-rbblg4pu	38	16	identification	identification	NN
cord-266455-rbblg4pu	38	17	of	of	IN
cord-266455-rbblg4pu	38	18	Streptococcus	streptococcus	NN
cord-266455-rbblg4pu	38	19	pneumoniae	pneumoniae	NN
cord-266455-rbblg4pu	38	20	facilitating	facilitate	VBG
cord-266455-rbblg4pu	38	21	a	a	DT
cord-266455-rbblg4pu	38	22	change	change	NN
cord-266455-rbblg4pu	38	23	of	of	IN
cord-266455-rbblg4pu	38	24	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	38	25	to	to	IN
cord-266455-rbblg4pu	38	26	penicillin	penicillin	NN
cord-266455-rbblg4pu	38	27	,	,	,
cord-266455-rbblg4pu	38	28	in	in	IN
cord-266455-rbblg4pu	38	29	geographical	geographical	JJ
cord-266455-rbblg4pu	38	30	areas	area	NNS
cord-266455-rbblg4pu	38	31	with	with	IN
cord-266455-rbblg4pu	38	32	a	a	DT
cord-266455-rbblg4pu	38	33	low	low	JJ
cord-266455-rbblg4pu	38	34	prevalence	prevalence	NN
cord-266455-rbblg4pu	38	35	of	of	IN
cord-266455-rbblg4pu	38	36	penicillin	penicillin	NN
cord-266455-rbblg4pu	38	37	resistant	resistant	JJ
cord-266455-rbblg4pu	38	38	S.	S.	NNP
cord-266455-rbblg4pu	38	39	pneumoniae	pneumoniae	NN
cord-266455-rbblg4pu	38	40	.	.	.
cord-266455-rbblg4pu	39	1	In	in	IN
cord-266455-rbblg4pu	39	2	other	other	JJ
cord-266455-rbblg4pu	39	3	cases	case	NNS
cord-266455-rbblg4pu	39	4	,	,	,
cord-266455-rbblg4pu	39	5	it	-PRON-	PRP
cord-266455-rbblg4pu	39	6	may	may	MD
cord-266455-rbblg4pu	39	7	facilitate	facilitate	VB
cord-266455-rbblg4pu	39	8	a	a	DT
cord-266455-rbblg4pu	39	9	change	change	NN
cord-266455-rbblg4pu	39	10	or	or	CC
cord-266455-rbblg4pu	39	11	escalation	escalation	NN
cord-266455-rbblg4pu	39	12	of	of	IN
cord-266455-rbblg4pu	39	13	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	39	14	therapy	therapy	NN
cord-266455-rbblg4pu	39	15	:	:	:
cord-266455-rbblg4pu	39	16	for	for	IN
cord-266455-rbblg4pu	39	17	example	example	NN
cord-266455-rbblg4pu	39	18	,	,	,
cord-266455-rbblg4pu	39	19	the	the	DT
cord-266455-rbblg4pu	39	20	identification	identification	NN
cord-266455-rbblg4pu	39	21	of	of	IN
cord-266455-rbblg4pu	39	22	methicillin	methicillin	NN
cord-266455-rbblg4pu	39	23	resistant	resistant	JJ
cord-266455-rbblg4pu	39	24	Staphylococcus	Staphylococcus	NNP
cord-266455-rbblg4pu	39	25	aureus	aureus	NN
cord-266455-rbblg4pu	39	26	(	(	-LRB-
cord-266455-rbblg4pu	39	27	MRSA	MRSA	NNP
cord-266455-rbblg4pu	39	28	)	)	-RRB-
cord-266455-rbblg4pu	39	29	which	which	WDT
cord-266455-rbblg4pu	39	30	would	would	MD
cord-266455-rbblg4pu	39	31	not	not	RB
cord-266455-rbblg4pu	39	32	be	be	VB
cord-266455-rbblg4pu	39	33	covered	cover	VBN
cord-266455-rbblg4pu	39	34	by	by	IN
cord-266455-rbblg4pu	39	35	empirical	empirical	JJ
cord-266455-rbblg4pu	39	36	regimens	regimen	NNS
cord-266455-rbblg4pu	39	37	in	in	IN
cord-266455-rbblg4pu	39	38	many	many	JJ
cord-266455-rbblg4pu	39	39	areas	area	NNS
cord-266455-rbblg4pu	39	40	.	.	.
cord-266455-rbblg4pu	40	1	The	the	DT
cord-266455-rbblg4pu	40	2	absence	absence	NN
cord-266455-rbblg4pu	40	3	of	of	IN
cord-266455-rbblg4pu	40	4	detection	detection	NN
cord-266455-rbblg4pu	40	5	is	be	VBZ
cord-266455-rbblg4pu	40	6	also	also	RB
cord-266455-rbblg4pu	40	7	helpful	helpful	JJ
cord-266455-rbblg4pu	40	8	:	:	:
cord-266455-rbblg4pu	40	9	the	the	DT
cord-266455-rbblg4pu	40	10	sensitivity	sensitivity	NN
cord-266455-rbblg4pu	40	11	when	when	WRB
cord-266455-rbblg4pu	40	12	compared	compare	VBN
cord-266455-rbblg4pu	40	13	to	to	IN
cord-266455-rbblg4pu	40	14	culture	culture	NN
cord-266455-rbblg4pu	40	15	of	of	IN
cord-266455-rbblg4pu	40	16	molecular	molecular	JJ
cord-266455-rbblg4pu	40	17	assays	assay	NNS
cord-266455-rbblg4pu	40	18	is	be	VBZ
cord-266455-rbblg4pu	40	19	very	very	RB
cord-266455-rbblg4pu	40	20	high	high	JJ
cord-266455-rbblg4pu	40	21	so	so	RB
cord-266455-rbblg4pu	40	22	can	can	MD
cord-266455-rbblg4pu	40	23	reassure	reassure	VB
cord-266455-rbblg4pu	40	24	clinicians	clinician	NNS
cord-266455-rbblg4pu	40	25	that	that	IN
cord-266455-rbblg4pu	40	26	organisms	organism	NNS
cord-266455-rbblg4pu	40	27	are	be	VBP
cord-266455-rbblg4pu	40	28	not	not	RB
cord-266455-rbblg4pu	40	29	present	present	JJ
cord-266455-rbblg4pu	40	30	and	and	CC
cord-266455-rbblg4pu	40	31	so	so	RB
cord-266455-rbblg4pu	40	32	support	support	VB
cord-266455-rbblg4pu	40	33	decisions	decision	NNS
cord-266455-rbblg4pu	40	34	to	to	TO
cord-266455-rbblg4pu	40	35	stop	stop	VB
cord-266455-rbblg4pu	40	36	unnecessary	unnecessary	JJ
cord-266455-rbblg4pu	40	37	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	40	38	or	or	CC
cord-266455-rbblg4pu	40	39	to	to	TO
cord-266455-rbblg4pu	40	40	deescalate	deescalate	VB
cord-266455-rbblg4pu	40	41	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	40	42	that	that	WDT
cord-266455-rbblg4pu	40	43	were	be	VBD
cord-266455-rbblg4pu	40	44	used	use	VBN
cord-266455-rbblg4pu	40	45	empirically	empirically	RB
cord-266455-rbblg4pu	40	46	to	to	TO
cord-266455-rbblg4pu	40	47	cover	cover	VB
cord-266455-rbblg4pu	40	48	organisms	organism	NNS
cord-266455-rbblg4pu	40	49	subsequently	subsequently	RB
cord-266455-rbblg4pu	40	50	not	not	RB
cord-266455-rbblg4pu	40	51	detected	detect	VBN
cord-266455-rbblg4pu	40	52	.	.	.
cord-266455-rbblg4pu	41	1	The	the	DT
cord-266455-rbblg4pu	41	2	impact	impact	NN
cord-266455-rbblg4pu	41	3	of	of	IN
cord-266455-rbblg4pu	41	4	this	this	DT
cord-266455-rbblg4pu	41	5	improved	improve	VBN
cord-266455-rbblg4pu	41	6	use	use	NN
cord-266455-rbblg4pu	41	7	of	of	IN
cord-266455-rbblg4pu	41	8	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	41	9	are	be	VBP
cord-266455-rbblg4pu	41	10	twofold	twofold	JJ
cord-266455-rbblg4pu	41	11	:	:	:
cord-266455-rbblg4pu	41	12	firstly	firstly	RB
cord-266455-rbblg4pu	41	13	,	,	,
cord-266455-rbblg4pu	41	14	earlier	early	RBR
cord-266455-rbblg4pu	41	15	appropriate	appropriate	JJ
cord-266455-rbblg4pu	41	16	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	41	17	should	should	MD
cord-266455-rbblg4pu	41	18	improve	improve	VB
cord-266455-rbblg4pu	41	19	clinical	clinical	JJ
cord-266455-rbblg4pu	41	20	outcomes	outcome	NNS
cord-266455-rbblg4pu	41	21	including	include	VBG
cord-266455-rbblg4pu	41	22	mortality	mortality	NN
cord-266455-rbblg4pu	41	23	and	and	CC
cord-266455-rbblg4pu	41	24	length	length	NN
cord-266455-rbblg4pu	41	25	of	of	IN
cord-266455-rbblg4pu	41	26	stay	stay	NN
cord-266455-rbblg4pu	41	27	.	.	.
cord-266455-rbblg4pu	42	1	Secondly	secondly	RB
cord-266455-rbblg4pu	42	2	,	,	,
cord-266455-rbblg4pu	42	3	it	-PRON-	PRP
cord-266455-rbblg4pu	42	4	prevents	prevent	VBZ
cord-266455-rbblg4pu	42	5	unnecessary	unnecessary	JJ
cord-266455-rbblg4pu	42	6	broad	broad	JJ
cord-266455-rbblg4pu	42	7	-	-	HYPH
cord-266455-rbblg4pu	42	8	spectrum	spectrum	NN
cord-266455-rbblg4pu	42	9	antibiotic	antibiotic	NN
cord-266455-rbblg4pu	42	10	use	use	NN
cord-266455-rbblg4pu	42	11	,	,	,
cord-266455-rbblg4pu	42	12	which	which	WDT
cord-266455-rbblg4pu	42	13	facilitates	facilitate	VBZ
cord-266455-rbblg4pu	42	14	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	42	15	stewardship	stewardship	NN
cord-266455-rbblg4pu	42	16	and	and	CC
cord-266455-rbblg4pu	42	17	reduces	reduce	VBZ
cord-266455-rbblg4pu	42	18	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	42	19	related	related	JJ
cord-266455-rbblg4pu	42	20	adverse	adverse	JJ
cord-266455-rbblg4pu	42	21	events	event	NNS
cord-266455-rbblg4pu	42	22	.	.	.
cord-266455-rbblg4pu	43	1	The	the	DT
cord-266455-rbblg4pu	43	2	aetiology	aetiology	NN
cord-266455-rbblg4pu	43	3	of	of	IN
cord-266455-rbblg4pu	43	4	CAP	cap	NN
cord-266455-rbblg4pu	43	5	and	and	CC
cord-266455-rbblg4pu	43	6	HAP	HAP	NNP
cord-266455-rbblg4pu	43	7	/	/	SYM
cord-266455-rbblg4pu	43	8	VAP	VAP	NNP
cord-266455-rbblg4pu	43	9	are	be	VBP
cord-266455-rbblg4pu	43	10	highly	highly	RB
cord-266455-rbblg4pu	43	11	variable	variable	JJ
cord-266455-rbblg4pu	43	12	between	between	IN
cord-266455-rbblg4pu	43	13	different	different	JJ
cord-266455-rbblg4pu	43	14	regions	region	NNS
cord-266455-rbblg4pu	43	15	and	and	CC
cord-266455-rbblg4pu	43	16	times	time	NNS
cord-266455-rbblg4pu	43	17	,	,	,
cord-266455-rbblg4pu	43	18	and	and	CC
cord-266455-rbblg4pu	43	19	this	this	DT
cord-266455-rbblg4pu	43	20	is	be	VBZ
cord-266455-rbblg4pu	43	21	reflected	reflect	VBN
cord-266455-rbblg4pu	43	22	in	in	IN
cord-266455-rbblg4pu	43	23	studies	study	NNS
cord-266455-rbblg4pu	43	24	of	of	IN
cord-266455-rbblg4pu	43	25	causative	causative	JJ
cord-266455-rbblg4pu	43	26	microbial	microbial	JJ
cord-266455-rbblg4pu	43	27	agents	agent	NNS
cord-266455-rbblg4pu	43	28	as	as	IN
cord-266455-rbblg4pu	43	29	identified	identify	VBN
cord-266455-rbblg4pu	43	30	by	by	IN
cord-266455-rbblg4pu	43	31	culture	culture	NN
cord-266455-rbblg4pu	43	32	.	.	.
cord-266455-rbblg4pu	44	1	Patients	patient	NNS
cord-266455-rbblg4pu	44	2	with	with	IN
cord-266455-rbblg4pu	44	3	underlying	underlie	VBG
cord-266455-rbblg4pu	44	4	lung	lung	NN
cord-266455-rbblg4pu	44	5	diseases	disease	NNS
cord-266455-rbblg4pu	44	6	,	,	,
cord-266455-rbblg4pu	44	7	for	for	IN
cord-266455-rbblg4pu	44	8	example	example	NN
cord-266455-rbblg4pu	44	9	chronic	chronic	JJ
cord-266455-rbblg4pu	44	10	obstructive	obstructive	JJ
cord-266455-rbblg4pu	44	11	pulmonary	pulmonary	JJ
cord-266455-rbblg4pu	44	12	disease	disease	NN
cord-266455-rbblg4pu	44	13	,	,	,
cord-266455-rbblg4pu	44	14	can	can	MD
cord-266455-rbblg4pu	44	15	be	be	VB
cord-266455-rbblg4pu	44	16	colonised	colonise	VBN
cord-266455-rbblg4pu	44	17	with	with	IN
cord-266455-rbblg4pu	44	18	microbial	microbial	JJ
cord-266455-rbblg4pu	44	19	flora	flora	NNS
cord-266455-rbblg4pu	44	20	which	which	WDT
cord-266455-rbblg4pu	44	21	are	be	VBP
cord-266455-rbblg4pu	44	22	more	more	RBR
cord-266455-rbblg4pu	44	23	typical	typical	JJ
cord-266455-rbblg4pu	44	24	pathogens	pathogen	NNS
cord-266455-rbblg4pu	44	25	of	of	IN
cord-266455-rbblg4pu	44	26	HAP	HAP	NNP
cord-266455-rbblg4pu	44	27	.	.	.
cord-266455-rbblg4pu	45	1	As	as	IN
cord-266455-rbblg4pu	45	2	a	a	DT
cord-266455-rbblg4pu	45	3	result	result	NN
cord-266455-rbblg4pu	45	4	,	,	,
cord-266455-rbblg4pu	45	5	they	-PRON-	PRP
cord-266455-rbblg4pu	45	6	may	may	MD
cord-266455-rbblg4pu	45	7	develop	develop	VB
cord-266455-rbblg4pu	45	8	community	community	NN
cord-266455-rbblg4pu	45	9	acquired	acquire	VBN
cord-266455-rbblg4pu	45	10	infections	infection	NNS
cord-266455-rbblg4pu	45	11	caused	cause	VBN
cord-266455-rbblg4pu	45	12	by	by	IN
cord-266455-rbblg4pu	45	13	these	these	DT
cord-266455-rbblg4pu	45	14	agents	agent	NNS
cord-266455-rbblg4pu	45	15	.	.	.
cord-266455-rbblg4pu	46	1	S.	S.	NNP
cord-266455-rbblg4pu	46	2	pneumoniae	pneumoniae	NN
cord-266455-rbblg4pu	46	3	,	,	,
cord-266455-rbblg4pu	46	4	Haemophilius	Haemophilius	NNP
cord-266455-rbblg4pu	46	5	influenzae	influenzae	NN
cord-266455-rbblg4pu	46	6	,	,	,
cord-266455-rbblg4pu	46	7	S.	S.	NNP
cord-266455-rbblg4pu	46	8	aureus	aureus	NN
cord-266455-rbblg4pu	46	9	,	,	,
cord-266455-rbblg4pu	46	10	Moraxella	Moraxella	NNP
cord-266455-rbblg4pu	46	11	catarrhalis	catarrhalis	NNP
cord-266455-rbblg4pu	46	12	and	and	CC
cord-266455-rbblg4pu	46	13	'	'	``
cord-266455-rbblg4pu	46	14	atypical	atypical	JJ
cord-266455-rbblg4pu	46	15	'	'	''
cord-266455-rbblg4pu	46	16	organisms	organism	NNS
cord-266455-rbblg4pu	46	17	including	include	VBG
cord-266455-rbblg4pu	46	18	Mycoplasma	mycoplasma	NN
cord-266455-rbblg4pu	46	19	pneumoniae	pneumoniae	NNS
cord-266455-rbblg4pu	46	20	and	and	CC
cord-266455-rbblg4pu	46	21	Legionella	Legionella	NNP
cord-266455-rbblg4pu	46	22	pneumophila	pneumophila	NN
cord-266455-rbblg4pu	46	23	are	be	VBP
cord-266455-rbblg4pu	46	24	all	all	DT
cord-266455-rbblg4pu	46	25	cultured	culture	VBN
cord-266455-rbblg4pu	46	26	from	from	IN
cord-266455-rbblg4pu	46	27	the	the	DT
cord-266455-rbblg4pu	46	28	sputum	sputum	NN
cord-266455-rbblg4pu	46	29	of	of	IN
cord-266455-rbblg4pu	46	30	patients	patient	NNS
cord-266455-rbblg4pu	46	31	with	with	IN
cord-266455-rbblg4pu	46	32	CAP	CAP	NNP
cord-266455-rbblg4pu	46	33	.	.	.
cord-266455-rbblg4pu	47	1	Many	many	JJ
cord-266455-rbblg4pu	47	2	of	of	IN
cord-266455-rbblg4pu	47	3	these	these	DT
cord-266455-rbblg4pu	47	4	organisms	organism	NNS
cord-266455-rbblg4pu	47	5	have	have	VBP
cord-266455-rbblg4pu	47	6	predictable	predictable	JJ
cord-266455-rbblg4pu	47	7	resistance	resistance	NN
cord-266455-rbblg4pu	47	8	patterns	pattern	NNS
cord-266455-rbblg4pu	47	9	when	when	WRB
cord-266455-rbblg4pu	47	10	interpreted	interpret	VBN
cord-266455-rbblg4pu	47	11	with	with	IN
cord-266455-rbblg4pu	47	12	local	local	JJ
cord-266455-rbblg4pu	47	13	epidemiological	epidemiological	JJ
cord-266455-rbblg4pu	47	14	data	datum	NNS
cord-266455-rbblg4pu	47	15	.	.	.
cord-266455-rbblg4pu	48	1	Gadsby	Gadsby	NNP
cord-266455-rbblg4pu	48	2	et	et	FW
cord-266455-rbblg4pu	48	3	al	al	NNP
cord-266455-rbblg4pu	48	4	.	.	NNP
cord-266455-rbblg4pu	48	5	developed	develop	VBD
cord-266455-rbblg4pu	48	6	and	and	CC
cord-266455-rbblg4pu	48	7	internally	internally	RB
cord-266455-rbblg4pu	48	8	validated	validate	VBD
cord-266455-rbblg4pu	48	9	their	-PRON-	PRP$
cord-266455-rbblg4pu	48	10	own	own	JJ
cord-266455-rbblg4pu	48	11	syndromic	syndromic	JJ
cord-266455-rbblg4pu	48	12	molecular	molecular	JJ
cord-266455-rbblg4pu	48	13	assay	assay	NN
cord-266455-rbblg4pu	48	14	for	for	IN
cord-266455-rbblg4pu	48	15	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	48	16	.	.	.
cord-266455-rbblg4pu	49	1	They	-PRON-	PRP
cord-266455-rbblg4pu	49	2	used	use	VBD
cord-266455-rbblg4pu	49	3	this	this	DT
cord-266455-rbblg4pu	49	4	to	to	TO
cord-266455-rbblg4pu	49	5	test	test	VB
cord-266455-rbblg4pu	49	6	sputum	sputum	NN
cord-266455-rbblg4pu	49	7	samples	sample	NNS
cord-266455-rbblg4pu	49	8	of	of	IN
cord-266455-rbblg4pu	49	9	323	323	CD
cord-266455-rbblg4pu	49	10	adults	adult	NNS
cord-266455-rbblg4pu	49	11	admitted	admit	VBN
cord-266455-rbblg4pu	49	12	to	to	IN
cord-266455-rbblg4pu	49	13	hospital	hospital	NN
cord-266455-rbblg4pu	49	14	with	with	IN
cord-266455-rbblg4pu	49	15	CAP	CAP	NNP
cord-266455-rbblg4pu	49	16	16	16	CD
cord-266455-rbblg4pu	49	17	.	.	.
cord-266455-rbblg4pu	50	1	Their	-PRON-	PRP$
cord-266455-rbblg4pu	50	2	assay	assay	NN
cord-266455-rbblg4pu	50	3	detected	detect	VBD
cord-266455-rbblg4pu	50	4	a	a	DT
cord-266455-rbblg4pu	50	5	pathogen	pathogen	NN
cord-266455-rbblg4pu	50	6	in	in	IN
cord-266455-rbblg4pu	50	7	87	87	CD
cord-266455-rbblg4pu	50	8	%	%	NN
cord-266455-rbblg4pu	50	9	of	of	IN
cord-266455-rbblg4pu	50	10	patients	patient	NNS
cord-266455-rbblg4pu	50	11	(	(	-LRB-
cord-266455-rbblg4pu	50	12	as	as	IN
cord-266455-rbblg4pu	50	13	opposed	oppose	VBN
cord-266455-rbblg4pu	50	14	to	to	IN
cord-266455-rbblg4pu	50	15	39	39	CD
cord-266455-rbblg4pu	50	16	%	%	NN
cord-266455-rbblg4pu	50	17	of	of	IN
cord-266455-rbblg4pu	50	18	patients	patient	NNS
cord-266455-rbblg4pu	50	19	using	use	VBG
cord-266455-rbblg4pu	50	20	only	only	RB
cord-266455-rbblg4pu	50	21	routine	routine	JJ
cord-266455-rbblg4pu	50	22	culture	culture	NN
cord-266455-rbblg4pu	50	23	)	)	-RRB-
cord-266455-rbblg4pu	50	24	.	.	.
cord-266455-rbblg4pu	51	1	As	as	IN
cord-266455-rbblg4pu	51	2	a	a	DT
cord-266455-rbblg4pu	51	3	result	result	NN
cord-266455-rbblg4pu	51	4	,	,	,
cord-266455-rbblg4pu	51	5	they	-PRON-	PRP
cord-266455-rbblg4pu	51	6	proposed	propose	VBD
cord-266455-rbblg4pu	51	7	that	that	IN
cord-266455-rbblg4pu	51	8	77	77	CD
cord-266455-rbblg4pu	51	9	%	%	NN
cord-266455-rbblg4pu	51	10	of	of	IN
cord-266455-rbblg4pu	51	11	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	51	12	prescriptions	prescription	NNS
cord-266455-rbblg4pu	51	13	in	in	IN
cord-266455-rbblg4pu	51	14	CAP	cap	NN
cord-266455-rbblg4pu	51	15	could	could	MD
cord-266455-rbblg4pu	51	16	have	have	VB
cord-266455-rbblg4pu	51	17	been	be	VBN
cord-266455-rbblg4pu	51	18	deescalated	deescalate	VBN
cord-266455-rbblg4pu	51	19	based	base	VBN
cord-266455-rbblg4pu	51	20	on	on	IN
cord-266455-rbblg4pu	51	21	results	result	NNS
cord-266455-rbblg4pu	51	22	from	from	IN
cord-266455-rbblg4pu	51	23	multiplex	multiplex	NN
cord-266455-rbblg4pu	51	24	PCR	PCR	NNP
cord-266455-rbblg4pu	51	25	testing	testing	NN
cord-266455-rbblg4pu	51	26	.	.	.
cord-266455-rbblg4pu	52	1	The	the	DT
cord-266455-rbblg4pu	52	2	majority	majority	NN
cord-266455-rbblg4pu	52	3	of	of	IN
cord-266455-rbblg4pu	52	4	these	these	DT
cord-266455-rbblg4pu	52	5	potential	potential	JJ
cord-266455-rbblg4pu	52	6	interventions	intervention	NNS
cord-266455-rbblg4pu	52	7	involved	involve	VBN
cord-266455-rbblg4pu	52	8	stopping	stop	VBG
cord-266455-rbblg4pu	52	9	clarithromycin	clarithromycin	NNS
cord-266455-rbblg4pu	52	10	when	when	WRB
cord-266455-rbblg4pu	52	11	atypical	atypical	JJ
cord-266455-rbblg4pu	52	12	organisms	organism	NNS
cord-266455-rbblg4pu	52	13	were	be	VBD
cord-266455-rbblg4pu	52	14	not	not	RB
cord-266455-rbblg4pu	52	15	detected	detect	VBN
cord-266455-rbblg4pu	52	16	or	or	CC
cord-266455-rbblg4pu	52	17	'	'	``
cord-266455-rbblg4pu	52	18	narrowing	narrow	VBG
cord-266455-rbblg4pu	52	19	'	'	''
cord-266455-rbblg4pu	52	20	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	52	21	when	when	WRB
cord-266455-rbblg4pu	52	22	a	a	DT
cord-266455-rbblg4pu	52	23	likely	likely	JJ
cord-266455-rbblg4pu	52	24	sensitive	sensitive	JJ
cord-266455-rbblg4pu	52	25	pathogen	pathogen	NN
cord-266455-rbblg4pu	52	26	had	have	VBD
cord-266455-rbblg4pu	52	27	been	be	VBN
cord-266455-rbblg4pu	52	28	detected	detect	VBN
cord-266455-rbblg4pu	52	29	.	.	.
cord-266455-rbblg4pu	53	1	In	in	IN
cord-266455-rbblg4pu	53	2	HAP	HAP	NNP
cord-266455-rbblg4pu	53	3	and	and	CC
cord-266455-rbblg4pu	53	4	VAP	VAP	NNP
cord-266455-rbblg4pu	53	5	,	,	,
cord-266455-rbblg4pu	53	6	frequently	frequently	RB
cord-266455-rbblg4pu	53	7	cultured	cultured	JJ
cord-266455-rbblg4pu	53	8	bacterial	bacterial	JJ
cord-266455-rbblg4pu	53	9	pathogens	pathogen	NNS
cord-266455-rbblg4pu	53	10	include	include	VBP
cord-266455-rbblg4pu	53	11	S.	S.	NNP
cord-266455-rbblg4pu	53	12	aureus	aureus	NN
cord-266455-rbblg4pu	53	13	,	,	,
cord-266455-rbblg4pu	53	14	Pseudomonas	Pseudomonas	NNP
cord-266455-rbblg4pu	53	15	aeruginosa	aeruginosa	NN
cord-266455-rbblg4pu	53	16	,	,	,
cord-266455-rbblg4pu	53	17	Klebsiella	Klebsiella	NNP
cord-266455-rbblg4pu	53	18	species	specie	NNS
cord-266455-rbblg4pu	53	19	,	,	,
cord-266455-rbblg4pu	53	20	Escherichia	escherichia	NN
cord-266455-rbblg4pu	53	21	coli	coli	NNS
cord-266455-rbblg4pu	53	22	,	,	,
cord-266455-rbblg4pu	53	23	Acinetobacter	Acinetobacter	NNP
cord-266455-rbblg4pu	53	24	species	specie	NNS
cord-266455-rbblg4pu	53	25	and	and	CC
cord-266455-rbblg4pu	53	26	Enterobacter	Enterobacter	NNP
cord-266455-rbblg4pu	53	27	species	specie	VBZ
cord-266455-rbblg4pu	53	28	20	20	CD
cord-266455-rbblg4pu	53	29	.	.	.
cord-266455-rbblg4pu	54	1	Empirical	empirical	JJ
cord-266455-rbblg4pu	54	2	regimens	regimen	NNS
cord-266455-rbblg4pu	54	3	are	be	VBP
cord-266455-rbblg4pu	54	4	therefore	therefore	RB
cord-266455-rbblg4pu	54	5	broad	broad	JJ
cord-266455-rbblg4pu	54	6	spectrum	spectrum	NN
cord-266455-rbblg4pu	54	7	and	and	CC
cord-266455-rbblg4pu	54	8	large	large	JJ
cord-266455-rbblg4pu	54	9	numbers	number	NNS
cord-266455-rbblg4pu	54	10	of	of	IN
cord-266455-rbblg4pu	54	11	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	54	12	are	be	VBP
cord-266455-rbblg4pu	54	13	consumed	consume	VBN
cord-266455-rbblg4pu	54	14	.	.	.
cord-266455-rbblg4pu	55	1	The	the	DT
cord-266455-rbblg4pu	55	2	absence	absence	NN
cord-266455-rbblg4pu	55	3	of	of	IN
cord-266455-rbblg4pu	55	4	certain	certain	JJ
cord-266455-rbblg4pu	55	5	organisms	organism	NNS
cord-266455-rbblg4pu	55	6	(	(	-LRB-
cord-266455-rbblg4pu	55	7	for	for	IN
cord-266455-rbblg4pu	55	8	example	example	NN
cord-266455-rbblg4pu	55	9	P.	P.	NNP
cord-266455-rbblg4pu	55	10	aeruginosa	aeruginosa	NNP
cord-266455-rbblg4pu	55	11	)	)	-RRB-
cord-266455-rbblg4pu	55	12	could	could	MD
cord-266455-rbblg4pu	55	13	facilitate	facilitate	VB
cord-266455-rbblg4pu	55	14	a	a	DT
cord-266455-rbblg4pu	55	15	narrowing	narrowing	NN
cord-266455-rbblg4pu	55	16	of	of	IN
cord-266455-rbblg4pu	55	17	the	the	DT
cord-266455-rbblg4pu	55	18	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	55	19	spectrum	spectrum	NN
cord-266455-rbblg4pu	55	20	with	with	IN
cord-266455-rbblg4pu	55	21	a	a	DT
cord-266455-rbblg4pu	55	22	knock	knock	VB
cord-266455-rbblg4pu	55	23	-	-	HYPH
cord-266455-rbblg4pu	55	24	on	on	RP
cord-266455-rbblg4pu	55	25	effect	effect	NN
cord-266455-rbblg4pu	55	26	of	of	IN
cord-266455-rbblg4pu	55	27	reducing	reduce	VBG
cord-266455-rbblg4pu	55	28	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	55	29	related	related	JJ
cord-266455-rbblg4pu	55	30	adverse	adverse	JJ
cord-266455-rbblg4pu	55	31	effects	effect	NNS
cord-266455-rbblg4pu	55	32	and	and	CC
cord-266455-rbblg4pu	55	33	improving	improve	VBG
cord-266455-rbblg4pu	55	34	stewardship	stewardship	NN
cord-266455-rbblg4pu	55	35	.	.	.
cord-266455-rbblg4pu	56	1	Furthermore	furthermore	RB
cord-266455-rbblg4pu	56	2	,	,	,
cord-266455-rbblg4pu	56	3	common	common	JJ
cord-266455-rbblg4pu	56	4	Gram	Gram	NNP
cord-266455-rbblg4pu	56	5	negative	negative	JJ
cord-266455-rbblg4pu	56	6	isolates	isolate	NNS
cord-266455-rbblg4pu	56	7	are	be	VBP
cord-266455-rbblg4pu	56	8	increasingly	increasingly	RB
cord-266455-rbblg4pu	56	9	resistant	resistant	JJ
cord-266455-rbblg4pu	56	10	in	in	IN
cord-266455-rbblg4pu	56	11	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	56	12	surveillance	surveillance	NN
cord-266455-rbblg4pu	56	13	studies	study	NNS
cord-266455-rbblg4pu	56	14	21	21	CD
cord-266455-rbblg4pu	56	15	.	.	.
cord-266455-rbblg4pu	57	1	Rapid	rapid	JJ
cord-266455-rbblg4pu	57	2	molecular	molecular	JJ
cord-266455-rbblg4pu	57	3	detection	detection	NN
cord-266455-rbblg4pu	57	4	of	of	IN
cord-266455-rbblg4pu	57	5	these	these	DT
cord-266455-rbblg4pu	57	6	resistance	resistance	NN
cord-266455-rbblg4pu	57	7	genes	gene	NNS
cord-266455-rbblg4pu	57	8	should	should	MD
cord-266455-rbblg4pu	57	9	facilitate	facilitate	VB
cord-266455-rbblg4pu	57	10	earlier	early	JJR
cord-266455-rbblg4pu	57	11	initiation	initiation	NN
cord-266455-rbblg4pu	57	12	of	of	IN
cord-266455-rbblg4pu	57	13	effective	effective	JJ
cord-266455-rbblg4pu	57	14	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	57	15	and	and	CC
cord-266455-rbblg4pu	57	16	this	this	DT
cord-266455-rbblg4pu	57	17	should	should	MD
cord-266455-rbblg4pu	57	18	lead	lead	VB
cord-266455-rbblg4pu	57	19	to	to	IN
cord-266455-rbblg4pu	57	20	better	well	JJR
cord-266455-rbblg4pu	57	21	outcomes	outcome	NNS
cord-266455-rbblg4pu	57	22	.	.	.
cord-266455-rbblg4pu	58	1	In	in	IN
cord-266455-rbblg4pu	58	2	adults	adult	NNS
cord-266455-rbblg4pu	58	3	,	,	,
cord-266455-rbblg4pu	58	4	respiratory	respiratory	JJ
cord-266455-rbblg4pu	58	5	viruses	virus	NNS
cord-266455-rbblg4pu	58	6	are	be	VBP
cord-266455-rbblg4pu	58	7	found	find	VBN
cord-266455-rbblg4pu	58	8	in	in	IN
cord-266455-rbblg4pu	58	9	approximately	approximately	RB
cord-266455-rbblg4pu	58	10	one	one	CD
cord-266455-rbblg4pu	58	11	third	third	NN
cord-266455-rbblg4pu	58	12	of	of	IN
cord-266455-rbblg4pu	58	13	community	community	NN
cord-266455-rbblg4pu	58	14	acquired	acquire	VBD
cord-266455-rbblg4pu	58	15	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	58	16	cases	case	NNS
cord-266455-rbblg4pu	58	17	4	4	CD
cord-266455-rbblg4pu	58	18	,	,	,
cord-266455-rbblg4pu	58	19	22	22	CD
cord-266455-rbblg4pu	58	20	.	.	.
cord-266455-rbblg4pu	59	1	One	one	CD
cord-266455-rbblg4pu	59	2	study	study	NN
cord-266455-rbblg4pu	59	3	found	find	VBD
cord-266455-rbblg4pu	59	4	that	that	IN
cord-266455-rbblg4pu	59	5	36	36	CD
cord-266455-rbblg4pu	59	6	%	%	NN
cord-266455-rbblg4pu	59	7	of	of	IN
cord-266455-rbblg4pu	59	8	patients	patient	NNS
cord-266455-rbblg4pu	59	9	admitted	admit	VBN
cord-266455-rbblg4pu	59	10	to	to	IN
cord-266455-rbblg4pu	59	11	intensive	intensive	JJ
cord-266455-rbblg4pu	59	12	care	care	NN
cord-266455-rbblg4pu	59	13	with	with	IN
cord-266455-rbblg4pu	59	14	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	59	15	were	be	VBD
cord-266455-rbblg4pu	59	16	positive	positive	JJ
cord-266455-rbblg4pu	59	17	for	for	IN
cord-266455-rbblg4pu	59	18	a	a	DT
cord-266455-rbblg4pu	59	19	respiratory	respiratory	JJ
cord-266455-rbblg4pu	59	20	virus	virus	NN
cord-266455-rbblg4pu	59	21	,	,	,
cord-266455-rbblg4pu	59	22	with	with	IN
cord-266455-rbblg4pu	59	23	a	a	DT
cord-266455-rbblg4pu	59	24	broad	broad	JJ
cord-266455-rbblg4pu	59	25	range	range	NN
cord-266455-rbblg4pu	59	26	of	of	IN
cord-266455-rbblg4pu	59	27	viruses	virus	NNS
cord-266455-rbblg4pu	59	28	detected	detect	VBD
cord-266455-rbblg4pu	59	29	23	23	CD
cord-266455-rbblg4pu	59	30	.	.	.
cord-266455-rbblg4pu	60	1	Detection	detection	NN
cord-266455-rbblg4pu	60	2	of	of	IN
cord-266455-rbblg4pu	60	3	certain	certain	JJ
cord-266455-rbblg4pu	60	4	viruses	virus	NNS
cord-266455-rbblg4pu	60	5	such	such	JJ
cord-266455-rbblg4pu	60	6	as	as	IN
cord-266455-rbblg4pu	60	7	influenza	influenza	NN
cord-266455-rbblg4pu	60	8	and	and	CC
cord-266455-rbblg4pu	60	9	adenovirus	adenovirus	NN
cord-266455-rbblg4pu	60	10	which	which	WDT
cord-266455-rbblg4pu	60	11	are	be	VBP
cord-266455-rbblg4pu	60	12	known	know	VBN
cord-266455-rbblg4pu	60	13	to	to	TO
cord-266455-rbblg4pu	60	14	cause	cause	VB
cord-266455-rbblg4pu	60	15	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	60	16	,	,	,
cord-266455-rbblg4pu	60	17	coupled	couple	VBN
cord-266455-rbblg4pu	60	18	with	with	IN
cord-266455-rbblg4pu	60	19	the	the	DT
cord-266455-rbblg4pu	60	20	absence	absence	NN
cord-266455-rbblg4pu	60	21	of	of	IN
cord-266455-rbblg4pu	60	22	detection	detection	NN
cord-266455-rbblg4pu	60	23	of	of	IN
cord-266455-rbblg4pu	60	24	bacteria	bacteria	NNS
cord-266455-rbblg4pu	60	25	and	and	CC
cord-266455-rbblg4pu	60	26	low	low	JJ
cord-266455-rbblg4pu	60	27	levels	level	NNS
cord-266455-rbblg4pu	60	28	of	of	IN
cord-266455-rbblg4pu	60	29	serum	serum	NN
cord-266455-rbblg4pu	60	30	biomarkers	biomarker	NNS
cord-266455-rbblg4pu	60	31	such	such	JJ
cord-266455-rbblg4pu	60	32	as	as	IN
cord-266455-rbblg4pu	60	33	procalcitonin	procalcitonin	NNP
cord-266455-rbblg4pu	60	34	(	(	-LRB-
cord-266455-rbblg4pu	60	35	which	which	WDT
cord-266455-rbblg4pu	60	36	is	be	VBZ
cord-266455-rbblg4pu	60	37	elevated	elevate	VBN
cord-266455-rbblg4pu	60	38	in	in	IN
cord-266455-rbblg4pu	60	39	patients	patient	NNS
cord-266455-rbblg4pu	60	40	with	with	IN
cord-266455-rbblg4pu	60	41	bacterial	bacterial	JJ
cord-266455-rbblg4pu	60	42	infection	infection	NN
cord-266455-rbblg4pu	60	43	)	)	-RRB-
cord-266455-rbblg4pu	60	44	,	,	,
cord-266455-rbblg4pu	60	45	could	could	MD
cord-266455-rbblg4pu	60	46	support	support	VB
cord-266455-rbblg4pu	60	47	decisions	decision	NNS
cord-266455-rbblg4pu	60	48	to	to	TO
cord-266455-rbblg4pu	60	49	stop	stop	VB
cord-266455-rbblg4pu	60	50	or	or	CC
cord-266455-rbblg4pu	60	51	use	use	VB
cord-266455-rbblg4pu	60	52	an	an	DT
cord-266455-rbblg4pu	60	53	abbreviated	abbreviated	JJ
cord-266455-rbblg4pu	60	54	course	course	NN
cord-266455-rbblg4pu	60	55	of	of	IN
cord-266455-rbblg4pu	60	56	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	60	57	.	.	.
cord-266455-rbblg4pu	61	1	The	the	DT
cord-266455-rbblg4pu	61	2	ResPOC	respoc	JJ
cord-266455-rbblg4pu	61	3	trial	trial	NN
cord-266455-rbblg4pu	61	4	was	be	VBD
cord-266455-rbblg4pu	61	5	a	a	DT
cord-266455-rbblg4pu	61	6	pragmatic	pragmatic	JJ
cord-266455-rbblg4pu	61	7	randomised	randomised	JJ
cord-266455-rbblg4pu	61	8	controlled	control	VBN
cord-266455-rbblg4pu	61	9	trial	trial	NN
cord-266455-rbblg4pu	61	10	that	that	WDT
cord-266455-rbblg4pu	61	11	tested	test	VBD
cord-266455-rbblg4pu	61	12	patients	patient	NNS
cord-266455-rbblg4pu	61	13	with	with	IN
cord-266455-rbblg4pu	61	14	community	community	NN
cord-266455-rbblg4pu	61	15	acquired	acquire	VBD
cord-266455-rbblg4pu	61	16	acute	acute	JJ
cord-266455-rbblg4pu	61	17	respiratory	respiratory	JJ
cord-266455-rbblg4pu	61	18	illness	illness	NN
cord-266455-rbblg4pu	61	19	using	use	VBG
cord-266455-rbblg4pu	61	20	the	the	DT
cord-266455-rbblg4pu	61	21	BioFire	BioFire	NNP
cord-266455-rbblg4pu	61	22	Respiratory	Respiratory	NNP
cord-266455-rbblg4pu	61	23	Panel	Panel	NNP
cord-266455-rbblg4pu	61	24	(	(	-LRB-
cord-266455-rbblg4pu	61	25	which	which	WDT
cord-266455-rbblg4pu	61	26	tests	test	VBZ
cord-266455-rbblg4pu	61	27	comprehensively	comprehensively	RB
cord-266455-rbblg4pu	61	28	for	for	IN
cord-266455-rbblg4pu	61	29	respiratory	respiratory	JJ
cord-266455-rbblg4pu	61	30	viruses	virus	NNS
cord-266455-rbblg4pu	61	31	and	and	CC
cord-266455-rbblg4pu	61	32	atypical	atypical	JJ
cord-266455-rbblg4pu	61	33	bacteria	bacteria	NNS
cord-266455-rbblg4pu	61	34	)	)	-RRB-
cord-266455-rbblg4pu	61	35	at	at	IN
cord-266455-rbblg4pu	61	36	the	the	DT
cord-266455-rbblg4pu	61	37	point	point	NN
cord-266455-rbblg4pu	61	38	-	-	HYPH
cord-266455-rbblg4pu	61	39	of	of	IN
cord-266455-rbblg4pu	61	40	-	-	HYPH
cord-266455-rbblg4pu	61	41	care	care	NN
cord-266455-rbblg4pu	61	42	.	.	.
cord-266455-rbblg4pu	62	1	It	-PRON-	PRP
cord-266455-rbblg4pu	62	2	found	find	VBD
cord-266455-rbblg4pu	62	3	that	that	IN
cord-266455-rbblg4pu	62	4	patients	patient	NNS
cord-266455-rbblg4pu	62	5	who	who	WP
cord-266455-rbblg4pu	62	6	were	be	VBD
cord-266455-rbblg4pu	62	7	tested	test	VBN
cord-266455-rbblg4pu	62	8	with	with	IN
cord-266455-rbblg4pu	62	9	the	the	DT
cord-266455-rbblg4pu	62	10	FilmArray	FilmArray	NNP
cord-266455-rbblg4pu	62	11	were	be	VBD
cord-266455-rbblg4pu	62	12	significantly	significantly	RB
cord-266455-rbblg4pu	62	13	more	more	RBR
cord-266455-rbblg4pu	62	14	likely	likely	JJ
cord-266455-rbblg4pu	62	15	to	to	TO
cord-266455-rbblg4pu	62	16	receive	receive	VB
cord-266455-rbblg4pu	62	17	a	a	DT
cord-266455-rbblg4pu	62	18	single	single	JJ
cord-266455-rbblg4pu	62	19	dose	dose	NN
cord-266455-rbblg4pu	62	20	or	or	CC
cord-266455-rbblg4pu	62	21	shorter	short	JJR
cord-266455-rbblg4pu	62	22	course	course	NN
cord-266455-rbblg4pu	62	23	of	of	IN
cord-266455-rbblg4pu	62	24	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	62	25	24	24	CD
cord-266455-rbblg4pu	62	26	than	than	IN
cord-266455-rbblg4pu	62	27	those	those	DT
cord-266455-rbblg4pu	62	28	who	who	WP
cord-266455-rbblg4pu	62	29	were	be	VBD
cord-266455-rbblg4pu	62	30	not	not	RB
cord-266455-rbblg4pu	62	31	.	.	.
cord-266455-rbblg4pu	63	1	It	-PRON-	PRP
cord-266455-rbblg4pu	63	2	also	also	RB
cord-266455-rbblg4pu	63	3	found	find	VBD
cord-266455-rbblg4pu	63	4	a	a	DT
cord-266455-rbblg4pu	63	5	significant	significant	JJ
cord-266455-rbblg4pu	63	6	reduction	reduction	NN
cord-266455-rbblg4pu	63	7	in	in	IN
cord-266455-rbblg4pu	63	8	length	length	NN
cord-266455-rbblg4pu	63	9	of	of	IN
cord-266455-rbblg4pu	63	10	hospital	hospital	NN
cord-266455-rbblg4pu	63	11	stay	stay	NN
cord-266455-rbblg4pu	63	12	in	in	IN
cord-266455-rbblg4pu	63	13	the	the	DT
cord-266455-rbblg4pu	63	14	intervention	intervention	NN
cord-266455-rbblg4pu	63	15	group	group	NN
cord-266455-rbblg4pu	63	16	along	along	IN
cord-266455-rbblg4pu	63	17	with	with	IN
cord-266455-rbblg4pu	63	18	improved	improved	JJ
cord-266455-rbblg4pu	63	19	use	use	NN
cord-266455-rbblg4pu	63	20	of	of	IN
cord-266455-rbblg4pu	63	21	neuraminidase	neuraminidase	NN
cord-266455-rbblg4pu	63	22	inhibitors	inhibitor	NNS
cord-266455-rbblg4pu	63	23	(	(	-LRB-
cord-266455-rbblg4pu	63	24	NAI	NAI	NNP
cord-266455-rbblg4pu	63	25	)	)	-RRB-
cord-266455-rbblg4pu	63	26	in	in	IN
cord-266455-rbblg4pu	63	27	patients	patient	NNS
cord-266455-rbblg4pu	63	28	with	with	IN
cord-266455-rbblg4pu	63	29	influenza	influenza	NN
cord-266455-rbblg4pu	63	30	.	.	.
cord-266455-rbblg4pu	64	1	Currently	currently	RB
cord-266455-rbblg4pu	64	2	there	there	EX
cord-266455-rbblg4pu	64	3	are	be	VBP
cord-266455-rbblg4pu	64	4	no	no	DT
cord-266455-rbblg4pu	64	5	licenced	licenced	JJ
cord-266455-rbblg4pu	64	6	antiviral	antiviral	JJ
cord-266455-rbblg4pu	64	7	agents	agent	NNS
cord-266455-rbblg4pu	64	8	for	for	IN
cord-266455-rbblg4pu	64	9	respiratory	respiratory	JJ
cord-266455-rbblg4pu	64	10	viruses	virus	NNS
cord-266455-rbblg4pu	64	11	other	other	JJ
cord-266455-rbblg4pu	64	12	than	than	IN
cord-266455-rbblg4pu	64	13	influenza	influenza	NN
cord-266455-rbblg4pu	64	14	.	.	.
cord-266455-rbblg4pu	65	1	The	the	DT
cord-266455-rbblg4pu	65	2	benefit	benefit	NN
cord-266455-rbblg4pu	65	3	from	from	IN
cord-266455-rbblg4pu	65	4	NAI	NAI	NNP
cord-266455-rbblg4pu	65	5	treatment	treatment	NN
cord-266455-rbblg4pu	65	6	is	be	VBZ
cord-266455-rbblg4pu	65	7	greatest	great	JJS
cord-266455-rbblg4pu	65	8	when	when	WRB
cord-266455-rbblg4pu	65	9	they	-PRON-	PRP
cord-266455-rbblg4pu	65	10	are	be	VBP
cord-266455-rbblg4pu	65	11	started	start	VBN
cord-266455-rbblg4pu	65	12	within	within	IN
cord-266455-rbblg4pu	65	13	48	48	CD
cord-266455-rbblg4pu	65	14	h	h	NN
cord-266455-rbblg4pu	65	15	of	of	IN
cord-266455-rbblg4pu	65	16	symptom	symptom	NN
cord-266455-rbblg4pu	65	17	onset	onset	NN
cord-266455-rbblg4pu	66	1	but	but	CC
cord-266455-rbblg4pu	66	2	there	there	EX
cord-266455-rbblg4pu	66	3	is	be	VBZ
cord-266455-rbblg4pu	66	4	evidence	evidence	NN
cord-266455-rbblg4pu	66	5	in	in	IN
cord-266455-rbblg4pu	66	6	adults	adult	NNS
cord-266455-rbblg4pu	66	7	to	to	TO
cord-266455-rbblg4pu	66	8	suggest	suggest	VB
cord-266455-rbblg4pu	66	9	ongoing	ongoing	JJ
cord-266455-rbblg4pu	66	10	benefit	benefit	NN
cord-266455-rbblg4pu	66	11	when	when	WRB
cord-266455-rbblg4pu	66	12	started	start	VBD
cord-266455-rbblg4pu	66	13	beyond	beyond	IN
cord-266455-rbblg4pu	66	14	this	this	DT
cord-266455-rbblg4pu	66	15	time	time	NN
cord-266455-rbblg4pu	66	16	25	25	CD
cord-266455-rbblg4pu	66	17	and	and	CC
cord-266455-rbblg4pu	66	18	a	a	DT
cord-266455-rbblg4pu	66	19	recent	recent	JJ
cord-266455-rbblg4pu	66	20	study	study	NN
cord-266455-rbblg4pu	66	21	suggests	suggest	VBZ
cord-266455-rbblg4pu	66	22	that	that	IN
cord-266455-rbblg4pu	66	23	treatment	treatment	NN
cord-266455-rbblg4pu	66	24	earlier	early	RBR
cord-266455-rbblg4pu	66	25	in	in	IN
cord-266455-rbblg4pu	66	26	admission	admission	NN
cord-266455-rbblg4pu	66	27	to	to	IN
cord-266455-rbblg4pu	66	28	hospital	hospital	NN
cord-266455-rbblg4pu	66	29	improves	improve	VBZ
cord-266455-rbblg4pu	66	30	outcome	outcome	NN
cord-266455-rbblg4pu	66	31	irrespective	irrespective	RB
cord-266455-rbblg4pu	66	32	of	of	IN
cord-266455-rbblg4pu	66	33	overall	overall	JJ
cord-266455-rbblg4pu	66	34	duration	duration	NN
cord-266455-rbblg4pu	66	35	of	of	IN
cord-266455-rbblg4pu	66	36	illness	illness	NN
cord-266455-rbblg4pu	66	37	26	26	CD
cord-266455-rbblg4pu	66	38	.	.	.
cord-266455-rbblg4pu	67	1	As	as	IN
cord-266455-rbblg4pu	67	2	such	such	JJ
cord-266455-rbblg4pu	67	3	,	,	,
cord-266455-rbblg4pu	67	4	timely	timely	JJ
cord-266455-rbblg4pu	67	5	identification	identification	NN
cord-266455-rbblg4pu	67	6	and	and	CC
cord-266455-rbblg4pu	67	7	treatment	treatment	NN
cord-266455-rbblg4pu	67	8	is	be	VBZ
cord-266455-rbblg4pu	67	9	critical	critical	JJ
cord-266455-rbblg4pu	67	10	.	.	.
cord-266455-rbblg4pu	68	1	Antiviral	antiviral	JJ
cord-266455-rbblg4pu	68	2	treatments	treatment	NNS
cord-266455-rbblg4pu	68	3	for	for	IN
cord-266455-rbblg4pu	68	4	other	other	JJ
cord-266455-rbblg4pu	68	5	respiratory	respiratory	JJ
cord-266455-rbblg4pu	68	6	viruses	virus	NNS
cord-266455-rbblg4pu	68	7	,	,	,
cord-266455-rbblg4pu	68	8	including	include	VBG
cord-266455-rbblg4pu	68	9	respiratory	respiratory	JJ
cord-266455-rbblg4pu	68	10	syncytial	syncytial	JJ
cord-266455-rbblg4pu	68	11	virus	virus	NN
cord-266455-rbblg4pu	68	12	(	(	-LRB-
cord-266455-rbblg4pu	68	13	RSV	RSV	NNP
cord-266455-rbblg4pu	68	14	)	)	-RRB-
cord-266455-rbblg4pu	68	15	are	be	VBP
cord-266455-rbblg4pu	68	16	in	in	IN
cord-266455-rbblg4pu	68	17	development	development	NN
cord-266455-rbblg4pu	68	18	.	.	.
cord-266455-rbblg4pu	69	1	Since	since	IN
cord-266455-rbblg4pu	69	2	the	the	DT
cord-266455-rbblg4pu	69	3	1990s	1990	NNS
cord-266455-rbblg4pu	69	4	infection	infection	NN
cord-266455-rbblg4pu	69	5	control	control	NN
cord-266455-rbblg4pu	69	6	methods	method	NNS
cord-266455-rbblg4pu	69	7	including	include	VBG
cord-266455-rbblg4pu	69	8	patient	patient	JJ
cord-266455-rbblg4pu	69	9	source	source	NN
cord-266455-rbblg4pu	69	10	isolation	isolation	NN
cord-266455-rbblg4pu	69	11	and	and	CC
cord-266455-rbblg4pu	69	12	deep	deep	JJ
cord-266455-rbblg4pu	69	13	cleaning	cleaning	NN
cord-266455-rbblg4pu	69	14	with	with	IN
cord-266455-rbblg4pu	69	15	targeted	target	VBN
cord-266455-rbblg4pu	69	16	decolonisation	decolonisation	NN
cord-266455-rbblg4pu	69	17	have	have	VBP
cord-266455-rbblg4pu	69	18	been	be	VBN
cord-266455-rbblg4pu	69	19	highly	highly	RB
cord-266455-rbblg4pu	69	20	successful	successful	JJ
cord-266455-rbblg4pu	69	21	at	at	IN
cord-266455-rbblg4pu	69	22	reducing	reduce	VBG
cord-266455-rbblg4pu	69	23	the	the	DT
cord-266455-rbblg4pu	69	24	spread	spread	NN
cord-266455-rbblg4pu	69	25	of	of	IN
cord-266455-rbblg4pu	69	26	MRSA	MRSA	NNP
cord-266455-rbblg4pu	69	27	.	.	.
cord-266455-rbblg4pu	70	1	Enhanced	enhanced	JJ
cord-266455-rbblg4pu	70	2	infection	infection	NN
cord-266455-rbblg4pu	70	3	control	control	NN
cord-266455-rbblg4pu	70	4	practices	practice	NNS
cord-266455-rbblg4pu	70	5	are	be	VBP
cord-266455-rbblg4pu	70	6	recommended	recommend	VBN
cord-266455-rbblg4pu	70	7	for	for	IN
cord-266455-rbblg4pu	70	8	a	a	DT
cord-266455-rbblg4pu	70	9	number	number	NN
cord-266455-rbblg4pu	70	10	of	of	IN
cord-266455-rbblg4pu	70	11	pathogens	pathogen	NNS
cord-266455-rbblg4pu	70	12	that	that	WDT
cord-266455-rbblg4pu	70	13	may	may	MD
cord-266455-rbblg4pu	70	14	be	be	VB
cord-266455-rbblg4pu	70	15	present	present	JJ
cord-266455-rbblg4pu	70	16	in	in	IN
cord-266455-rbblg4pu	70	17	patients	patient	NNS
cord-266455-rbblg4pu	70	18	with	with	IN
cord-266455-rbblg4pu	70	19	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	70	20	.	.	.
cord-266455-rbblg4pu	71	1	Early	early	JJ
cord-266455-rbblg4pu	71	2	identification	identification	NN
cord-266455-rbblg4pu	71	3	of	of	IN
cord-266455-rbblg4pu	71	4	these	these	DT
cord-266455-rbblg4pu	71	5	should	should	MD
cord-266455-rbblg4pu	71	6	reduce	reduce	VB
cord-266455-rbblg4pu	71	7	the	the	DT
cord-266455-rbblg4pu	71	8	spread	spread	NN
cord-266455-rbblg4pu	71	9	of	of	IN
cord-266455-rbblg4pu	71	10	these	these	DT
cord-266455-rbblg4pu	71	11	organisms	organism	NNS
cord-266455-rbblg4pu	71	12	,	,	,
cord-266455-rbblg4pu	71	13	especially	especially	RB
cord-266455-rbblg4pu	71	14	in	in	IN
cord-266455-rbblg4pu	71	15	hospitalised	hospitalise	VBN
cord-266455-rbblg4pu	71	16	patients	patient	NNS
cord-266455-rbblg4pu	71	17	.	.	.
cord-266455-rbblg4pu	72	1	Some	some	DT
cord-266455-rbblg4pu	72	2	examples	example	NNS
cord-266455-rbblg4pu	72	3	of	of	IN
cord-266455-rbblg4pu	72	4	these	these	DT
cord-266455-rbblg4pu	72	5	which	which	WDT
cord-266455-rbblg4pu	72	6	are	be	VBP
cord-266455-rbblg4pu	72	7	found	find	VBN
cord-266455-rbblg4pu	72	8	on	on	IN
cord-266455-rbblg4pu	72	9	commercially	commercially	RB
cord-266455-rbblg4pu	72	10	available	available	JJ
cord-266455-rbblg4pu	72	11	molecular	molecular	JJ
cord-266455-rbblg4pu	72	12	tests	test	NNS
cord-266455-rbblg4pu	72	13	are	be	VBP
cord-266455-rbblg4pu	72	14	extended	extend	VBN
cord-266455-rbblg4pu	72	15	spectrum	spectrum	NN
cord-266455-rbblg4pu	72	16	beta	beta	NN
cord-266455-rbblg4pu	72	17	lactamases	lactamase	NNS
cord-266455-rbblg4pu	72	18	(	(	-LRB-
cord-266455-rbblg4pu	72	19	ESBLs	esbl	NNS
cord-266455-rbblg4pu	72	20	)	)	-RRB-
cord-266455-rbblg4pu	72	21	,	,	,
cord-266455-rbblg4pu	72	22	carbapenemase	carbapenemase	NNP
cord-266455-rbblg4pu	72	23	producing	produce	VBG
cord-266455-rbblg4pu	72	24	enterobacteriaceae	enterobacteriaceae	NNP
cord-266455-rbblg4pu	72	25	(	(	-LRB-
cord-266455-rbblg4pu	72	26	CPEs	CPEs	NNP
cord-266455-rbblg4pu	72	27	)	)	-RRB-
cord-266455-rbblg4pu	72	28	,	,	,
cord-266455-rbblg4pu	72	29	MRSA	MRSA	NNP
cord-266455-rbblg4pu	72	30	,	,	,
cord-266455-rbblg4pu	72	31	Influenza	Influenza	NNP
cord-266455-rbblg4pu	72	32	and	and	CC
cord-266455-rbblg4pu	72	33	RSV	RSV	NNP
cord-266455-rbblg4pu	72	34	.	.	.
cord-266455-rbblg4pu	73	1	In	in	IN
cord-266455-rbblg4pu	73	2	the	the	DT
cord-266455-rbblg4pu	73	3	UK	UK	NNP
cord-266455-rbblg4pu	73	4	there	there	EX
cord-266455-rbblg4pu	73	5	is	be	VBZ
cord-266455-rbblg4pu	73	6	a	a	DT
cord-266455-rbblg4pu	73	7	mandatory	mandatory	JJ
cord-266455-rbblg4pu	73	8	requirement	requirement	NN
cord-266455-rbblg4pu	73	9	to	to	TO
cord-266455-rbblg4pu	73	10	report	report	VB
cord-266455-rbblg4pu	73	11	certain	certain	JJ
cord-266455-rbblg4pu	73	12	infectious	infectious	JJ
cord-266455-rbblg4pu	73	13	diseases	disease	NNS
cord-266455-rbblg4pu	73	14	to	to	IN
cord-266455-rbblg4pu	73	15	Public	Public	NNP
cord-266455-rbblg4pu	73	16	Health	Health	NNP
cord-266455-rbblg4pu	73	17	England	England	NNP
cord-266455-rbblg4pu	73	18	,	,	,
cord-266455-rbblg4pu	73	19	so	so	IN
cord-266455-rbblg4pu	73	20	they	-PRON-	PRP
cord-266455-rbblg4pu	73	21	can	can	MD
cord-266455-rbblg4pu	73	22	be	be	VB
cord-266455-rbblg4pu	73	23	investigated	investigate	VBN
cord-266455-rbblg4pu	73	24	.	.	.
cord-266455-rbblg4pu	74	1	L.	L.	NNP
cord-266455-rbblg4pu	74	2	pneumophilia	pneumophilia	NNP
cord-266455-rbblg4pu	74	3	is	be	VBZ
cord-266455-rbblg4pu	74	4	associated	associate	VBN
cord-266455-rbblg4pu	74	5	with	with	IN
cord-266455-rbblg4pu	74	6	outbreaks	outbreak	NNS
cord-266455-rbblg4pu	74	7	from	from	IN
cord-266455-rbblg4pu	74	8	devices	device	NNS
cord-266455-rbblg4pu	74	9	that	that	WDT
cord-266455-rbblg4pu	74	10	aerosolize	aerosolize	VBP
cord-266455-rbblg4pu	74	11	water	water	NN
cord-266455-rbblg4pu	74	12	.	.	.
cord-266455-rbblg4pu	75	1	There	there	EX
cord-266455-rbblg4pu	75	2	were	be	VBD
cord-266455-rbblg4pu	75	3	532	532	CD
cord-266455-rbblg4pu	75	4	cases	case	NNS
cord-266455-rbblg4pu	75	5	in	in	IN
cord-266455-rbblg4pu	75	6	the	the	DT
cord-266455-rbblg4pu	75	7	UK	UK	NNP
cord-266455-rbblg4pu	75	8	in	in	IN
cord-266455-rbblg4pu	75	9	2018	2018	CD
cord-266455-rbblg4pu	75	10	27	27	CD
cord-266455-rbblg4pu	75	11	,	,	,
cord-266455-rbblg4pu	75	12	earlier	early	JJR
cord-266455-rbblg4pu	75	13	sensitive	sensitive	JJ
cord-266455-rbblg4pu	75	14	detection	detection	NN
cord-266455-rbblg4pu	75	15	of	of	IN
cord-266455-rbblg4pu	75	16	these	these	DT
cord-266455-rbblg4pu	75	17	would	would	MD
cord-266455-rbblg4pu	75	18	allow	allow	VB
cord-266455-rbblg4pu	75	19	outbreak	outbreak	NN
cord-266455-rbblg4pu	75	20	investigation	investigation	NN
cord-266455-rbblg4pu	75	21	to	to	TO
cord-266455-rbblg4pu	75	22	occur	occur	VB
cord-266455-rbblg4pu	75	23	sooner	soon	RBR
cord-266455-rbblg4pu	75	24	and	and	CC
cord-266455-rbblg4pu	75	25	potentially	potentially	RB
cord-266455-rbblg4pu	75	26	stop	stop	VB
cord-266455-rbblg4pu	75	27	further	further	JJ
cord-266455-rbblg4pu	75	28	cases	case	NNS
cord-266455-rbblg4pu	75	29	occurring	occur	VBG
cord-266455-rbblg4pu	75	30	.	.	.
cord-266455-rbblg4pu	76	1	At	at	IN
cord-266455-rbblg4pu	76	2	the	the	DT
cord-266455-rbblg4pu	76	3	current	current	JJ
cord-266455-rbblg4pu	76	4	time	time	NN
cord-266455-rbblg4pu	76	5	there	there	EX
cord-266455-rbblg4pu	76	6	are	be	VBP
cord-266455-rbblg4pu	76	7	2	2	CD
cord-266455-rbblg4pu	76	8	FDA	FDA	NNP
cord-266455-rbblg4pu	76	9	approved	approve	VBN
cord-266455-rbblg4pu	76	10	,	,	,
cord-266455-rbblg4pu	76	11	CE	CE	NNP
cord-266455-rbblg4pu	76	12	marked	mark	VBD
cord-266455-rbblg4pu	76	13	syndromic	syndromic	JJ
cord-266455-rbblg4pu	76	14	molecular	molecular	JJ
cord-266455-rbblg4pu	76	15	panels	panel	NNS
cord-266455-rbblg4pu	76	16	for	for	IN
cord-266455-rbblg4pu	76	17	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	76	18	which	which	WDT
cord-266455-rbblg4pu	76	19	are	be	VBP
cord-266455-rbblg4pu	76	20	commercially	commercially	RB
cord-266455-rbblg4pu	76	21	available	available	JJ
cord-266455-rbblg4pu	76	22	:	:	:
cord-266455-rbblg4pu	76	23	the	the	DT
cord-266455-rbblg4pu	76	24	Filmarray	Filmarray	NNP
cord-266455-rbblg4pu	76	25	(	(	-LRB-
cord-266455-rbblg4pu	76	26	Biofire	Biofire	NNP
cord-266455-rbblg4pu	76	27	diagnostics	diagnostic	NNS
cord-266455-rbblg4pu	76	28	LLC	LLC	NNP
cord-266455-rbblg4pu	76	29	,	,	,
cord-266455-rbblg4pu	76	30	Salt	Salt	NNP
cord-266455-rbblg4pu	76	31	Lake	Lake	NNP
cord-266455-rbblg4pu	76	32	City	City	NNP
cord-266455-rbblg4pu	76	33	,	,	,
cord-266455-rbblg4pu	76	34	Utah	Utah	NNP
cord-266455-rbblg4pu	76	35	,	,	,
cord-266455-rbblg4pu	76	36	US	US	NNP
cord-266455-rbblg4pu	76	37	)	)	-RRB-
cord-266455-rbblg4pu	76	38	Pneumonia	Pneumonia	NNP
cord-266455-rbblg4pu	76	39	panel	panel	NN
cord-266455-rbblg4pu	76	40	and	and	CC
cord-266455-rbblg4pu	76	41	the	the	DT
cord-266455-rbblg4pu	76	42	Unyvero	Unyvero	NNP
cord-266455-rbblg4pu	77	1	(	(	-LRB-
cord-266455-rbblg4pu	77	2	Curetis	Curetis	NNP
cord-266455-rbblg4pu	77	3	GmbH	GmbH	NNP
cord-266455-rbblg4pu	77	4	,	,	,
cord-266455-rbblg4pu	77	5	Holzgerlingen	Holzgerlingen	NNP
cord-266455-rbblg4pu	77	6	,	,	,
cord-266455-rbblg4pu	77	7	Germany	Germany	NNP
cord-266455-rbblg4pu	77	8	)	)	-RRB-
cord-266455-rbblg4pu	78	1	Hospitalised	Hospitalised	NNP
cord-266455-rbblg4pu	78	2	Pneumonia	pneumonia	NN
cord-266455-rbblg4pu	78	3	(	(	-LRB-
cord-266455-rbblg4pu	78	4	HPN	HPN	NNP
cord-266455-rbblg4pu	78	5	)	)	-RRB-
cord-266455-rbblg4pu	78	6	panel	panel	NN
cord-266455-rbblg4pu	78	7	.	.	.
cord-266455-rbblg4pu	79	1	Fast	Fast	NNP
cord-266455-rbblg4pu	79	2	Track	Track	NNP
cord-266455-rbblg4pu	79	3	Diagnostics	Diagnostics	NNP
cord-266455-rbblg4pu	79	4	respiratory	respiratory	JJ
cord-266455-rbblg4pu	79	5	panel	panel	NN
cord-266455-rbblg4pu	79	6	33	33	CD
cord-266455-rbblg4pu	80	1	(	(	-LRB-
cord-266455-rbblg4pu	80	2	Fast	Fast	NNP
cord-266455-rbblg4pu	80	3	Track	Track	NNP
cord-266455-rbblg4pu	80	4	Diagnostics	Diagnostics	NNP
cord-266455-rbblg4pu	80	5	SARL	SARL	NNP
cord-266455-rbblg4pu	80	6	,	,	,
cord-266455-rbblg4pu	80	7	Luxembourg	Luxembourg	NNP
cord-266455-rbblg4pu	80	8	)	)	-RRB-
cord-266455-rbblg4pu	80	9	is	be	VBZ
cord-266455-rbblg4pu	80	10	another	another	DT
cord-266455-rbblg4pu	80	11	available	available	JJ
cord-266455-rbblg4pu	80	12	platform	platform	NN
cord-266455-rbblg4pu	80	13	with	with	IN
cord-266455-rbblg4pu	80	14	a	a	DT
cord-266455-rbblg4pu	80	15	large	large	JJ
cord-266455-rbblg4pu	80	16	number	number	NN
cord-266455-rbblg4pu	80	17	of	of	IN
cord-266455-rbblg4pu	80	18	targets	target	NNS
cord-266455-rbblg4pu	80	19	,	,	,
cord-266455-rbblg4pu	80	20	but	but	CC
cord-266455-rbblg4pu	80	21	insufficient	insufficient	JJ
cord-266455-rbblg4pu	80	22	bacterial	bacterial	JJ
cord-266455-rbblg4pu	80	23	targets	target	NNS
cord-266455-rbblg4pu	80	24	for	for	IN
cord-266455-rbblg4pu	80	25	it	-PRON-	PRP
cord-266455-rbblg4pu	80	26	to	to	TO
cord-266455-rbblg4pu	80	27	be	be	VB
cord-266455-rbblg4pu	80	28	considered	consider	VBN
cord-266455-rbblg4pu	80	29	a	a	DT
cord-266455-rbblg4pu	80	30	true	true	JJ
cord-266455-rbblg4pu	80	31	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	80	32	panel	panel	NN
cord-266455-rbblg4pu	80	33	so	so	IN
cord-266455-rbblg4pu	80	34	this	this	DT
cord-266455-rbblg4pu	80	35	will	will	MD
cord-266455-rbblg4pu	80	36	only	only	RB
cord-266455-rbblg4pu	80	37	be	be	VB
cord-266455-rbblg4pu	80	38	considered	consider	VBN
cord-266455-rbblg4pu	80	39	in	in	IN
cord-266455-rbblg4pu	80	40	brief	brief	NN
cord-266455-rbblg4pu	80	41	.	.	.
cord-266455-rbblg4pu	81	1	The	the	DT
cord-266455-rbblg4pu	81	2	commercially	commercially	RB
cord-266455-rbblg4pu	81	3	available	available	JJ
cord-266455-rbblg4pu	81	4	platforms	platform	NNS
cord-266455-rbblg4pu	81	5	are	be	VBP
cord-266455-rbblg4pu	81	6	summarised	summarise	VBN
cord-266455-rbblg4pu	81	7	in	in	IN
cord-266455-rbblg4pu	81	8	Table	Table	NNP
cord-266455-rbblg4pu	81	9	1	1	CD
cord-266455-rbblg4pu	81	10	.	.	.
cord-266455-rbblg4pu	82	1	The	the	DT
cord-266455-rbblg4pu	82	2	authors	author	NNS
cord-266455-rbblg4pu	82	3	are	be	VBP
cord-266455-rbblg4pu	82	4	aware	aware	JJ
cord-266455-rbblg4pu	82	5	of	of	IN
cord-266455-rbblg4pu	82	6	further	further	JJ
cord-266455-rbblg4pu	82	7	panels	panel	NNS
cord-266455-rbblg4pu	82	8	in	in	IN
cord-266455-rbblg4pu	82	9	development	development	NN
cord-266455-rbblg4pu	82	10	from	from	IN
cord-266455-rbblg4pu	82	11	Mobidiag	Mobidiag	NNP
cord-266455-rbblg4pu	82	12	,	,	,
cord-266455-rbblg4pu	82	13	Bruker	Bruker	NNP
cord-266455-rbblg4pu	82	14	,	,	,
cord-266455-rbblg4pu	82	15	Accelerate	accelerate	VB
cord-266455-rbblg4pu	82	16	and	and	CC
cord-266455-rbblg4pu	82	17	Axo	Axo	NNP
cord-266455-rbblg4pu	82	18	Science	Science	NNP
cord-266455-rbblg4pu	82	19	28	28	CD
cord-266455-rbblg4pu	82	20	but	but	CC
cord-266455-rbblg4pu	82	21	published	publish	VBN
cord-266455-rbblg4pu	82	22	data	datum	NNS
cord-266455-rbblg4pu	82	23	is	be	VBZ
cord-266455-rbblg4pu	82	24	only	only	RB
cord-266455-rbblg4pu	82	25	available	available	JJ
cord-266455-rbblg4pu	82	26	for	for	IN
cord-266455-rbblg4pu	82	27	the	the	DT
cord-266455-rbblg4pu	82	28	latter	latter	JJ
cord-266455-rbblg4pu	82	29	.	.	.
cord-266455-rbblg4pu	83	1	There	there	EX
cord-266455-rbblg4pu	83	2	are	be	VBP
cord-266455-rbblg4pu	83	3	also	also	RB
cord-266455-rbblg4pu	83	4	several	several	JJ
cord-266455-rbblg4pu	83	5	research	research	NN
cord-266455-rbblg4pu	83	6	groups	group	NNS
cord-266455-rbblg4pu	83	7	who	who	WP
cord-266455-rbblg4pu	83	8	have	have	VBP
cord-266455-rbblg4pu	83	9	developed	develop	VBN
cord-266455-rbblg4pu	83	10	their	-PRON-	PRP$
cord-266455-rbblg4pu	83	11	own	own	JJ
cord-266455-rbblg4pu	83	12	syndromic	syndromic	JJ
cord-266455-rbblg4pu	83	13	molecular	molecular	JJ
cord-266455-rbblg4pu	83	14	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	83	15	tests	test	NNS
cord-266455-rbblg4pu	83	16	,	,	,
cord-266455-rbblg4pu	83	17	most	most	RBS
cord-266455-rbblg4pu	83	18	notably	notably	RB
cord-266455-rbblg4pu	83	19	Gadsby	Gadsby	NNP
cord-266455-rbblg4pu	83	20	et	et	NNP
cord-266455-rbblg4pu	83	21	al	al	NNP
cord-266455-rbblg4pu	83	22	16	16	CD
cord-266455-rbblg4pu	83	23	.	.	.
cord-266455-rbblg4pu	84	1	There	there	EX
cord-266455-rbblg4pu	84	2	are	be	VBP
cord-266455-rbblg4pu	84	3	a	a	DT
cord-266455-rbblg4pu	84	4	multitude	multitude	NN
cord-266455-rbblg4pu	84	5	of	of	IN
cord-266455-rbblg4pu	84	6	other	other	JJ
cord-266455-rbblg4pu	84	7	'	'	``
cord-266455-rbblg4pu	84	8	respiratory	respiratory	JJ
cord-266455-rbblg4pu	84	9	pathogen	pathogen	NN
cord-266455-rbblg4pu	84	10	'	'	''
cord-266455-rbblg4pu	84	11	multiplex	multiplex	JJ
cord-266455-rbblg4pu	84	12	panels	panel	NNS
cord-266455-rbblg4pu	84	13	which	which	WDT
cord-266455-rbblg4pu	84	14	have	have	VBP
cord-266455-rbblg4pu	84	15	targets	target	NNS
cord-266455-rbblg4pu	84	16	only	only	RB
cord-266455-rbblg4pu	84	17	for	for	IN
cord-266455-rbblg4pu	84	18	respiratory	respiratory	JJ
cord-266455-rbblg4pu	84	19	viruses	virus	NNS
cord-266455-rbblg4pu	84	20	,	,	,
cord-266455-rbblg4pu	84	21	atypical	atypical	JJ
cord-266455-rbblg4pu	84	22	bacterial	bacterial	JJ
cord-266455-rbblg4pu	84	23	targets	target	NNS
cord-266455-rbblg4pu	84	24	or	or	CC
cord-266455-rbblg4pu	84	25	a	a	DT
cord-266455-rbblg4pu	84	26	very	very	RB
cord-266455-rbblg4pu	84	27	small	small	JJ
cord-266455-rbblg4pu	84	28	range	range	NN
cord-266455-rbblg4pu	84	29	of	of	IN
cord-266455-rbblg4pu	84	30	typical	typical	JJ
cord-266455-rbblg4pu	84	31	bacteria	bacteria	NNS
cord-266455-rbblg4pu	84	32	.	.	.
cord-266455-rbblg4pu	85	1	These	these	DT
cord-266455-rbblg4pu	85	2	are	be	VBP
cord-266455-rbblg4pu	85	3	beyond	beyond	IN
cord-266455-rbblg4pu	85	4	the	the	DT
cord-266455-rbblg4pu	85	5	scope	scope	NN
cord-266455-rbblg4pu	85	6	of	of	IN
cord-266455-rbblg4pu	85	7	this	this	DT
cord-266455-rbblg4pu	85	8	review	review	NN
cord-266455-rbblg4pu	85	9	article	article	NN
cord-266455-rbblg4pu	85	10	.	.	.
cord-266455-rbblg4pu	86	1	We	-PRON-	PRP
cord-266455-rbblg4pu	86	2	have	have	VBP
cord-266455-rbblg4pu	86	3	only	only	RB
cord-266455-rbblg4pu	86	4	included	include	VBN
cord-266455-rbblg4pu	86	5	assays	assay	NNS
cord-266455-rbblg4pu	86	6	with	with	IN
cord-266455-rbblg4pu	86	7	targets	target	NNS
cord-266455-rbblg4pu	86	8	for	for	IN
cord-266455-rbblg4pu	86	9	a	a	DT
cord-266455-rbblg4pu	86	10	wide	wide	JJ
cord-266455-rbblg4pu	86	11	range	range	NN
cord-266455-rbblg4pu	86	12	of	of	IN
cord-266455-rbblg4pu	86	13	typical	typical	JJ
cord-266455-rbblg4pu	86	14	pathogens	pathogen	NNS
cord-266455-rbblg4pu	86	15	for	for	IN
cord-266455-rbblg4pu	86	16	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	86	17	.	.	.
cord-266455-rbblg4pu	87	1	This	this	DT
cord-266455-rbblg4pu	87	2	is	be	VBZ
cord-266455-rbblg4pu	87	3	an	an	DT
cord-266455-rbblg4pu	87	4	FDA	FDA	NNP
cord-266455-rbblg4pu	87	5	approved	approve	VBN
cord-266455-rbblg4pu	87	6	and	and	CC
cord-266455-rbblg4pu	87	7	CE	CE	NNP
cord-266455-rbblg4pu	87	8	marked	mark	VBD
cord-266455-rbblg4pu	87	9	platform	platform	NN
cord-266455-rbblg4pu	87	10	that	that	WDT
cord-266455-rbblg4pu	87	11	uses	use	VBZ
cord-266455-rbblg4pu	87	12	nested	nest	VBN
cord-266455-rbblg4pu	87	13	real	real	JJ
cord-266455-rbblg4pu	87	14	-	-	HYPH
cord-266455-rbblg4pu	87	15	time	time	NN
cord-266455-rbblg4pu	87	16	PCR	PCR	NNP
cord-266455-rbblg4pu	87	17	to	to	TO
cord-266455-rbblg4pu	87	18	detect	detect	VB
cord-266455-rbblg4pu	87	19	34	34	CD
cord-266455-rbblg4pu	87	20	clinically	clinically	RB
cord-266455-rbblg4pu	87	21	important	important	JJ
cord-266455-rbblg4pu	87	22	respiratory	respiratory	JJ
cord-266455-rbblg4pu	87	23	targets	target	NNS
cord-266455-rbblg4pu	87	24	(	(	-LRB-
cord-266455-rbblg4pu	87	25	15	15	CD
cord-266455-rbblg4pu	87	26	semi	semi	JJ
cord-266455-rbblg4pu	87	27	-	-	JJ
cord-266455-rbblg4pu	87	28	quantitative	quantitative	JJ
cord-266455-rbblg4pu	87	29	bacterial	bacterial	JJ
cord-266455-rbblg4pu	87	30	targets	target	NNS
cord-266455-rbblg4pu	87	31	,	,	,
cord-266455-rbblg4pu	87	32	3	3	CD
cord-266455-rbblg4pu	87	33	qualitative	qualitative	JJ
cord-266455-rbblg4pu	87	34	atypical	atypical	JJ
cord-266455-rbblg4pu	87	35	bacterial	bacterial	JJ
cord-266455-rbblg4pu	87	36	targets	target	NNS
cord-266455-rbblg4pu	87	37	,	,	,
cord-266455-rbblg4pu	87	38	8	8	CD
cord-266455-rbblg4pu	87	39	[	[	-LRB-
cord-266455-rbblg4pu	87	40	30	30	CD
cord-266455-rbblg4pu	87	41	]	]	-RRB-
cord-266455-rbblg4pu	87	42	[	[	-LRB-
cord-266455-rbblg4pu	87	43	31	31	CD
cord-266455-rbblg4pu	87	44	]	]	-RRB-
cord-266455-rbblg4pu	88	1	[	[	-LRB-
cord-266455-rbblg4pu	88	2	32	32	CD
cord-266455-rbblg4pu	88	3	]	]	-RRB-
cord-266455-rbblg4pu	89	1	Furthermore	furthermore	RB
cord-266455-rbblg4pu	89	2	,	,	,
cord-266455-rbblg4pu	89	3	the	the	DT
cord-266455-rbblg4pu	89	4	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	89	5	panel	panel	NN
cord-266455-rbblg4pu	89	6	detects	detect	VBZ
cord-266455-rbblg4pu	89	7	pathogens	pathogen	NNS
cord-266455-rbblg4pu	89	8	in	in	IN
cord-266455-rbblg4pu	89	9	a	a	DT
cord-266455-rbblg4pu	89	10	much	much	RB
cord-266455-rbblg4pu	89	11	higher	high	JJR
cord-266455-rbblg4pu	89	12	proportion	proportion	NN
cord-266455-rbblg4pu	89	13	of	of	IN
cord-266455-rbblg4pu	89	14	samples	sample	NNS
cord-266455-rbblg4pu	89	15	than	than	IN
cord-266455-rbblg4pu	89	16	culture	culture	NN
cord-266455-rbblg4pu	89	17	.	.	.
cord-266455-rbblg4pu	90	1	Buchan	Buchan	NNP
cord-266455-rbblg4pu	90	2	et	et	NNP
cord-266455-rbblg4pu	90	3	al	al	NNP
cord-266455-rbblg4pu	90	4	31	31	CD
cord-266455-rbblg4pu	90	5	reported	report	VBD
cord-266455-rbblg4pu	90	6	that	that	IN
cord-266455-rbblg4pu	90	7	the	the	DT
cord-266455-rbblg4pu	90	8	Filmarray	Filmarray	NNP
cord-266455-rbblg4pu	90	9	detected	detect	VBD
cord-266455-rbblg4pu	90	10	a	a	DT
cord-266455-rbblg4pu	90	11	bacterial	bacterial	JJ
cord-266455-rbblg4pu	90	12	target	target	NN
cord-266455-rbblg4pu	90	13	in	in	IN
cord-266455-rbblg4pu	90	14	71	71	CD
cord-266455-rbblg4pu	90	15	%	%	NN
cord-266455-rbblg4pu	90	16	more	more	JJR
cord-266455-rbblg4pu	90	17	specimens	specimen	NNS
cord-266455-rbblg4pu	90	18	than	than	IN
cord-266455-rbblg4pu	90	19	routine	routine	JJ
cord-266455-rbblg4pu	90	20	culture	culture	NN
cord-266455-rbblg4pu	90	21	,	,	,
cord-266455-rbblg4pu	90	22	equating	equate	VBG
cord-266455-rbblg4pu	90	23	to	to	IN
cord-266455-rbblg4pu	90	24	over	over	IN
cord-266455-rbblg4pu	90	25	100	100	CD
cord-266455-rbblg4pu	90	26	%	%	NN
cord-266455-rbblg4pu	90	27	increase	increase	NN
cord-266455-rbblg4pu	90	28	in	in	IN
cord-266455-rbblg4pu	90	29	total	total	JJ
cord-266455-rbblg4pu	90	30	bacterial	bacterial	JJ
cord-266455-rbblg4pu	90	31	detections	detection	NNS
cord-266455-rbblg4pu	90	32	.	.	.
cord-266455-rbblg4pu	91	1	The	the	DT
cord-266455-rbblg4pu	91	2	relative	relative	JJ
cord-266455-rbblg4pu	91	3	abundance	abundance	NN
cord-266455-rbblg4pu	91	4	of	of	IN
cord-266455-rbblg4pu	91	5	organism	organism	NN
cord-266455-rbblg4pu	91	6	for	for	IN
cord-266455-rbblg4pu	91	7	the	the	DT
cord-266455-rbblg4pu	91	8	15	15	CD
cord-266455-rbblg4pu	91	9	bacterial	bacterial	JJ
cord-266455-rbblg4pu	91	10	targets	target	NNS
cord-266455-rbblg4pu	91	11	is	be	VBZ
cord-266455-rbblg4pu	91	12	estimated	estimate	VBN
cord-266455-rbblg4pu	91	13	based	base	VBN
cord-266455-rbblg4pu	91	14	on	on	IN
cord-266455-rbblg4pu	91	15	real	real	JJ
cord-266455-rbblg4pu	91	16	-	-	HYPH
cord-266455-rbblg4pu	91	17	time	time	NN
cord-266455-rbblg4pu	91	18	PCR	pcr	NN
cord-266455-rbblg4pu	91	19	relative	relative	JJ
cord-266455-rbblg4pu	91	20	to	to	IN
cord-266455-rbblg4pu	91	21	a	a	DT
cord-266455-rbblg4pu	91	22	material	material	NN
cord-266455-rbblg4pu	91	23	of	of	IN
cord-266455-rbblg4pu	91	24	known	know	VBN
cord-266455-rbblg4pu	91	25	quantity	quantity	NN
cord-266455-rbblg4pu	91	26	and	and	CC
cord-266455-rbblg4pu	91	27	is	be	VBZ
cord-266455-rbblg4pu	91	28	grouped	group	VBN
cord-266455-rbblg4pu	91	29	for	for	IN
cord-266455-rbblg4pu	91	30	reporting	report	VBG
cord-266455-rbblg4pu	91	31	into	into	IN
cord-266455-rbblg4pu	91	32	bins	bin	NNS
cord-266455-rbblg4pu	91	33	.	.	.
cord-266455-rbblg4pu	92	1	These	these	DT
cord-266455-rbblg4pu	92	2	represent	represent	VBP
cord-266455-rbblg4pu	92	3	approximately	approximately	RB
cord-266455-rbblg4pu	92	4	10	10	CD
cord-266455-rbblg4pu	92	5	4	4	CD
cord-266455-rbblg4pu	92	6	,	,	,
cord-266455-rbblg4pu	92	7	10	10	CD
cord-266455-rbblg4pu	92	8	5	5	CD
cord-266455-rbblg4pu	92	9	,	,	,
cord-266455-rbblg4pu	92	10	10	10	CD
cord-266455-rbblg4pu	92	11	6	6	CD
cord-266455-rbblg4pu	92	12	and	and	CC
cord-266455-rbblg4pu	92	13	>	>	XX
cord-266455-rbblg4pu	92	14	10	10	CD
cord-266455-rbblg4pu	92	15	7	7	CD
cord-266455-rbblg4pu	92	16	genomic	genomic	JJ
cord-266455-rbblg4pu	92	17	copies	copy	NNS
cord-266455-rbblg4pu	92	18	of	of	IN
cord-266455-rbblg4pu	92	19	bacterial	bacterial	JJ
cord-266455-rbblg4pu	92	20	nucleic	nucleic	JJ
cord-266455-rbblg4pu	92	21	acid	acid	NN
cord-266455-rbblg4pu	92	22	per	per	IN
cord-266455-rbblg4pu	92	23	millilitre	millilitre	NN
cord-266455-rbblg4pu	92	24	of	of	IN
cord-266455-rbblg4pu	92	25	specimen	specimen	NN
cord-266455-rbblg4pu	92	26	respectively	respectively	RB
cord-266455-rbblg4pu	92	27	.	.	.
cord-266455-rbblg4pu	93	1	Concordance	concordance	NN
cord-266455-rbblg4pu	93	2	with	with	IN
cord-266455-rbblg4pu	93	3	reference	reference	NN
cord-266455-rbblg4pu	93	4	molecular	molecular	JJ
cord-266455-rbblg4pu	93	5	testing	testing	NN
cord-266455-rbblg4pu	93	6	is	be	VBZ
cord-266455-rbblg4pu	93	7	very	very	RB
cord-266455-rbblg4pu	93	8	high	high	JJ
cord-266455-rbblg4pu	93	9	33	33	CD
cord-266455-rbblg4pu	93	10	but	but	CC
cord-266455-rbblg4pu	93	11	as	as	IN
cord-266455-rbblg4pu	93	12	expected	expect	VBN
cord-266455-rbblg4pu	93	13	the	the	DT
cord-266455-rbblg4pu	93	14	overall	overall	JJ
cord-266455-rbblg4pu	93	15	concordance	concordance	NN
cord-266455-rbblg4pu	93	16	between	between	IN
cord-266455-rbblg4pu	93	17	bin	bin	NNP
cord-266455-rbblg4pu	93	18	and	and	CC
cord-266455-rbblg4pu	93	19	reference	reference	NN
cord-266455-rbblg4pu	93	20	sputum	sputum	NN
cord-266455-rbblg4pu	93	21	culture	culture	NN
cord-266455-rbblg4pu	93	22	(	(	-LRB-
cord-266455-rbblg4pu	93	23	CFU	CFU	NNP
cord-266455-rbblg4pu	93	24	/	/	SYM
cord-266455-rbblg4pu	93	25	ml	ml	NN
cord-266455-rbblg4pu	93	26	)	)	-RRB-
cord-266455-rbblg4pu	93	27	concentration	concentration	NN
cord-266455-rbblg4pu	93	28	was	be	VBD
cord-266455-rbblg4pu	93	29	lower	low	JJR
cord-266455-rbblg4pu	93	30	at	at	IN
cord-266455-rbblg4pu	93	31	around	around	RB
cord-266455-rbblg4pu	93	32	40	40	CD
cord-266455-rbblg4pu	93	33	%	%	NN
cord-266455-rbblg4pu	93	34	29	29	CD
cord-266455-rbblg4pu	93	35	and	and	CC
cord-266455-rbblg4pu	93	36	was	be	VBD
cord-266455-rbblg4pu	93	37	highly	highly	RB
cord-266455-rbblg4pu	93	38	variable	variable	JJ
cord-266455-rbblg4pu	93	39	between	between	IN
cord-266455-rbblg4pu	93	40	organisms	organism	NNS
cord-266455-rbblg4pu	93	41	.	.	.
cord-266455-rbblg4pu	94	1	As	as	IN
cord-266455-rbblg4pu	94	2	such	such	PDT
cord-266455-rbblg4pu	94	3	the	the	DT
cord-266455-rbblg4pu	94	4	manufacturer	manufacturer	NN
cord-266455-rbblg4pu	94	5	advises	advise	VBZ
cord-266455-rbblg4pu	94	6	clinical	clinical	JJ
cord-266455-rbblg4pu	94	7	correlation	correlation	NN
cord-266455-rbblg4pu	94	8	in	in	IN
cord-266455-rbblg4pu	94	9	interpretation	interpretation	NN
cord-266455-rbblg4pu	94	10	of	of	IN
cord-266455-rbblg4pu	94	11	semi	semi	JJ
cord-266455-rbblg4pu	94	12	-	-	JJ
cord-266455-rbblg4pu	94	13	quantitative	quantitative	JJ
cord-266455-rbblg4pu	94	14	results	result	NNS
cord-266455-rbblg4pu	94	15	.	.	.
cord-266455-rbblg4pu	95	1	To	to	IN
cord-266455-rbblg4pu	95	2	date	date	NN
cord-266455-rbblg4pu	95	3	there	there	EX
cord-266455-rbblg4pu	95	4	have	have	VBP
cord-266455-rbblg4pu	95	5	been	be	VBN
cord-266455-rbblg4pu	95	6	no	no	DT
cord-266455-rbblg4pu	95	7	published	publish	VBN
cord-266455-rbblg4pu	95	8	prospective	prospective	JJ
cord-266455-rbblg4pu	95	9	interventional	interventional	JJ
cord-266455-rbblg4pu	95	10	studies	study	NNS
cord-266455-rbblg4pu	95	11	evaluating	evaluate	VBG
cord-266455-rbblg4pu	95	12	the	the	DT
cord-266455-rbblg4pu	95	13	clinical	clinical	JJ
cord-266455-rbblg4pu	95	14	impacts	impact	NNS
cord-266455-rbblg4pu	95	15	of	of	IN
cord-266455-rbblg4pu	95	16	using	use	VBG
cord-266455-rbblg4pu	95	17	the	the	DT
cord-266455-rbblg4pu	95	18	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	95	19	panel	panel	NN
cord-266455-rbblg4pu	95	20	in	in	IN
cord-266455-rbblg4pu	95	21	patients	patient	NNS
cord-266455-rbblg4pu	95	22	with	with	IN
cord-266455-rbblg4pu	95	23	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	95	24	.	.	.
cord-266455-rbblg4pu	96	1	Observational	observational	JJ
cord-266455-rbblg4pu	96	2	data	datum	NNS
cord-266455-rbblg4pu	96	3	based	base	VBN
cord-266455-rbblg4pu	96	4	on	on	IN
cord-266455-rbblg4pu	96	5	lower	low	JJR
cord-266455-rbblg4pu	96	6	respiratory	respiratory	JJ
cord-266455-rbblg4pu	96	7	tract	tract	NN
cord-266455-rbblg4pu	96	8	assays	assay	NNS
cord-266455-rbblg4pu	96	9	which	which	WDT
cord-266455-rbblg4pu	96	10	preceded	precede	VBD
cord-266455-rbblg4pu	96	11	the	the	DT
cord-266455-rbblg4pu	96	12	final	final	JJ
cord-266455-rbblg4pu	96	13	,	,	,
cord-266455-rbblg4pu	96	14	FDA	FDA	NNP
cord-266455-rbblg4pu	96	15	approved	approve	VBD
cord-266455-rbblg4pu	96	16	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	96	17	panel	panel	NN
cord-266455-rbblg4pu	96	18	suggested	suggest	VBD
cord-266455-rbblg4pu	96	19	change	change	NN
cord-266455-rbblg4pu	96	20	of	of	IN
cord-266455-rbblg4pu	96	21	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	96	22	could	could	MD
cord-266455-rbblg4pu	96	23	be	be	VB
cord-266455-rbblg4pu	96	24	supported	support	VBN
cord-266455-rbblg4pu	96	25	in	in	IN
cord-266455-rbblg4pu	96	26	>	>	$
cord-266455-rbblg4pu	96	27	50	50	CD
cord-266455-rbblg4pu	96	28	%	%	NN
cord-266455-rbblg4pu	96	29	of	of	IN
cord-266455-rbblg4pu	96	30	cases	case	NNS
cord-266455-rbblg4pu	96	31	31	31	CD
cord-266455-rbblg4pu	96	32	,	,	,
cord-266455-rbblg4pu	96	33	34	34	CD
cord-266455-rbblg4pu	96	34	.	.	.
cord-266455-rbblg4pu	97	1	The	the	DT
cord-266455-rbblg4pu	97	2	HPN	HPN	NNP
cord-266455-rbblg4pu	97	3	panel	panel	NN
cord-266455-rbblg4pu	97	4	is	be	VBZ
cord-266455-rbblg4pu	97	5	CE	CE	NNP
cord-266455-rbblg4pu	97	6	marked	mark	VBN
cord-266455-rbblg4pu	97	7	and	and	CC
cord-266455-rbblg4pu	97	8	runs	run	NNS
cord-266455-rbblg4pu	97	9	on	on	IN
cord-266455-rbblg4pu	97	10	the	the	DT
cord-266455-rbblg4pu	97	11	Unyvero	Unyvero	NNP
cord-266455-rbblg4pu	97	12	platform	platform	NN
cord-266455-rbblg4pu	97	13	which	which	WDT
cord-266455-rbblg4pu	97	14	includes	include	VBZ
cord-266455-rbblg4pu	97	15	the	the	DT
cord-266455-rbblg4pu	97	16	Unyvero	Unyvero	NNP
cord-266455-rbblg4pu	97	17	Lysator	Lysator	NNP
cord-266455-rbblg4pu	97	18	,	,	,
cord-266455-rbblg4pu	97	19	the	the	DT
cord-266455-rbblg4pu	97	20	Unyvero	Unyvero	NNP
cord-266455-rbblg4pu	97	21	Cockpit	Cockpit	NNP
cord-266455-rbblg4pu	97	22	and	and	CC
cord-266455-rbblg4pu	97	23	the	the	DT
cord-266455-rbblg4pu	97	24	Unyvero	Unyvero	NNP
cord-266455-rbblg4pu	97	25	analyzer	analyzer	NN
cord-266455-rbblg4pu	97	26	.	.	.
cord-266455-rbblg4pu	98	1	Amplicons	Amplicons	NNP
cord-266455-rbblg4pu	98	2	generated	generate	VBN
cord-266455-rbblg4pu	98	3	by	by	IN
cord-266455-rbblg4pu	98	4	8	8	CD
cord-266455-rbblg4pu	98	5	parallel	parallel	NN
cord-266455-rbblg4pu	98	6	multiplex	multiplex	NN
cord-266455-rbblg4pu	98	7	PCR	PCR	NNP
cord-266455-rbblg4pu	98	8	reactions	reaction	NNS
cord-266455-rbblg4pu	98	9	are	be	VBP
cord-266455-rbblg4pu	98	10	qualitatively	qualitatively	RB
cord-266455-rbblg4pu	98	11	detected	detect	VBN
cord-266455-rbblg4pu	98	12	by	by	IN
cord-266455-rbblg4pu	98	13	hybridisation	hybridisation	NN
cord-266455-rbblg4pu	98	14	on	on	IN
cord-266455-rbblg4pu	98	15	arrays	array	NNS
cord-266455-rbblg4pu	98	16	in	in	IN
cord-266455-rbblg4pu	98	17	a	a	DT
cord-266455-rbblg4pu	98	18	single	single	JJ
cord-266455-rbblg4pu	98	19	use	use	NN
cord-266455-rbblg4pu	98	20	cartridge	cartridge	NN
cord-266455-rbblg4pu	98	21	.	.	.
cord-266455-rbblg4pu	99	1	It	-PRON-	PRP
cord-266455-rbblg4pu	99	2	has	have	VBZ
cord-266455-rbblg4pu	99	3	a	a	DT
cord-266455-rbblg4pu	99	4	wide	wide	JJ
cord-266455-rbblg4pu	99	5	range	range	NN
cord-266455-rbblg4pu	99	6	of	of	IN
cord-266455-rbblg4pu	99	7	bacterial	bacterial	JJ
cord-266455-rbblg4pu	99	8	and	and	CC
cord-266455-rbblg4pu	99	9	resistance	resistance	NN
cord-266455-rbblg4pu	99	10	gene	gene	NN
cord-266455-rbblg4pu	99	11	targets	target	NNS
cord-266455-rbblg4pu	99	12	including	include	VBG
cord-266455-rbblg4pu	99	13	29	29	CD
cord-266455-rbblg4pu	100	1	The	the	DT
cord-266455-rbblg4pu	100	2	assay	assay	NN
cord-266455-rbblg4pu	100	3	is	be	VBZ
cord-266455-rbblg4pu	100	4	validated	validate	VBN
cord-266455-rbblg4pu	100	5	for	for	IN
cord-266455-rbblg4pu	100	6	use	use	NN
cord-266455-rbblg4pu	100	7	on	on	IN
cord-266455-rbblg4pu	100	8	sputum	sputum	NN
cord-266455-rbblg4pu	100	9	(	(	-LRB-
cord-266455-rbblg4pu	100	10	including	include	VBG
cord-266455-rbblg4pu	100	11	expectorated	expectorate	VBN
cord-266455-rbblg4pu	100	12	sputum	sputum	NN
cord-266455-rbblg4pu	100	13	,	,	,
cord-266455-rbblg4pu	100	14	BAL	BAL	NNP
cord-266455-rbblg4pu	100	15	and	and	CC
cord-266455-rbblg4pu	100	16	ET	ET	NNP
cord-266455-rbblg4pu	100	17	aspirate	aspirate	VB
cord-266455-rbblg4pu	100	18	)	)	-RRB-
cord-266455-rbblg4pu	100	19	.	.	.
cord-266455-rbblg4pu	101	1	Like	like	IN
cord-266455-rbblg4pu	101	2	the	the	DT
cord-266455-rbblg4pu	101	3	FilmArray	FilmArray	NNP
cord-266455-rbblg4pu	101	4	,	,	,
cord-266455-rbblg4pu	101	5	the	the	DT
cord-266455-rbblg4pu	101	6	Unyvero	Unyvero	NNP
cord-266455-rbblg4pu	101	7	is	be	VBZ
cord-266455-rbblg4pu	101	8	a	a	DT
cord-266455-rbblg4pu	101	9	platform	platform	NN
cord-266455-rbblg4pu	101	10	designed	design	VBN
cord-266455-rbblg4pu	101	11	as	as	IN
cord-266455-rbblg4pu	101	12	a	a	DT
cord-266455-rbblg4pu	101	13	'	'	``
cord-266455-rbblg4pu	101	14	sample	sample	NN
cord-266455-rbblg4pu	101	15	-	-	HYPH
cord-266455-rbblg4pu	101	16	to	to	IN
cord-266455-rbblg4pu	101	17	-	-	HYPH
cord-266455-rbblg4pu	101	18	answer	answer	NN
cord-266455-rbblg4pu	101	19	'	'	''
cord-266455-rbblg4pu	101	20	solution	solution	NN
cord-266455-rbblg4pu	101	21	taking	take	VBG
cord-266455-rbblg4pu	101	22	5	5	CD
cord-266455-rbblg4pu	101	23	min	min	NN
cord-266455-rbblg4pu	101	24	of	of	IN
cord-266455-rbblg4pu	101	25	low	low	JJ
cord-266455-rbblg4pu	101	26	skill	skill	NN
cord-266455-rbblg4pu	101	27	hands	hand	NNS
cord-266455-rbblg4pu	101	28	-	-	HYPH
cord-266455-rbblg4pu	101	29	on	on	RP
cord-266455-rbblg4pu	101	30	time	time	NN
cord-266455-rbblg4pu	101	31	with	with	IN
cord-266455-rbblg4pu	101	32	a	a	DT
cord-266455-rbblg4pu	101	33	total	total	JJ
cord-266455-rbblg4pu	101	34	turnaround	turnaround	NN
cord-266455-rbblg4pu	101	35	time	time	NN
cord-266455-rbblg4pu	101	36	of	of	IN
cord-266455-rbblg4pu	101	37	4	4	CD
cord-266455-rbblg4pu	101	38	-	-	SYM
cord-266455-rbblg4pu	101	39	5	5	CD
cord-266455-rbblg4pu	101	40	h.	h.	NN
cord-266455-rbblg4pu	102	1	An	an	DT
cord-266455-rbblg4pu	102	2	equivalent	equivalent	JJ
cord-266455-rbblg4pu	102	3	test	test	NN
cord-266455-rbblg4pu	102	4	,	,	,
cord-266455-rbblg4pu	102	5	the	the	DT
cord-266455-rbblg4pu	102	6	lower	low	JJR
cord-266455-rbblg4pu	102	7	respiratory	respiratory	JJ
cord-266455-rbblg4pu	102	8	tract	tract	NN
cord-266455-rbblg4pu	102	9	panel	panel	NN
cord-266455-rbblg4pu	102	10	(	(	-LRB-
cord-266455-rbblg4pu	102	11	LRT	LRT	NNP
cord-266455-rbblg4pu	102	12	)	)	-RRB-
cord-266455-rbblg4pu	102	13	has	have	VBZ
cord-266455-rbblg4pu	102	14	FDA	FDA	NNP
cord-266455-rbblg4pu	102	15	approval	approval	NN
cord-266455-rbblg4pu	102	16	in	in	IN
cord-266455-rbblg4pu	102	17	the	the	DT
cord-266455-rbblg4pu	102	18	US	US	NNP
cord-266455-rbblg4pu	102	19	but	but	CC
cord-266455-rbblg4pu	102	20	is	be	VBZ
cord-266455-rbblg4pu	102	21	only	only	RB
cord-266455-rbblg4pu	102	22	validated	validate	VBN
cord-266455-rbblg4pu	102	23	for	for	IN
cord-266455-rbblg4pu	102	24	use	use	NN
cord-266455-rbblg4pu	102	25	on	on	IN
cord-266455-rbblg4pu	102	26	tracheal	tracheal	JJ
cord-266455-rbblg4pu	102	27	aspirates	aspirate	NNS
cord-266455-rbblg4pu	102	28	.	.	.
cord-266455-rbblg4pu	103	1	Manufacturer	manufacturer	NN
cord-266455-rbblg4pu	103	2	reported	report	VBD
cord-266455-rbblg4pu	103	3	diagnostic	diagnostic	JJ
cord-266455-rbblg4pu	103	4	sensitivity	sensitivity	NN
cord-266455-rbblg4pu	103	5	for	for	IN
cord-266455-rbblg4pu	103	6	bacterial	bacterial	JJ
cord-266455-rbblg4pu	103	7	detection	detection	NN
cord-266455-rbblg4pu	103	8	(	(	-LRB-
cord-266455-rbblg4pu	103	9	when	when	WRB
cord-266455-rbblg4pu	103	10	compared	compare	VBN
cord-266455-rbblg4pu	103	11	to	to	IN
cord-266455-rbblg4pu	103	12	reference	reference	NN
cord-266455-rbblg4pu	103	13	culture	culture	NN
cord-266455-rbblg4pu	103	14	and	and	CC
cord-266455-rbblg4pu	103	15	molecular	molecular	JJ
cord-266455-rbblg4pu	103	16	detection	detection	NN
cord-266455-rbblg4pu	103	17	in	in	IN
cord-266455-rbblg4pu	103	18	cases	case	NNS
cord-266455-rbblg4pu	103	19	of	of	IN
cord-266455-rbblg4pu	103	20	discrepancy	discrepancy	NN
cord-266455-rbblg4pu	103	21	)	)	-RRB-
cord-266455-rbblg4pu	103	22	is	be	VBZ
cord-266455-rbblg4pu	103	23	between	between	IN
cord-266455-rbblg4pu	103	24	80	80	CD
cord-266455-rbblg4pu	103	25	and	and	CC
cord-266455-rbblg4pu	103	26	100	100	CD
cord-266455-rbblg4pu	103	27	%	%	NN
cord-266455-rbblg4pu	103	28	with	with	IN
cord-266455-rbblg4pu	103	29	the	the	DT
cord-266455-rbblg4pu	103	30	majority	majority	NN
cord-266455-rbblg4pu	103	31	of	of	IN
cord-266455-rbblg4pu	103	32	targets	target	NNS
cord-266455-rbblg4pu	104	1	In	in	IN
cord-266455-rbblg4pu	104	2	the	the	DT
cord-266455-rbblg4pu	104	3	diagnostic	diagnostic	JJ
cord-266455-rbblg4pu	104	4	performance	performance	NN
cord-266455-rbblg4pu	104	5	data	datum	NNS
cord-266455-rbblg4pu	104	6	presented	present	VBN
cord-266455-rbblg4pu	104	7	by	by	IN
cord-266455-rbblg4pu	104	8	the	the	DT
cord-266455-rbblg4pu	104	9	manufacturer	manufacturer	NN
cord-266455-rbblg4pu	104	10	,	,	,
cord-266455-rbblg4pu	104	11	resistance	resistance	NN
cord-266455-rbblg4pu	104	12	marker	marker	NN
cord-266455-rbblg4pu	104	13	detection	detection	NN
cord-266455-rbblg4pu	104	14	aligned	align	VBN
cord-266455-rbblg4pu	104	15	poorly	poorly	RB
cord-266455-rbblg4pu	104	16	with	with	IN
cord-266455-rbblg4pu	104	17	organism	organism	NN
cord-266455-rbblg4pu	104	18	antibiogram	antibiogram	NNP
cord-266455-rbblg4pu	104	19	:	:	:
cord-266455-rbblg4pu	104	20	for	for	IN
cord-266455-rbblg4pu	104	21	example	example	NN
cord-266455-rbblg4pu	104	22	,	,	,
cord-266455-rbblg4pu	104	23	matching	match	VBG
cord-266455-rbblg4pu	104	24	in	in	IN
cord-266455-rbblg4pu	104	25	only	only	RB
cord-266455-rbblg4pu	104	26	4/11	4/11	CD
cord-266455-rbblg4pu	104	27	mecA	meca	JJ
cord-266455-rbblg4pu	104	28	detections	detection	NNS
cord-266455-rbblg4pu	104	29	or	or	CC
cord-266455-rbblg4pu	104	30	9/13	9/13	CD
cord-266455-rbblg4pu	104	31	quinolone	quinolone	NN
cord-266455-rbblg4pu	104	32	resistance	resistance	NN
cord-266455-rbblg4pu	104	33	markers	marker	NNS
cord-266455-rbblg4pu	104	34	in	in	IN
cord-266455-rbblg4pu	104	35	E.	E.	NNP
cord-266455-rbblg4pu	104	36	coli	coli	NNS
cord-266455-rbblg4pu	104	37	.	.	.
cord-266455-rbblg4pu	105	1	This	this	DT
cord-266455-rbblg4pu	105	2	issue	issue	NN
cord-266455-rbblg4pu	105	3	was	be	VBD
cord-266455-rbblg4pu	105	4	noted	note	VBN
cord-266455-rbblg4pu	105	5	by	by	IN
cord-266455-rbblg4pu	105	6	Gadbsy	Gadbsy	NNP
cord-266455-rbblg4pu	105	7	et	et	NNP
cord-266455-rbblg4pu	105	8	al	al	NNP
cord-266455-rbblg4pu	105	9	39	39	CD
cord-266455-rbblg4pu	105	10	for	for	IN
cord-266455-rbblg4pu	105	11	the	the	DT
cord-266455-rbblg4pu	105	12	P55	P55	NNP
cord-266455-rbblg4pu	105	13	assay	assay	NN
cord-266455-rbblg4pu	105	14	where	where	WRB
cord-266455-rbblg4pu	105	15	the	the	DT
cord-266455-rbblg4pu	105	16	sensitivity	sensitivity	NN
cord-266455-rbblg4pu	105	17	for	for	IN
cord-266455-rbblg4pu	105	18	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	105	19	resistance	resistance	NN
cord-266455-rbblg4pu	105	20	detection	detection	NN
cord-266455-rbblg4pu	105	21	was	be	VBD
cord-266455-rbblg4pu	105	22	18	18	CD
cord-266455-rbblg4pu	105	23	%	%	NN
cord-266455-rbblg4pu	105	24	.	.	.
cord-266455-rbblg4pu	106	1	Two	two	CD
cord-266455-rbblg4pu	106	2	predecessors	predecessor	NNS
cord-266455-rbblg4pu	106	3	to	to	IN
cord-266455-rbblg4pu	106	4	the	the	DT
cord-266455-rbblg4pu	106	5	HPN	HPN	NNP
cord-266455-rbblg4pu	106	6	cartridge	cartridge	NN
cord-266455-rbblg4pu	106	7	have	have	VBP
cord-266455-rbblg4pu	106	8	been	be	VBN
cord-266455-rbblg4pu	106	9	developed	develop	VBN
cord-266455-rbblg4pu	106	10	and	and	CC
cord-266455-rbblg4pu	106	11	CE	CE	NNP
cord-266455-rbblg4pu	106	12	marked	mark	VBD
cord-266455-rbblg4pu	106	13	:	:	:
cord-266455-rbblg4pu	106	14	the	the	DT
cord-266455-rbblg4pu	106	15	earlier	early	JJR
cord-266455-rbblg4pu	106	16	P50	P50	NNP
cord-266455-rbblg4pu	106	17	,	,	,
cord-266455-rbblg4pu	106	18	and	and	CC
cord-266455-rbblg4pu	106	19	the	the	DT
cord-266455-rbblg4pu	106	20	later	later	JJ
cord-266455-rbblg4pu	106	21	P55	P55	NNP
cord-266455-rbblg4pu	106	22	.	.	.
cord-266455-rbblg4pu	107	1	The	the	DT
cord-266455-rbblg4pu	107	2	former	former	JJ
cord-266455-rbblg4pu	107	3	of	of	IN
cord-266455-rbblg4pu	107	4	these	these	DT
cord-266455-rbblg4pu	107	5	was	be	VBD
cord-266455-rbblg4pu	107	6	evaluated	evaluate	VBN
cord-266455-rbblg4pu	107	7	most	most	RBS
cord-266455-rbblg4pu	107	8	extensively	extensively	RB
cord-266455-rbblg4pu	107	9	by	by	IN
cord-266455-rbblg4pu	107	10	Personne	Personne	NNP
cord-266455-rbblg4pu	107	11	et	et	FW
cord-266455-rbblg4pu	107	12	al	al	NNP
cord-266455-rbblg4pu	107	13	.	.	.
cord-266455-rbblg4pu	108	1	who	who	WP
cord-266455-rbblg4pu	108	2	found	find	VBD
cord-266455-rbblg4pu	108	3	the	the	DT
cord-266455-rbblg4pu	108	4	test	test	NN
cord-266455-rbblg4pu	108	5	to	to	TO
cord-266455-rbblg4pu	108	6	be	be	VB
cord-266455-rbblg4pu	108	7	sensitive	sensitive	JJ
cord-266455-rbblg4pu	108	8	for	for	IN
cord-266455-rbblg4pu	108	9	bacterial	bacterial	JJ
cord-266455-rbblg4pu	108	10	detection	detection	NN
cord-266455-rbblg4pu	108	11	but	but	CC
cord-266455-rbblg4pu	108	12	with	with	IN
cord-266455-rbblg4pu	108	13	a	a	DT
cord-266455-rbblg4pu	108	14	run	run	NN
cord-266455-rbblg4pu	108	15	failure	failure	NN
cord-266455-rbblg4pu	108	16	rate	rate	NN
cord-266455-rbblg4pu	108	17	of	of	IN
cord-266455-rbblg4pu	108	18	12.6	12.6	CD
cord-266455-rbblg4pu	108	19	%	%	NN
cord-266455-rbblg4pu	108	20	and	and	CC
cord-266455-rbblg4pu	108	21	extensive	extensive	JJ
cord-266455-rbblg4pu	108	22	discrepancies	discrepancy	NNS
cord-266455-rbblg4pu	108	23	with	with	IN
cord-266455-rbblg4pu	108	24	regards	regard	NNS
cord-266455-rbblg4pu	108	25	to	to	IN
cord-266455-rbblg4pu	108	26	sensitivity	sensitivity	NN
cord-266455-rbblg4pu	108	27	testing	testing	NN
cord-266455-rbblg4pu	108	28	40	40	CD
cord-266455-rbblg4pu	108	29	.	.	.
cord-266455-rbblg4pu	109	1	Furthermore	furthermore	RB
cord-266455-rbblg4pu	109	2	,	,	,
cord-266455-rbblg4pu	109	3	the	the	DT
cord-266455-rbblg4pu	109	4	test	test	NN
cord-266455-rbblg4pu	109	5	was	be	VBD
cord-266455-rbblg4pu	109	6	unable	unable	JJ
cord-266455-rbblg4pu	109	7	to	to	TO
cord-266455-rbblg4pu	109	8	differentiate	differentiate	VB
cord-266455-rbblg4pu	109	9	S.	S.	NNP
cord-266455-rbblg4pu	109	10	pneumoniae	pneumoniae	NN
cord-266455-rbblg4pu	109	11	from	from	IN
cord-266455-rbblg4pu	109	12	the	the	DT
cord-266455-rbblg4pu	109	13	S.	S.	NNP
cord-266455-rbblg4pu	109	14	mitis	mitis	NN
cord-266455-rbblg4pu	109	15	group	group	NN
cord-266455-rbblg4pu	109	16	.	.	.
cord-266455-rbblg4pu	110	1	Papan	Papan	NNP
cord-266455-rbblg4pu	110	2	et	et	NNP
cord-266455-rbblg4pu	110	3	al	al	NNP
cord-266455-rbblg4pu	110	4	.	.	NNP
cord-266455-rbblg4pu	110	5	reported	report	VBD
cord-266455-rbblg4pu	110	6	that	that	IN
cord-266455-rbblg4pu	110	7	the	the	DT
cord-266455-rbblg4pu	110	8	P50	P50	NNP
cord-266455-rbblg4pu	110	9	had	have	VBD
cord-266455-rbblg4pu	110	10	a	a	DT
cord-266455-rbblg4pu	110	11	low	low	JJ
cord-266455-rbblg4pu	110	12	sensitivity	sensitivity	NN
cord-266455-rbblg4pu	110	13	for	for	IN
cord-266455-rbblg4pu	110	14	Gram	gram	NN
cord-266455-rbblg4pu	110	15	positive	positive	JJ
cord-266455-rbblg4pu	110	16	organisms	organism	NNS
cord-266455-rbblg4pu	110	17	(	(	-LRB-
cord-266455-rbblg4pu	110	18	when	when	WRB
cord-266455-rbblg4pu	110	19	evaluated	evaluate	VBN
cord-266455-rbblg4pu	110	20	on	on	IN
cord-266455-rbblg4pu	110	21	paediatric	paediatric	JJ
cord-266455-rbblg4pu	110	22	samples	sample	NNS
cord-266455-rbblg4pu	110	23	)	)	-RRB-
cord-266455-rbblg4pu	110	24	41	41	CD
cord-266455-rbblg4pu	110	25	.	.	.
cord-266455-rbblg4pu	111	1	The	the	DT
cord-266455-rbblg4pu	111	2	resistance	resistance	NN
cord-266455-rbblg4pu	111	3	panel	panel	NN
cord-266455-rbblg4pu	111	4	on	on	IN
cord-266455-rbblg4pu	111	5	the	the	DT
cord-266455-rbblg4pu	111	6	P50	P50	NNP
cord-266455-rbblg4pu	111	7	was	be	VBD
cord-266455-rbblg4pu	111	8	broad	broad	JJ
cord-266455-rbblg4pu	111	9	but	but	CC
cord-266455-rbblg4pu	111	10	lacked	lack	VBD
cord-266455-rbblg4pu	111	11	several	several	JJ
cord-266455-rbblg4pu	111	12	key	key	JJ
cord-266455-rbblg4pu	111	13	emerging	emerge	VBG
cord-266455-rbblg4pu	111	14	carbapenemase	carbapenemase	NN
cord-266455-rbblg4pu	111	15	gene	gene	NN
cord-266455-rbblg4pu	111	16	targets	target	NNS
cord-266455-rbblg4pu	111	17	.	.	.
cord-266455-rbblg4pu	112	1	The	the	DT
cord-266455-rbblg4pu	112	2	P55	P55	NNP
cord-266455-rbblg4pu	112	3	panel	panel	NN
cord-266455-rbblg4pu	112	4	rebalanced	rebalance	VBD
cord-266455-rbblg4pu	112	5	this	this	DT
cord-266455-rbblg4pu	112	6	by	by	IN
cord-266455-rbblg4pu	112	7	removing	remove	VBG
cord-266455-rbblg4pu	112	8	less	less	RBR
cord-266455-rbblg4pu	112	9	clinically	clinically	RB
cord-266455-rbblg4pu	112	10	relevant	relevant	JJ
cord-266455-rbblg4pu	112	11	resistance	resistance	NN
cord-266455-rbblg4pu	112	12	genes	gene	NNS
cord-266455-rbblg4pu	112	13	.	.	.
cord-266455-rbblg4pu	113	1	It	-PRON-	PRP
cord-266455-rbblg4pu	113	2	added	add	VBD
cord-266455-rbblg4pu	113	3	targets	target	NNS
cord-266455-rbblg4pu	113	4	for	for	IN
cord-266455-rbblg4pu	113	5	S.	S.	NNP
cord-266455-rbblg4pu	113	6	pneumoniae	pneumoniae	NN
cord-266455-rbblg4pu	113	7	and	and	CC
cord-266455-rbblg4pu	113	8	M.	M.	NNP
cord-266455-rbblg4pu	113	9	pneumoniae	pneumoniae	NNS
cord-266455-rbblg4pu	113	10	.	.	.
cord-266455-rbblg4pu	114	1	Again	again	RB
cord-266455-rbblg4pu	114	2	,	,	,
cord-266455-rbblg4pu	114	3	the	the	DT
cord-266455-rbblg4pu	114	4	sensitivity	sensitivity	NN
cord-266455-rbblg4pu	114	5	for	for	IN
cord-266455-rbblg4pu	114	6	bacterial	bacterial	JJ
cord-266455-rbblg4pu	114	7	detection	detection	NN
cord-266455-rbblg4pu	114	8	remained	remain	VBD
cord-266455-rbblg4pu	114	9	high	high	JJ
cord-266455-rbblg4pu	114	10	when	when	WRB
cord-266455-rbblg4pu	114	11	assessed	assess	VBN
cord-266455-rbblg4pu	114	12	by	by	IN
cord-266455-rbblg4pu	114	13	Ozongwu	Ozongwu	NNP
cord-266455-rbblg4pu	114	14	et	et	NNP
cord-266455-rbblg4pu	114	15	al	al	NNP
cord-266455-rbblg4pu	114	16	.	.	.
cord-266455-rbblg4pu	115	1	albeit	albeit	IN
cord-266455-rbblg4pu	115	2	with	with	IN
cord-266455-rbblg4pu	115	3	a	a	DT
cord-266455-rbblg4pu	115	4	high	high	JJ
cord-266455-rbblg4pu	115	5	overall	overall	JJ
cord-266455-rbblg4pu	115	6	run	run	NN
cord-266455-rbblg4pu	115	7	failure	failure	NN
cord-266455-rbblg4pu	115	8	rate	rate	NN
cord-266455-rbblg4pu	115	9	of	of	IN
cord-266455-rbblg4pu	115	10	10	10	CD
cord-266455-rbblg4pu	115	11	%	%	NN
cord-266455-rbblg4pu	115	12	17	17	CD
cord-266455-rbblg4pu	115	13	.	.	.
cord-266455-rbblg4pu	116	1	The	the	DT
cord-266455-rbblg4pu	116	2	targets	target	NNS
cord-266455-rbblg4pu	116	3	on	on	IN
cord-266455-rbblg4pu	116	4	the	the	DT
cord-266455-rbblg4pu	116	5	panel	panel	NN
cord-266455-rbblg4pu	116	6	for	for	IN
cord-266455-rbblg4pu	116	7	the	the	DT
cord-266455-rbblg4pu	116	8	HPN	HPN	NNP
cord-266455-rbblg4pu	116	9	are	be	VBP
cord-266455-rbblg4pu	116	10	the	the	DT
cord-266455-rbblg4pu	116	11	same	same	JJ
cord-266455-rbblg4pu	116	12	as	as	IN
cord-266455-rbblg4pu	116	13	the	the	DT
cord-266455-rbblg4pu	116	14	P55	P55	NNP
cord-266455-rbblg4pu	116	15	,	,	,
cord-266455-rbblg4pu	116	16	but	but	CC
cord-266455-rbblg4pu	116	17	the	the	DT
cord-266455-rbblg4pu	116	18	manufacturer	manufacturer	NN
cord-266455-rbblg4pu	116	19	claims	claim	VBZ
cord-266455-rbblg4pu	116	20	it	-PRON-	PRP
cord-266455-rbblg4pu	116	21	has	have	VBZ
cord-266455-rbblg4pu	116	22	a	a	DT
cord-266455-rbblg4pu	116	23	higher	high	JJR
cord-266455-rbblg4pu	116	24	sensitivity	sensitivity	NN
cord-266455-rbblg4pu	116	25	and	and	CC
cord-266455-rbblg4pu	116	26	specificity	specificity	NN
cord-266455-rbblg4pu	116	27	.	.	.
cord-266455-rbblg4pu	117	1	To	to	IN
cord-266455-rbblg4pu	117	2	date	date	NN
cord-266455-rbblg4pu	117	3	there	there	EX
cord-266455-rbblg4pu	117	4	are	be	VBP
cord-266455-rbblg4pu	117	5	no	no	DT
cord-266455-rbblg4pu	117	6	published	publish	VBN
cord-266455-rbblg4pu	117	7	randomised	randomised	JJ
cord-266455-rbblg4pu	117	8	controlled	control	VBN
cord-266455-rbblg4pu	117	9	trials	trial	NNS
cord-266455-rbblg4pu	117	10	evaluating	evaluate	VBG
cord-266455-rbblg4pu	117	11	the	the	DT
cord-266455-rbblg4pu	117	12	clinical	clinical	JJ
cord-266455-rbblg4pu	117	13	impact	impact	NN
cord-266455-rbblg4pu	117	14	of	of	IN
cord-266455-rbblg4pu	117	15	the	the	DT
cord-266455-rbblg4pu	117	16	Unyvero	Unyvero	NNP
cord-266455-rbblg4pu	117	17	HPN	HPN	NNP
cord-266455-rbblg4pu	117	18	system	system	NN
cord-266455-rbblg4pu	117	19	in	in	IN
cord-266455-rbblg4pu	117	20	patients	patient	NNS
cord-266455-rbblg4pu	117	21	with	with	IN
cord-266455-rbblg4pu	117	22	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	117	23	.	.	.
cord-266455-rbblg4pu	118	1	Jamal	Jamal	NNP
cord-266455-rbblg4pu	118	2	et	et	NNP
cord-266455-rbblg4pu	118	3	al	al	NNP
cord-266455-rbblg4pu	118	4	42	42	CD
cord-266455-rbblg4pu	118	5	performed	perform	VBD
cord-266455-rbblg4pu	118	6	a	a	DT
cord-266455-rbblg4pu	118	7	non	non	JJ
cord-266455-rbblg4pu	118	8	-	-	JJ
cord-266455-rbblg4pu	118	9	randomised	randomised	JJ
cord-266455-rbblg4pu	118	10	interventional	interventional	JJ
cord-266455-rbblg4pu	118	11	study	study	NN
cord-266455-rbblg4pu	118	12	using	use	VBG
cord-266455-rbblg4pu	118	13	the	the	DT
cord-266455-rbblg4pu	118	14	P50	P50	NNP
cord-266455-rbblg4pu	118	15	assay	assay	NN
cord-266455-rbblg4pu	118	16	where	where	WRB
cord-266455-rbblg4pu	118	17	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	118	18	were	be	VBD
cord-266455-rbblg4pu	118	19	adjusted	adjust	VBN
cord-266455-rbblg4pu	118	20	based	base	VBN
cord-266455-rbblg4pu	118	21	on	on	IN
cord-266455-rbblg4pu	118	22	the	the	DT
cord-266455-rbblg4pu	118	23	results	result	NNS
cord-266455-rbblg4pu	118	24	and	and	CC
cord-266455-rbblg4pu	118	25	pathogens	pathogen	NNS
cord-266455-rbblg4pu	118	26	detected	detect	VBN
cord-266455-rbblg4pu	118	27	were	be	VBD
cord-266455-rbblg4pu	118	28	compared	compare	VBN
cord-266455-rbblg4pu	118	29	to	to	IN
cord-266455-rbblg4pu	118	30	culture	culture	NN
cord-266455-rbblg4pu	118	31	.	.	.
cord-266455-rbblg4pu	119	1	The	the	DT
cord-266455-rbblg4pu	119	2	turnaround	turnaround	NN
cord-266455-rbblg4pu	119	3	time	time	NN
cord-266455-rbblg4pu	119	4	for	for	IN
cord-266455-rbblg4pu	119	5	result	result	NN
cord-266455-rbblg4pu	119	6	was	be	VBD
cord-266455-rbblg4pu	119	7	very	very	RB
cord-266455-rbblg4pu	119	8	quick	quick	JJ
cord-266455-rbblg4pu	120	1	(	(	-LRB-
cord-266455-rbblg4pu	120	2	∼4	∼4	NNP
cord-266455-rbblg4pu	120	3	h	h	NNP
cord-266455-rbblg4pu	120	4	)	)	-RRB-
cord-266455-rbblg4pu	120	5	compared	compare	VBN
cord-266455-rbblg4pu	120	6	to	to	IN
cord-266455-rbblg4pu	120	7	culture	culture	NN
cord-266455-rbblg4pu	120	8	(	(	-LRB-
cord-266455-rbblg4pu	120	9	48	48	CD
cord-266455-rbblg4pu	120	10	-	-	SYM
cord-266455-rbblg4pu	120	11	96	96	CD
cord-266455-rbblg4pu	120	12	h	h	NN
cord-266455-rbblg4pu	120	13	)	)	-RRB-
cord-266455-rbblg4pu	120	14	and	and	CC
cord-266455-rbblg4pu	121	1	a	a	DT
cord-266455-rbblg4pu	121	2	large	large	JJ
cord-266455-rbblg4pu	121	3	proportion	proportion	NN
cord-266455-rbblg4pu	121	4	of	of	IN
cord-266455-rbblg4pu	121	5	patients	patient	NNS
cord-266455-rbblg4pu	121	6	had	have	VBD
cord-266455-rbblg4pu	121	7	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	121	8	changed	change	VBN
cord-266455-rbblg4pu	121	9	based	base	VBN
cord-266455-rbblg4pu	121	10	on	on	IN
cord-266455-rbblg4pu	121	11	the	the	DT
cord-266455-rbblg4pu	121	12	P50	P50	NNP
cord-266455-rbblg4pu	121	13	results	result	NNS
cord-266455-rbblg4pu	121	14	,	,	,
cord-266455-rbblg4pu	121	15	however	however	RB
cord-266455-rbblg4pu	121	16	the	the	DT
cord-266455-rbblg4pu	121	17	small	small	JJ
cord-266455-rbblg4pu	121	18	number	number	NN
cord-266455-rbblg4pu	121	19	of	of	IN
cord-266455-rbblg4pu	121	20	patients	patient	NNS
cord-266455-rbblg4pu	121	21	studied	study	VBN
cord-266455-rbblg4pu	121	22	and	and	CC
cord-266455-rbblg4pu	121	23	the	the	DT
cord-266455-rbblg4pu	121	24	lack	lack	NN
cord-266455-rbblg4pu	121	25	of	of	IN
cord-266455-rbblg4pu	121	26	a	a	DT
cord-266455-rbblg4pu	121	27	comparator	comparator	NN
cord-266455-rbblg4pu	121	28	group	group	NN
cord-266455-rbblg4pu	121	29	make	make	VBP
cord-266455-rbblg4pu	121	30	definitive	definitive	JJ
cord-266455-rbblg4pu	121	31	conclusions	conclusion	NNS
cord-266455-rbblg4pu	121	32	impossible	impossible	JJ
cord-266455-rbblg4pu	121	33	.	.	.
cord-266455-rbblg4pu	122	1	Gadsby	Gadsby	NNP
cord-266455-rbblg4pu	122	2	et	et	FW
cord-266455-rbblg4pu	122	3	al	al	NNP
cord-266455-rbblg4pu	122	4	.	.	.
cord-266455-rbblg4pu	123	1	retrospectively	retrospectively	RB
cord-266455-rbblg4pu	123	2	tested	test	VBN
cord-266455-rbblg4pu	123	3	BAL	BAL	NNP
cord-266455-rbblg4pu	123	4	samples	sample	NNS
cord-266455-rbblg4pu	123	5	with	with	IN
cord-266455-rbblg4pu	123	6	the	the	DT
cord-266455-rbblg4pu	123	7	P55	P55	NNP
cord-266455-rbblg4pu	123	8	and	and	CC
cord-266455-rbblg4pu	123	9	reviewed	review	VBD
cord-266455-rbblg4pu	123	10	patient	patient	JJ
cord-266455-rbblg4pu	123	11	notes	note	NNS
cord-266455-rbblg4pu	123	12	.	.	.
cord-266455-rbblg4pu	124	1	They	-PRON-	PRP
cord-266455-rbblg4pu	124	2	reported	report	VBD
cord-266455-rbblg4pu	124	3	that	that	IN
cord-266455-rbblg4pu	124	4	53.6	53.6	CD
cord-266455-rbblg4pu	124	5	%	%	NN
cord-266455-rbblg4pu	124	6	of	of	IN
cord-266455-rbblg4pu	124	7	patients	patient	NNS
cord-266455-rbblg4pu	124	8	who	who	WP
cord-266455-rbblg4pu	124	9	had	have	VBD
cord-266455-rbblg4pu	124	10	positive	positive	JJ
cord-266455-rbblg4pu	124	11	standard	standard	NN
cord-266455-rbblg4pu	124	12	of	of	IN
cord-266455-rbblg4pu	124	13	care	care	NN
cord-266455-rbblg4pu	124	14	microbiology	microbiology	NN
cord-266455-rbblg4pu	124	15	could	could	MD
cord-266455-rbblg4pu	124	16	potentially	potentially	RB
cord-266455-rbblg4pu	124	17	have	have	VB
cord-266455-rbblg4pu	124	18	had	have	VBN
cord-266455-rbblg4pu	124	19	a	a	DT
cord-266455-rbblg4pu	124	20	change	change	NN
cord-266455-rbblg4pu	124	21	in	in	IN
cord-266455-rbblg4pu	124	22	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	124	23	earlier	early	RBR
cord-266455-rbblg4pu	124	24	based	base	VBN
cord-266455-rbblg4pu	124	25	on	on	IN
cord-266455-rbblg4pu	124	26	P55	P55	NNP
cord-266455-rbblg4pu	124	27	results	result	VBZ
cord-266455-rbblg4pu	124	28	39	39	CD
cord-266455-rbblg4pu	124	29	.	.	.
cord-266455-rbblg4pu	125	1	Conversely	conversely	RB
cord-266455-rbblg4pu	125	2	,	,	,
cord-266455-rbblg4pu	125	3	they	-PRON-	PRP
cord-266455-rbblg4pu	125	4	reported	report	VBD
cord-266455-rbblg4pu	125	5	a	a	DT
cord-266455-rbblg4pu	125	6	false	false	JJ
cord-266455-rbblg4pu	125	7	negative	negative	JJ
cord-266455-rbblg4pu	125	8	P55	P55	NNP
cord-266455-rbblg4pu	125	9	result	result	NN
cord-266455-rbblg4pu	125	10	in	in	IN
cord-266455-rbblg4pu	125	11	∼20	∼20	NNS
cord-266455-rbblg4pu	125	12	%	%	NN
cord-266455-rbblg4pu	125	13	of	of	IN
cord-266455-rbblg4pu	125	14	those	those	DT
cord-266455-rbblg4pu	125	15	with	with	IN
cord-266455-rbblg4pu	125	16	a	a	DT
cord-266455-rbblg4pu	125	17	positive	positive	JJ
cord-266455-rbblg4pu	125	18	culture	culture	NN
cord-266455-rbblg4pu	125	19	which	which	WDT
cord-266455-rbblg4pu	125	20	could	could	MD
cord-266455-rbblg4pu	125	21	have	have	VB
cord-266455-rbblg4pu	125	22	caused	cause	VBN
cord-266455-rbblg4pu	125	23	harm	harm	NN
cord-266455-rbblg4pu	125	24	if	if	IN
cord-266455-rbblg4pu	125	25	acted	act	VBN
cord-266455-rbblg4pu	125	26	upon	upon	IN
cord-266455-rbblg4pu	125	27	.	.	.
cord-266455-rbblg4pu	126	1	The	the	DT
cord-266455-rbblg4pu	126	2	Respiratory	respiratory	JJ
cord-266455-rbblg4pu	126	3	pathogens	pathogen	NNS
cord-266455-rbblg4pu	126	4	33	33	CD
cord-266455-rbblg4pu	126	5	panel	panel	NN
cord-266455-rbblg4pu	126	6	differs	differ	VBZ
cord-266455-rbblg4pu	126	7	from	from	IN
cord-266455-rbblg4pu	126	8	the	the	DT
cord-266455-rbblg4pu	126	9	first	first	JJ
cord-266455-rbblg4pu	126	10	two	two	CD
cord-266455-rbblg4pu	126	11	tests	test	NNS
cord-266455-rbblg4pu	126	12	discussed	discuss	VBN
cord-266455-rbblg4pu	126	13	in	in	IN
cord-266455-rbblg4pu	126	14	that	that	IN
cord-266455-rbblg4pu	126	15	it	-PRON-	PRP
cord-266455-rbblg4pu	126	16	is	be	VBZ
cord-266455-rbblg4pu	126	17	exclusively	exclusively	RB
cord-266455-rbblg4pu	126	18	a	a	DT
cord-266455-rbblg4pu	126	19	laboratory	laboratory	NN
cord-266455-rbblg4pu	126	20	centred	centre	VBN
cord-266455-rbblg4pu	126	21	assay	assay	NN
cord-266455-rbblg4pu	126	22	.	.	.
cord-266455-rbblg4pu	127	1	The	the	DT
cord-266455-rbblg4pu	127	2	CE	CE	NNP
cord-266455-rbblg4pu	127	3	marked	mark	VBD
cord-266455-rbblg4pu	127	4	Respiratory	respiratory	JJ
cord-266455-rbblg4pu	127	5	pathogens	pathogen	NNS
cord-266455-rbblg4pu	127	6	33	33	CD
cord-266455-rbblg4pu	127	7	kit	kit	NN
cord-266455-rbblg4pu	127	8	can	can	MD
cord-266455-rbblg4pu	127	9	be	be	VB
cord-266455-rbblg4pu	127	10	used	use	VBN
cord-266455-rbblg4pu	127	11	on	on	IN
cord-266455-rbblg4pu	127	12	several	several	JJ
cord-266455-rbblg4pu	127	13	standard	standard	JJ
cord-266455-rbblg4pu	127	14	laboratory	laboratory	NN
cord-266455-rbblg4pu	127	15	cyclers	cycler	NNS
cord-266455-rbblg4pu	127	16	.	.	.
cord-266455-rbblg4pu	128	1	As	as	IN
cord-266455-rbblg4pu	128	2	such	such	JJ
cord-266455-rbblg4pu	128	3	there	there	EX
cord-266455-rbblg4pu	128	4	is	be	VBZ
cord-266455-rbblg4pu	128	5	no	no	DT
cord-266455-rbblg4pu	128	6	reported	report	VBN
cord-266455-rbblg4pu	128	7	standard	standard	JJ
cord-266455-rbblg4pu	128	8	turnaround	turnaround	NN
cord-266455-rbblg4pu	128	9	time	time	NN
cord-266455-rbblg4pu	128	10	although	although	IN
cord-266455-rbblg4pu	128	11	it	-PRON-	PRP
cord-266455-rbblg4pu	128	12	is	be	VBZ
cord-266455-rbblg4pu	129	1	greater	great	JJR
cord-266455-rbblg4pu	129	2	than	than	IN
cord-266455-rbblg4pu	129	3	6	6	CD
cord-266455-rbblg4pu	129	4	h.	h.	NN
cord-266455-rbblg4pu	129	5	Positive	positive	JJ
cord-266455-rbblg4pu	129	6	signals	signal	NNS
cord-266455-rbblg4pu	129	7	are	be	VBP
cord-266455-rbblg4pu	129	8	detected	detect	VBN
cord-266455-rbblg4pu	129	9	from	from	IN
cord-266455-rbblg4pu	129	10	eight	eight	CD
cord-266455-rbblg4pu	129	11	multiplex	multiplex	JJ
cord-266455-rbblg4pu	129	12	real	real	JJ
cord-266455-rbblg4pu	129	13	-	-	HYPH
cord-266455-rbblg4pu	129	14	time	time	NN
cord-266455-rbblg4pu	129	15	PCR	PCR	NNP
cord-266455-rbblg4pu	129	16	reactions	reaction	NNS
cord-266455-rbblg4pu	129	17	.	.	.
cord-266455-rbblg4pu	130	1	It	-PRON-	PRP
cord-266455-rbblg4pu	130	2	is	be	VBZ
cord-266455-rbblg4pu	130	3	not	not	RB
cord-266455-rbblg4pu	130	4	an	an	DT
cord-266455-rbblg4pu	130	5	automated	automated	JJ
cord-266455-rbblg4pu	130	6	process	process	NN
cord-266455-rbblg4pu	130	7	so	so	RB
cord-266455-rbblg4pu	130	8	will	will	MD
cord-266455-rbblg4pu	130	9	have	have	VB
cord-266455-rbblg4pu	130	10	a	a	DT
cord-266455-rbblg4pu	130	11	considerably	considerably	RB
cord-266455-rbblg4pu	130	12	longer	long	JJR
cord-266455-rbblg4pu	130	13	hands	hand	NNS
cord-266455-rbblg4pu	130	14	-	-	HYPH
cord-266455-rbblg4pu	130	15	on	on	RP
cord-266455-rbblg4pu	130	16	time	time	NN
cord-266455-rbblg4pu	130	17	requiring	require	VBG
cord-266455-rbblg4pu	130	18	skilled	skilled	JJ
cord-266455-rbblg4pu	130	19	extraction	extraction	NN
cord-266455-rbblg4pu	130	20	and	and	CC
cord-266455-rbblg4pu	130	21	setup	setup	NN
cord-266455-rbblg4pu	130	22	.	.	.
cord-266455-rbblg4pu	131	1	The	the	DT
cord-266455-rbblg4pu	131	2	 	 	_SP
cord-266455-rbblg4pu	131	3	There	there	EX
cord-266455-rbblg4pu	131	4	is	be	VBZ
cord-266455-rbblg4pu	131	5	very	very	RB
cord-266455-rbblg4pu	131	6	little	little	JJ
cord-266455-rbblg4pu	131	7	published	publish	VBN
cord-266455-rbblg4pu	131	8	data	datum	NNS
cord-266455-rbblg4pu	131	9	comparing	compare	VBG
cord-266455-rbblg4pu	131	10	different	different	JJ
cord-266455-rbblg4pu	131	11	syndromic	syndromic	JJ
cord-266455-rbblg4pu	131	12	molecular	molecular	JJ
cord-266455-rbblg4pu	131	13	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	131	14	tests	test	NNS
cord-266455-rbblg4pu	131	15	.	.	.
cord-266455-rbblg4pu	132	1	Enne	Enne	NNP
cord-266455-rbblg4pu	132	2	et	et	NNP
cord-266455-rbblg4pu	132	3	al	al	NNP
cord-266455-rbblg4pu	132	4	.	.	.
cord-266455-rbblg4pu	133	1	and	and	CC
cord-266455-rbblg4pu	133	2	the	the	DT
cord-266455-rbblg4pu	133	3	INHALE	INHALE	NNP
cord-266455-rbblg4pu	133	4	group	group	NN
cord-266455-rbblg4pu	133	5	presented	present	VBD
cord-266455-rbblg4pu	133	6	data	datum	NNS
cord-266455-rbblg4pu	133	7	at	at	IN
cord-266455-rbblg4pu	133	8	ECCMID	ECCMID	NNP
cord-266455-rbblg4pu	133	9	2019	2019	CD
cord-266455-rbblg4pu	133	10	where	where	WRB
cord-266455-rbblg4pu	133	11	they	-PRON-	PRP
cord-266455-rbblg4pu	133	12	compared	compare	VBD
cord-266455-rbblg4pu	133	13	the	the	DT
cord-266455-rbblg4pu	133	14	Unyvero	Unyvero	NNP
cord-266455-rbblg4pu	133	15	and	and	CC
cord-266455-rbblg4pu	133	16	the	the	DT
cord-266455-rbblg4pu	133	17	Filmarray	Filmarray	NNP
cord-266455-rbblg4pu	133	18	on	on	IN
cord-266455-rbblg4pu	133	19	654	654	CD
cord-266455-rbblg4pu	133	20	surplus	surplus	NN
cord-266455-rbblg4pu	133	21	intensive	intensive	JJ
cord-266455-rbblg4pu	133	22	care	care	NN
cord-266455-rbblg4pu	133	23	respiratory	respiratory	JJ
cord-266455-rbblg4pu	133	24	tract	tract	NN
cord-266455-rbblg4pu	133	25	samples	sample	NNS
cord-266455-rbblg4pu	133	26	36	36	CD
cord-266455-rbblg4pu	133	27	.	.	.
cord-266455-rbblg4pu	134	1	The	the	DT
cord-266455-rbblg4pu	134	2	Filmarray	Filmarray	NNP
cord-266455-rbblg4pu	134	3	had	have	VBD
cord-266455-rbblg4pu	134	4	slightly	slightly	RB
cord-266455-rbblg4pu	134	5	greater	great	JJR
cord-266455-rbblg4pu	134	6	sensitivity	sensitivity	NN
cord-266455-rbblg4pu	134	7	for	for	IN
cord-266455-rbblg4pu	134	8	common	common	JJ
cord-266455-rbblg4pu	134	9	pathogens	pathogen	NNS
cord-266455-rbblg4pu	134	10	,	,	,
cord-266455-rbblg4pu	134	11	fewer	few	JJR
cord-266455-rbblg4pu	134	12	major	major	JJ
cord-266455-rbblg4pu	134	13	discordances	discordance	NNS
cord-266455-rbblg4pu	134	14	(	(	-LRB-
cord-266455-rbblg4pu	134	15	defined	define	VBN
cord-266455-rbblg4pu	134	16	as	as	IN
cord-266455-rbblg4pu	134	17	routine	routine	JJ
cord-266455-rbblg4pu	134	18	culture	culture	NN
cord-266455-rbblg4pu	134	19	finding	find	VBG
cord-266455-rbblg4pu	134	20	1	1	CD
cord-266455-rbblg4pu	134	21	or	or	CC
cord-266455-rbblg4pu	134	22	more	more	JJR
cord-266455-rbblg4pu	134	23	undetected	undetected	JJ
cord-266455-rbblg4pu	134	24	organisms	organism	NNS
cord-266455-rbblg4pu	134	25	)	)	-RRB-
cord-266455-rbblg4pu	134	26	and	and	CC
cord-266455-rbblg4pu	134	27	fewer	few	JJR
cord-266455-rbblg4pu	134	28	machine	machine	NN
cord-266455-rbblg4pu	134	29	failures	failure	NNS
cord-266455-rbblg4pu	134	30	.	.	.
cord-266455-rbblg4pu	135	1	The	the	DT
cord-266455-rbblg4pu	135	2	Unyvero	Unyvero	NNP
cord-266455-rbblg4pu	135	3	had	have	VBD
cord-266455-rbblg4pu	135	4	slightly	slightly	RB
cord-266455-rbblg4pu	135	5	higher	high	JJR
cord-266455-rbblg4pu	135	6	specificity	specificity	NN
cord-266455-rbblg4pu	135	7	and	and	CC
cord-266455-rbblg4pu	135	8	overall	overall	JJ
cord-266455-rbblg4pu	135	9	concordance	concordance	NN
cord-266455-rbblg4pu	135	10	with	with	IN
cord-266455-rbblg4pu	135	11	reference	reference	NN
cord-266455-rbblg4pu	135	12	culture	culture	NN
cord-266455-rbblg4pu	135	13	.	.	.
cord-266455-rbblg4pu	136	1	Whilst	whilst	IN
cord-266455-rbblg4pu	136	2	the	the	DT
cord-266455-rbblg4pu	136	3	data	datum	NNS
cord-266455-rbblg4pu	136	4	presented	present	VBN
cord-266455-rbblg4pu	136	5	for	for	IN
cord-266455-rbblg4pu	136	6	syndromic	syndromic	NNP
cord-266455-rbblg4pu	136	7	molecular	molecular	JJ
cord-266455-rbblg4pu	136	8	test	test	NN
cord-266455-rbblg4pu	136	9	for	for	IN
cord-266455-rbblg4pu	136	10	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	136	11	clearly	clearly	RB
cord-266455-rbblg4pu	136	12	demonstrates	demonstrate	VBZ
cord-266455-rbblg4pu	136	13	high	high	JJ
cord-266455-rbblg4pu	136	14	accuracy	accuracy	NN
cord-266455-rbblg4pu	136	15	and	and	CC
cord-266455-rbblg4pu	136	16	the	the	DT
cord-266455-rbblg4pu	136	17	detection	detection	NN
cord-266455-rbblg4pu	136	18	of	of	IN
cord-266455-rbblg4pu	136	19	many	many	JJ
cord-266455-rbblg4pu	136	20	more	more	JJR
cord-266455-rbblg4pu	136	21	pathogens	pathogen	NNS
cord-266455-rbblg4pu	136	22	than	than	IN
cord-266455-rbblg4pu	136	23	culture	culture	NN
cord-266455-rbblg4pu	136	24	,	,	,
cord-266455-rbblg4pu	136	25	no	no	DT
cord-266455-rbblg4pu	136	26	data	data	NN
cord-266455-rbblg4pu	136	27	has	have	VBZ
cord-266455-rbblg4pu	136	28	yet	yet	RB
cord-266455-rbblg4pu	136	29	been	be	VBN
cord-266455-rbblg4pu	136	30	published	publish	VBN
cord-266455-rbblg4pu	136	31	showing	show	VBG
cord-266455-rbblg4pu	136	32	that	that	IN
cord-266455-rbblg4pu	136	33	this	this	DT
cord-266455-rbblg4pu	136	34	translates	translate	VBZ
cord-266455-rbblg4pu	136	35	into	into	IN
cord-266455-rbblg4pu	136	36	improved	improved	JJ
cord-266455-rbblg4pu	136	37	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	136	38	use	use	NN
cord-266455-rbblg4pu	136	39	or	or	CC
cord-266455-rbblg4pu	136	40	clinical	clinical	JJ
cord-266455-rbblg4pu	136	41	benefit	benefit	NN
cord-266455-rbblg4pu	136	42	.	.	.
cord-266455-rbblg4pu	137	1	Other	other	JJ
cord-266455-rbblg4pu	137	2	molecular	molecular	JJ
cord-266455-rbblg4pu	137	3	diagnostics	diagnostic	NNS
cord-266455-rbblg4pu	137	4	studies	study	NNS
cord-266455-rbblg4pu	137	5	for	for	IN
cord-266455-rbblg4pu	137	6	blood	blood	NN
cord-266455-rbblg4pu	137	7	stream	stream	NN
cord-266455-rbblg4pu	137	8	infection	infection	NN
cord-266455-rbblg4pu	137	9	45	45	CD
cord-266455-rbblg4pu	137	10	have	have	VBP
cord-266455-rbblg4pu	137	11	shown	show	VBN
cord-266455-rbblg4pu	137	12	improved	improve	VBN
cord-266455-rbblg4pu	137	13	diagnostic	diagnostic	JJ
cord-266455-rbblg4pu	137	14	performance	performance	NN
cord-266455-rbblg4pu	137	15	,	,	,
cord-266455-rbblg4pu	137	16	but	but	CC
cord-266455-rbblg4pu	137	17	negligible	negligible	JJ
cord-266455-rbblg4pu	137	18	impact	impact	NN
cord-266455-rbblg4pu	137	19	on	on	IN
cord-266455-rbblg4pu	137	20	clinical	clinical	JJ
cord-266455-rbblg4pu	137	21	outcomes	outcome	NNS
cord-266455-rbblg4pu	137	22	when	when	WRB
cord-266455-rbblg4pu	137	23	results	result	NNS
cord-266455-rbblg4pu	137	24	were	be	VBD
cord-266455-rbblg4pu	137	25	not	not	RB
cord-266455-rbblg4pu	137	26	provided	provide	VBN
cord-266455-rbblg4pu	137	27	to	to	IN
cord-266455-rbblg4pu	137	28	clinicians	clinician	NNS
cord-266455-rbblg4pu	137	29	along	along	IN
cord-266455-rbblg4pu	137	30	with	with	IN
cord-266455-rbblg4pu	137	31	infection	infection	NN
cord-266455-rbblg4pu	137	32	specialist	specialist	JJ
cord-266455-rbblg4pu	137	33	advice	advice	NN
cord-266455-rbblg4pu	137	34	.	.	.
cord-266455-rbblg4pu	138	1	It	-PRON-	PRP
cord-266455-rbblg4pu	138	2	seems	seem	VBZ
cord-266455-rbblg4pu	138	3	likely	likely	JJ
cord-266455-rbblg4pu	138	4	that	that	IN
cord-266455-rbblg4pu	138	5	such	such	PDT
cord-266455-rbblg4pu	138	6	a	a	DT
cord-266455-rbblg4pu	138	7	wealth	wealth	NN
cord-266455-rbblg4pu	138	8	of	of	IN
cord-266455-rbblg4pu	138	9	information	information	NN
cord-266455-rbblg4pu	138	10	generated	generate	VBN
cord-266455-rbblg4pu	138	11	will	will	MD
cord-266455-rbblg4pu	138	12	require	require	VB
cord-266455-rbblg4pu	138	13	careful	careful	JJ
cord-266455-rbblg4pu	138	14	interpretation	interpretation	NN
cord-266455-rbblg4pu	138	15	by	by	IN
cord-266455-rbblg4pu	138	16	an	an	DT
cord-266455-rbblg4pu	138	17	infection	infection	NN
cord-266455-rbblg4pu	138	18	specialist	specialist	NN
cord-266455-rbblg4pu	138	19	in	in	IN
cord-266455-rbblg4pu	138	20	consultation	consultation	NN
cord-266455-rbblg4pu	138	21	with	with	IN
cord-266455-rbblg4pu	138	22	the	the	DT
cord-266455-rbblg4pu	138	23	clinicians	clinician	NNS
cord-266455-rbblg4pu	138	24	directly	directly	RB
cord-266455-rbblg4pu	138	25	caring	care	VBG
cord-266455-rbblg4pu	138	26	for	for	IN
cord-266455-rbblg4pu	138	27	the	the	DT
cord-266455-rbblg4pu	138	28	patient	patient	NN
cord-266455-rbblg4pu	138	29	,	,	,
cord-266455-rbblg4pu	138	30	for	for	IN
cord-266455-rbblg4pu	138	31	these	these	DT
cord-266455-rbblg4pu	138	32	benefits	benefit	NNS
cord-266455-rbblg4pu	138	33	to	to	TO
cord-266455-rbblg4pu	138	34	be	be	VB
cord-266455-rbblg4pu	138	35	maximised	maximise	VBN
cord-266455-rbblg4pu	138	36	.	.	.
cord-266455-rbblg4pu	139	1	Rapid	Rapid	NNP
cord-266455-rbblg4pu	139	2	syndromic	syndromic	JJ
cord-266455-rbblg4pu	139	3	molecular	molecular	JJ
cord-266455-rbblg4pu	139	4	platforms	platform	NNS
cord-266455-rbblg4pu	139	5	have	have	VBP
cord-266455-rbblg4pu	139	6	the	the	DT
cord-266455-rbblg4pu	139	7	potential	potential	NN
cord-266455-rbblg4pu	139	8	to	to	TO
cord-266455-rbblg4pu	139	9	significantly	significantly	RB
cord-266455-rbblg4pu	139	10	improve	improve	VB
cord-266455-rbblg4pu	139	11	the	the	DT
cord-266455-rbblg4pu	139	12	use	use	NN
cord-266455-rbblg4pu	139	13	of	of	IN
cord-266455-rbblg4pu	139	14	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	139	15	and	and	CC
cord-266455-rbblg4pu	139	16	clinical	clinical	JJ
cord-266455-rbblg4pu	139	17	outcomes	outcome	NNS
cord-266455-rbblg4pu	139	18	in	in	IN
cord-266455-rbblg4pu	139	19	patient	patient	NN
cord-266455-rbblg4pu	139	20	with	with	IN
cord-266455-rbblg4pu	139	21	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	139	22	,	,	,
cord-266455-rbblg4pu	139	23	but	but	CC
cord-266455-rbblg4pu	139	24	high	high	JJ
cord-266455-rbblg4pu	139	25	quality	quality	NN
cord-266455-rbblg4pu	139	26	randomised	randomise	VBN
cord-266455-rbblg4pu	139	27	controlled	control	VBN
cord-266455-rbblg4pu	139	28	trials	trial	NNS
cord-266455-rbblg4pu	139	29	are	be	VBP
cord-266455-rbblg4pu	139	30	urgently	urgently	RB
cord-266455-rbblg4pu	139	31	required	require	VBN
cord-266455-rbblg4pu	139	32	to	to	TO
cord-266455-rbblg4pu	139	33	evaluate	evaluate	VB
cord-266455-rbblg4pu	139	34	their	-PRON-	PRP$
cord-266455-rbblg4pu	139	35	clinical	clinical	JJ
cord-266455-rbblg4pu	139	36	impact	impact	NN
cord-266455-rbblg4pu	139	37	.	.	.
cord-266455-rbblg4pu	140	1	We	-PRON-	PRP
cord-266455-rbblg4pu	140	2	are	be	VBP
cord-266455-rbblg4pu	140	3	aware	aware	JJ
cord-266455-rbblg4pu	140	4	of	of	IN
cord-266455-rbblg4pu	140	5	5	5	CD
cord-266455-rbblg4pu	140	6	trials	trial	NNS
cord-266455-rbblg4pu	140	7	that	that	WDT
cord-266455-rbblg4pu	140	8	are	be	VBP
cord-266455-rbblg4pu	140	9	currently	currently	RB
cord-266455-rbblg4pu	140	10	underway	underway	JJ
cord-266455-rbblg4pu	140	11	or	or	CC
cord-266455-rbblg4pu	140	12	in	in	IN
cord-266455-rbblg4pu	140	13	set	set	VBN
cord-266455-rbblg4pu	140	14	up	up	RP
cord-266455-rbblg4pu	140	15	that	that	WDT
cord-266455-rbblg4pu	140	16	may	may	MD
cord-266455-rbblg4pu	140	17	address	address	VB
cord-266455-rbblg4pu	140	18	this	this	DT
cord-266455-rbblg4pu	140	19	evidence	evidence	NN
cord-266455-rbblg4pu	140	20	gap	gap	NN
cord-266455-rbblg4pu	140	21	:	:	:
cord-266455-rbblg4pu	140	22	the	the	DT
cord-266455-rbblg4pu	140	23	SARIPOC	SARIPOC	NNP
cord-266455-rbblg4pu	140	24	study	study	NN
cord-266455-rbblg4pu	140	25	is	be	VBZ
cord-266455-rbblg4pu	140	26	a	a	DT
cord-266455-rbblg4pu	140	27	single	single	JJ
cord-266455-rbblg4pu	140	28	centre	centre	NN
cord-266455-rbblg4pu	140	29	randomised	randomise	VBN
cord-266455-rbblg4pu	140	30	controlled	control	VBN
cord-266455-rbblg4pu	140	31	trial	trial	NN
cord-266455-rbblg4pu	140	32	(	(	-LRB-
cord-266455-rbblg4pu	140	33	RCT	RCT	NNP
cord-266455-rbblg4pu	140	34	)	)	-RRB-
cord-266455-rbblg4pu	140	35	recruiting	recruit	VBG
cord-266455-rbblg4pu	140	36	critically	critically	RB
cord-266455-rbblg4pu	140	37	unwell	unwell	JJ
cord-266455-rbblg4pu	140	38	patients	patient	NNS
cord-266455-rbblg4pu	140	39	with	with	IN
cord-266455-rbblg4pu	140	40	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	140	41	in	in	IN
cord-266455-rbblg4pu	140	42	Southampton	Southampton	NNP
cord-266455-rbblg4pu	140	43	,	,	,
cord-266455-rbblg4pu	140	44	UK	UK	NNP
cord-266455-rbblg4pu	140	45	.	.	.
cord-266455-rbblg4pu	141	1	The	the	DT
cord-266455-rbblg4pu	141	2	INHALE	INHALE	NNP
cord-266455-rbblg4pu	141	3	study	study	NN
cord-266455-rbblg4pu	141	4	is	be	VBZ
cord-266455-rbblg4pu	141	5	a	a	DT
cord-266455-rbblg4pu	141	6	UK	UK	NNP
cord-266455-rbblg4pu	141	7	multicentre	multicentre	NN
cord-266455-rbblg4pu	141	8	,	,	,
cord-266455-rbblg4pu	141	9	RCT	RCT	NNP
cord-266455-rbblg4pu	141	10	recruiting	recruit	VBG
cord-266455-rbblg4pu	141	11	critically	critically	RB
cord-266455-rbblg4pu	141	12	unwell	unwell	JJ
cord-266455-rbblg4pu	141	13	patients	patient	NNS
cord-266455-rbblg4pu	141	14	with	with	IN
cord-266455-rbblg4pu	141	15	HAP	HAP	NNP
cord-266455-rbblg4pu	141	16	and	and	CC
cord-266455-rbblg4pu	141	17	VAP	VAP	NNP
cord-266455-rbblg4pu	141	18	.	.	.
cord-266455-rbblg4pu	142	1	PIBCAP	PIBCAP	NNP
cord-266455-rbblg4pu	142	2	is	be	VBZ
cord-266455-rbblg4pu	142	3	a	a	DT
cord-266455-rbblg4pu	142	4	UK	UK	NNP
cord-266455-rbblg4pu	142	5	multicentre	multicentre	NN
cord-266455-rbblg4pu	142	6	RCT	RCT	NNP
cord-266455-rbblg4pu	142	7	recruiting	recruit	VBG
cord-266455-rbblg4pu	142	8	patients	patient	NNS
cord-266455-rbblg4pu	142	9	with	with	IN
cord-266455-rbblg4pu	142	10	CAP	CAP	NNP
cord-266455-rbblg4pu	142	11	.	.	.
cord-266455-rbblg4pu	143	1	The	the	DT
cord-266455-rbblg4pu	143	2	NORCAP	NORCAP	NNP
cord-266455-rbblg4pu	143	3	trial	trial	NN
cord-266455-rbblg4pu	143	4	,	,	,
cord-266455-rbblg4pu	143	5	in	in	IN
cord-266455-rbblg4pu	143	6	Norway	Norway	NNP
cord-266455-rbblg4pu	143	7	is	be	VBZ
cord-266455-rbblg4pu	143	8	a	a	DT
cord-266455-rbblg4pu	143	9	single	single	JJ
cord-266455-rbblg4pu	143	10	centre	centre	NN
cord-266455-rbblg4pu	143	11	RCT	RCT	NNP
cord-266455-rbblg4pu	143	12	in	in	IN
cord-266455-rbblg4pu	143	13	set	set	VBN
cord-266455-rbblg4pu	143	14	up	up	RP
cord-266455-rbblg4pu	143	15	,	,	,
cord-266455-rbblg4pu	143	16	also	also	RB
cord-266455-rbblg4pu	143	17	aiming	aim	VBG
cord-266455-rbblg4pu	143	18	to	to	TO
cord-266455-rbblg4pu	143	19	recruit	recruit	VB
cord-266455-rbblg4pu	143	20	patients	patient	NNS
cord-266455-rbblg4pu	143	21	with	with	IN
cord-266455-rbblg4pu	143	22	CAP	CAP	NNP
cord-266455-rbblg4pu	143	23	.	.	.
cord-266455-rbblg4pu	144	1	A	a	DT
cord-266455-rbblg4pu	144	2	further	further	JJ
cord-266455-rbblg4pu	144	3	single	single	JJ
cord-266455-rbblg4pu	144	4	centre	centre	NN
cord-266455-rbblg4pu	144	5	RCT	RCT	NNP
cord-266455-rbblg4pu	144	6	in	in	IN
cord-266455-rbblg4pu	144	7	Edinburgh	Edinburgh	NNP
cord-266455-rbblg4pu	144	8	is	be	VBZ
cord-266455-rbblg4pu	144	9	using	use	VBG
cord-266455-rbblg4pu	144	10	molecular	molecular	JJ
cord-266455-rbblg4pu	144	11	testing	testing	NN
cord-266455-rbblg4pu	144	12	for	for	IN
cord-266455-rbblg4pu	144	13	broader	broad	JJR
cord-266455-rbblg4pu	144	14	community	community	NN
cord-266455-rbblg4pu	144	15	acquired	acquire	VBD
cord-266455-rbblg4pu	144	16	LRTI	LRTI	NNP
cord-266455-rbblg4pu	144	17	microbial	microbial	JJ
cord-266455-rbblg4pu	144	18	diagnosis	diagnosis	NN
cord-266455-rbblg4pu	144	19	.	.	.
cord-266455-rbblg4pu	145	1	The	the	DT
cord-266455-rbblg4pu	145	2	first	first	JJ
cord-266455-rbblg4pu	145	3	of	of	IN
cord-266455-rbblg4pu	145	4	these	these	DT
cord-266455-rbblg4pu	145	5	two	two	CD
cord-266455-rbblg4pu	145	6	studies	study	NNS
cord-266455-rbblg4pu	145	7	are	be	VBP
cord-266455-rbblg4pu	145	8	testing	test	VBG
cord-266455-rbblg4pu	145	9	patients	patient	NNS
cord-266455-rbblg4pu	145	10	at	at	IN
cord-266455-rbblg4pu	145	11	the	the	DT
cord-266455-rbblg4pu	145	12	point	point	NN
cord-266455-rbblg4pu	145	13	-	-	HYPH
cord-266455-rbblg4pu	145	14	of	of	IN
cord-266455-rbblg4pu	145	15	-	-	HYPH
cord-266455-rbblg4pu	145	16	care	care	NN
cord-266455-rbblg4pu	145	17	,	,	,
cord-266455-rbblg4pu	145	18	whereas	whereas	IN
cord-266455-rbblg4pu	145	19	the	the	DT
cord-266455-rbblg4pu	145	20	others	other	NNS
cord-266455-rbblg4pu	145	21	use	use	VBP
cord-266455-rbblg4pu	145	22	rapid	rapid	JJ
cord-266455-rbblg4pu	145	23	laboratory	laboratory	NN
cord-266455-rbblg4pu	145	24	-	-	HYPH
cord-266455-rbblg4pu	145	25	based	base	VBN
cord-266455-rbblg4pu	145	26	testing	testing	NN
cord-266455-rbblg4pu	145	27	.	.	.
cord-266455-rbblg4pu	146	1	Antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	146	2	de	de	NN
cord-266455-rbblg4pu	146	3	-	-	NN
cord-266455-rbblg4pu	146	4	escalation	escalation	NN
cord-266455-rbblg4pu	146	5	based	base	VBN
cord-266455-rbblg4pu	146	6	on	on	IN
cord-266455-rbblg4pu	146	7	results	result	NNS
cord-266455-rbblg4pu	146	8	is	be	VBZ
cord-266455-rbblg4pu	146	9	a	a	DT
cord-266455-rbblg4pu	146	10	key	key	JJ
cord-266455-rbblg4pu	146	11	component	component	NN
cord-266455-rbblg4pu	146	12	of	of	IN
cord-266455-rbblg4pu	146	13	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	146	14	stewardship	stewardship	NN
cord-266455-rbblg4pu	146	15	and	and	CC
cord-266455-rbblg4pu	146	16	is	be	VBZ
cord-266455-rbblg4pu	146	17	widely	widely	RB
cord-266455-rbblg4pu	146	18	accepted	accept	VBN
cord-266455-rbblg4pu	146	19	as	as	IN
cord-266455-rbblg4pu	146	20	good	good	JJ
cord-266455-rbblg4pu	146	21	practice	practice	NN
cord-266455-rbblg4pu	146	22	.	.	.
cord-266455-rbblg4pu	147	1	Trials	trial	NNS
cord-266455-rbblg4pu	147	2	looking	look	VBG
cord-266455-rbblg4pu	147	3	at	at	IN
cord-266455-rbblg4pu	147	4	the	the	DT
cord-266455-rbblg4pu	147	5	efficacy	efficacy	NN
cord-266455-rbblg4pu	147	6	and	and	CC
cord-266455-rbblg4pu	147	7	safety	safety	NN
cord-266455-rbblg4pu	147	8	of	of	IN
cord-266455-rbblg4pu	147	9	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	147	10	de	de	NN
cord-266455-rbblg4pu	147	11	-	-	NN
cord-266455-rbblg4pu	147	12	isolation	isolation	NN
cord-266455-rbblg4pu	147	13	based	base	VBN
cord-266455-rbblg4pu	147	14	on	on	IN
cord-266455-rbblg4pu	147	15	culture	culture	NN
cord-266455-rbblg4pu	147	16	results	result	NNS
cord-266455-rbblg4pu	147	17	are	be	VBP
cord-266455-rbblg4pu	147	18	sparse	sparse	JJ
cord-266455-rbblg4pu	147	19	.	.	.
cord-266455-rbblg4pu	148	1	The	the	DT
cord-266455-rbblg4pu	148	2	vast	vast	JJ
cord-266455-rbblg4pu	148	3	majority	majority	NN
cord-266455-rbblg4pu	148	4	of	of	IN
cord-266455-rbblg4pu	148	5	published	publish	VBN
cord-266455-rbblg4pu	148	6	studies	study	NNS
cord-266455-rbblg4pu	148	7	are	be	VBP
cord-266455-rbblg4pu	148	8	observational	observational	JJ
cord-266455-rbblg4pu	148	9	and	and	CC
cord-266455-rbblg4pu	148	10	comparison	comparison	NN
cord-266455-rbblg4pu	148	11	between	between	IN
cord-266455-rbblg4pu	148	12	studies	study	NNS
cord-266455-rbblg4pu	148	13	for	for	IN
cord-266455-rbblg4pu	148	14	so	so	RB
cord-266455-rbblg4pu	148	15	many	many	JJ
cord-266455-rbblg4pu	148	16	variables	variable	NNS
cord-266455-rbblg4pu	148	17	(	(	-LRB-
cord-266455-rbblg4pu	148	18	HAP	HAP	NNP
cord-266455-rbblg4pu	148	19	,	,	,
cord-266455-rbblg4pu	148	20	CAP	CAP	NNP
cord-266455-rbblg4pu	148	21	,	,	,
cord-266455-rbblg4pu	148	22	VAP	VAP	NNP
cord-266455-rbblg4pu	148	23	,	,	,
cord-266455-rbblg4pu	148	24	ICU/	ICU/	NNP
cord-266455-rbblg4pu	148	25	non	non	JJ
cord-266455-rbblg4pu	148	26	-	-	JJ
cord-266455-rbblg4pu	148	27	ICU	icu	JJ
cord-266455-rbblg4pu	148	28	,	,	,
cord-266455-rbblg4pu	148	29	severe	severe	JJ
cord-266455-rbblg4pu	148	30	sepsis	sepsis	NN
cord-266455-rbblg4pu	148	31	etc	etc	FW
cord-266455-rbblg4pu	148	32	.	.	.
cord-266455-rbblg4pu	148	33	)	)	-RRB-
cord-266455-rbblg4pu	148	34	are	be	VBP
cord-266455-rbblg4pu	148	35	fraught	fraught	JJ
cord-266455-rbblg4pu	148	36	with	with	IN
cord-266455-rbblg4pu	148	37	difficulties	difficulty	NNS
cord-266455-rbblg4pu	148	38	.	.	.
cord-266455-rbblg4pu	149	1	Furthermore	furthermore	RB
cord-266455-rbblg4pu	149	2	,	,	,
cord-266455-rbblg4pu	149	3	due	due	IN
cord-266455-rbblg4pu	149	4	to	to	IN
cord-266455-rbblg4pu	149	5	the	the	DT
cord-266455-rbblg4pu	149	6	geographic	geographic	JJ
cord-266455-rbblg4pu	149	7	variability	variability	NN
cord-266455-rbblg4pu	149	8	in	in	IN
cord-266455-rbblg4pu	149	9	causative	causative	JJ
cord-266455-rbblg4pu	149	10	organisms	organism	NNS
cord-266455-rbblg4pu	149	11	and	and	CC
cord-266455-rbblg4pu	149	12	prescribing	prescribe	VBG
cord-266455-rbblg4pu	149	13	practices	practice	NNS
cord-266455-rbblg4pu	149	14	,	,	,
cord-266455-rbblg4pu	149	15	they	-PRON-	PRP
cord-266455-rbblg4pu	149	16	are	be	VBP
cord-266455-rbblg4pu	149	17	often	often	RB
cord-266455-rbblg4pu	149	18	poorly	poorly	RB
cord-266455-rbblg4pu	149	19	transferrable	transferrable	JJ
cord-266455-rbblg4pu	149	20	between	between	IN
cord-266455-rbblg4pu	149	21	regions	region	NNS
cord-266455-rbblg4pu	149	22	.	.	.
cord-266455-rbblg4pu	150	1	To	to	IN
cord-266455-rbblg4pu	150	2	our	-PRON-	PRP$
cord-266455-rbblg4pu	150	3	knowledge	knowledge	NN
cord-266455-rbblg4pu	150	4	no	no	DT
cord-266455-rbblg4pu	150	5	interventional	interventional	JJ
cord-266455-rbblg4pu	150	6	studies	study	NNS
cord-266455-rbblg4pu	150	7	have	have	VBP
cord-266455-rbblg4pu	150	8	looked	look	VBN
cord-266455-rbblg4pu	150	9	at	at	IN
cord-266455-rbblg4pu	150	10	the	the	DT
cord-266455-rbblg4pu	150	11	safety	safety	NN
cord-266455-rbblg4pu	150	12	or	or	CC
cord-266455-rbblg4pu	150	13	efficacy	efficacy	NN
cord-266455-rbblg4pu	150	14	of	of	IN
cord-266455-rbblg4pu	150	15	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	150	16	de	de	NN
cord-266455-rbblg4pu	150	17	-	-	NN
cord-266455-rbblg4pu	150	18	escalation	escalation	NN
cord-266455-rbblg4pu	150	19	based	base	VBN
cord-266455-rbblg4pu	150	20	on	on	IN
cord-266455-rbblg4pu	150	21	multiplexed	multiplexed	JJ
cord-266455-rbblg4pu	150	22	PCR	PCR	NNP
cord-266455-rbblg4pu	150	23	for	for	IN
cord-266455-rbblg4pu	150	24	pathogens	pathogen	NNS
cord-266455-rbblg4pu	150	25	of	of	IN
cord-266455-rbblg4pu	150	26	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	150	27	.	.	.
cord-266455-rbblg4pu	151	1	Studies	study	NNS
cord-266455-rbblg4pu	151	2	to	to	IN
cord-266455-rbblg4pu	151	3	date	date	NN
cord-266455-rbblg4pu	151	4	have	have	VBP
cord-266455-rbblg4pu	151	5	made	make	VBN
cord-266455-rbblg4pu	151	6	their	-PRON-	PRP$
cord-266455-rbblg4pu	151	7	de	de	JJ
cord-266455-rbblg4pu	151	8	-	-	NN
cord-266455-rbblg4pu	151	9	escalation	escalation	NN
cord-266455-rbblg4pu	151	10	intervention	intervention	NN
cord-266455-rbblg4pu	151	11	after	after	IN
cord-266455-rbblg4pu	151	12	at	at	RB
cord-266455-rbblg4pu	151	13	least	least	JJS
cord-266455-rbblg4pu	151	14	48	48	CD
cord-266455-rbblg4pu	151	15	h	h	NN
cord-266455-rbblg4pu	151	16	when	when	WRB
cord-266455-rbblg4pu	151	17	the	the	DT
cord-266455-rbblg4pu	151	18	patient	patient	NN
cord-266455-rbblg4pu	151	19	has	have	VBZ
cord-266455-rbblg4pu	151	20	stabilised	stabilise	VBN
cord-266455-rbblg4pu	151	21	,	,	,
cord-266455-rbblg4pu	151	22	and	and	CC
cord-266455-rbblg4pu	151	23	culture	culture	NN
cord-266455-rbblg4pu	151	24	results	result	NNS
cord-266455-rbblg4pu	151	25	are	be	VBP
cord-266455-rbblg4pu	151	26	available	available	JJ
cord-266455-rbblg4pu	151	27	.	.	.
cord-266455-rbblg4pu	152	1	Both	both	DT
cord-266455-rbblg4pu	152	2	the	the	DT
cord-266455-rbblg4pu	152	3	IDSA	IDSA	NNP
cord-266455-rbblg4pu	152	4	and	and	CC
cord-266455-rbblg4pu	152	5	the	the	DT
cord-266455-rbblg4pu	152	6	National	National	NNP
cord-266455-rbblg4pu	152	7	Institute	Institute	NNP
cord-266455-rbblg4pu	152	8	for	for	IN
cord-266455-rbblg4pu	152	9	Clinical	Clinical	NNP
cord-266455-rbblg4pu	152	10	Excellence	Excellence	NNP
cord-266455-rbblg4pu	152	11	(	(	-LRB-
cord-266455-rbblg4pu	152	12	NICE	NICE	NNP
cord-266455-rbblg4pu	152	13	)	)	-RRB-
cord-266455-rbblg4pu	152	14	cite	cite	VB
cord-266455-rbblg4pu	152	15	an	an	DT
cord-266455-rbblg4pu	152	16	urgent	urgent	JJ
cord-266455-rbblg4pu	152	17	need	need	NN
cord-266455-rbblg4pu	152	18	for	for	IN
cord-266455-rbblg4pu	152	19	well	well	RB
cord-266455-rbblg4pu	152	20	-	-	HYPH
cord-266455-rbblg4pu	152	21	run	run	VBN
cord-266455-rbblg4pu	152	22	RCTs	rct	NNS
cord-266455-rbblg4pu	152	23	on	on	IN
cord-266455-rbblg4pu	152	24	the	the	DT
cord-266455-rbblg4pu	152	25	impact	impact	NN
cord-266455-rbblg4pu	152	26	of	of	IN
cord-266455-rbblg4pu	152	27	de	de	NN
cord-266455-rbblg4pu	152	28	-	-	JJ
cord-266455-rbblg4pu	152	29	escalating	escalate	VBG
cord-266455-rbblg4pu	152	30	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	152	31	therapy	therapy	NN
cord-266455-rbblg4pu	152	32	46	46	CD
cord-266455-rbblg4pu	152	33	,	,	,
cord-266455-rbblg4pu	152	34	47	47	CD
cord-266455-rbblg4pu	152	35	.	.	.
cord-266455-rbblg4pu	153	1	The	the	DT
cord-266455-rbblg4pu	153	2	IDSA	IDSA	NNP
cord-266455-rbblg4pu	153	3	and	and	CC
cord-266455-rbblg4pu	153	4	the	the	DT
cord-266455-rbblg4pu	153	5	American	American	NNP
cord-266455-rbblg4pu	153	6	Thoracic	Thoracic	NNP
cord-266455-rbblg4pu	153	7	Society	Society	NNP
cord-266455-rbblg4pu	153	8	advise	advise	VB
cord-266455-rbblg4pu	153	9	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	153	10	de	de	NN
cord-266455-rbblg4pu	153	11	-	-	NN
cord-266455-rbblg4pu	153	12	escalation	escalation	NN
cord-266455-rbblg4pu	153	13	in	in	IN
cord-266455-rbblg4pu	153	14	HAP	HAP	NNP
cord-266455-rbblg4pu	153	15	/	/	SYM
cord-266455-rbblg4pu	153	16	VAP	VAP	NNP
cord-266455-rbblg4pu	153	17	according	accord	VBG
cord-266455-rbblg4pu	153	18	to	to	IN
cord-266455-rbblg4pu	153	19	culture	culture	NN
cord-266455-rbblg4pu	153	20	results	result	NNS
cord-266455-rbblg4pu	153	21	on	on	IN
cord-266455-rbblg4pu	153	22	the	the	DT
cord-266455-rbblg4pu	153	23	basis	basis	NN
cord-266455-rbblg4pu	153	24	of	of	IN
cord-266455-rbblg4pu	153	25	expert	expert	JJ
cord-266455-rbblg4pu	153	26	opinion	opinion	NN
cord-266455-rbblg4pu	153	27	,	,	,
cord-266455-rbblg4pu	153	28	citing	cite	VBG
cord-266455-rbblg4pu	153	29	a	a	DT
cord-266455-rbblg4pu	153	30	high	high	JJ
cord-266455-rbblg4pu	153	31	level	level	NN
cord-266455-rbblg4pu	153	32	of	of	IN
cord-266455-rbblg4pu	153	33	confidence	confidence	NN
cord-266455-rbblg4pu	153	34	that	that	IN
cord-266455-rbblg4pu	153	35	it	-PRON-	PRP
cord-266455-rbblg4pu	153	36	'	'	``
cord-266455-rbblg4pu	153	37	reduces	reduce	VBZ
cord-266455-rbblg4pu	153	38	costs	cost	NNS
cord-266455-rbblg4pu	153	39	,	,	,
cord-266455-rbblg4pu	153	40	burdens	burden	NNS
cord-266455-rbblg4pu	153	41	,	,	,
cord-266455-rbblg4pu	153	42	and	and	CC
cord-266455-rbblg4pu	153	43	side	side	NN
cord-266455-rbblg4pu	153	44	effects	effect	NNS
cord-266455-rbblg4pu	153	45	,	,	,
cord-266455-rbblg4pu	153	46	and	and	CC
cord-266455-rbblg4pu	153	47	that	that	IN
cord-266455-rbblg4pu	153	48	it	-PRON-	PRP
cord-266455-rbblg4pu	153	49	is	be	VBZ
cord-266455-rbblg4pu	153	50	very	very	RB
cord-266455-rbblg4pu	153	51	likely	likely	JJ
cord-266455-rbblg4pu	153	52	that	that	IN
cord-266455-rbblg4pu	153	53	deescalation	deescalation	NN
cord-266455-rbblg4pu	153	54	also	also	RB
cord-266455-rbblg4pu	153	55	reduces	reduce	VBZ
cord-266455-rbblg4pu	153	56	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	153	57	resistance	resistance	NN
cord-266455-rbblg4pu	153	58	'	'	''
cord-266455-rbblg4pu	153	59	47	47	CD
cord-266455-rbblg4pu	153	60	.	.	.
cord-266455-rbblg4pu	154	1	There	there	EX
cord-266455-rbblg4pu	154	2	a	a	DT
cord-266455-rbblg4pu	154	3	small	small	JJ
cord-266455-rbblg4pu	154	4	number	number	NN
cord-266455-rbblg4pu	154	5	of	of	IN
cord-266455-rbblg4pu	154	6	interventional	interventional	JJ
cord-266455-rbblg4pu	154	7	studies	study	NNS
cord-266455-rbblg4pu	154	8	looking	look	VBG
cord-266455-rbblg4pu	154	9	at	at	IN
cord-266455-rbblg4pu	154	10	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	154	11	de	de	NN
cord-266455-rbblg4pu	154	12	-	-	NN
cord-266455-rbblg4pu	154	13	escalation	escalation	NN
cord-266455-rbblg4pu	154	14	based	base	VBN
cord-266455-rbblg4pu	154	15	upon	upon	IN
cord-266455-rbblg4pu	154	16	microbiological	microbiological	JJ
cord-266455-rbblg4pu	154	17	culture	culture	NN
cord-266455-rbblg4pu	154	18	results	result	NNS
cord-266455-rbblg4pu	154	19	in	in	IN
cord-266455-rbblg4pu	154	20	HAP	HAP	NNP
cord-266455-rbblg4pu	154	21	/	/	SYM
cord-266455-rbblg4pu	154	22	VAP	VAP	NNP
cord-266455-rbblg4pu	154	23	which	which	WDT
cord-266455-rbblg4pu	154	24	have	have	VBP
cord-266455-rbblg4pu	154	25	suggested	suggest	VBN
cord-266455-rbblg4pu	154	26	this	this	DT
cord-266455-rbblg4pu	154	27	practice	practice	NN
cord-266455-rbblg4pu	154	28	is	be	VBZ
cord-266455-rbblg4pu	154	29	safe	safe	JJ
cord-266455-rbblg4pu	154	30	48	48	CD
cord-266455-rbblg4pu	154	31	,	,	,
cord-266455-rbblg4pu	154	32	49	49	CD
cord-266455-rbblg4pu	154	33	.	.	.
cord-266455-rbblg4pu	155	1	High	high	JJ
cord-266455-rbblg4pu	155	2	quality	quality	NN
cord-266455-rbblg4pu	155	3	data	datum	NNS
cord-266455-rbblg4pu	155	4	for	for	IN
cord-266455-rbblg4pu	155	5	outcomes	outcome	NNS
cord-266455-rbblg4pu	155	6	,	,	,
cord-266455-rbblg4pu	155	7	including	include	VBG
cord-266455-rbblg4pu	155	8	length	length	NN
cord-266455-rbblg4pu	155	9	of	of	IN
cord-266455-rbblg4pu	155	10	intensive	intensive	JJ
cord-266455-rbblg4pu	155	11	care	care	NN
cord-266455-rbblg4pu	155	12	stay	stay	NN
cord-266455-rbblg4pu	155	13	and	and	CC
cord-266455-rbblg4pu	155	14	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	155	15	savings	saving	NNS
cord-266455-rbblg4pu	155	16	,	,	,
cord-266455-rbblg4pu	155	17	are	be	VBP
cord-266455-rbblg4pu	155	18	lacking	lack	VBG
cord-266455-rbblg4pu	155	19	and	and	CC
cord-266455-rbblg4pu	155	20	conflicting	conflicting	JJ
cord-266455-rbblg4pu	155	21	.	.	.
cord-266455-rbblg4pu	156	1	A	a	DT
cord-266455-rbblg4pu	156	2	meta	meta	JJ
cord-266455-rbblg4pu	156	3	-	-	HYPH
cord-266455-rbblg4pu	156	4	analysis	analysis	NN
cord-266455-rbblg4pu	156	5	by	by	IN
cord-266455-rbblg4pu	156	6	Khan	Khan	NNP
cord-266455-rbblg4pu	156	7	et	et	NNP
cord-266455-rbblg4pu	156	8	al	al	NNP
cord-266455-rbblg4pu	156	9	50	50	CD
cord-266455-rbblg4pu	156	10	of	of	IN
cord-266455-rbblg4pu	156	11	observational	observational	JJ
cord-266455-rbblg4pu	156	12	studies	study	NNS
cord-266455-rbblg4pu	156	13	reviewing	review	VBG
cord-266455-rbblg4pu	156	14	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	156	15	de	de	NN
cord-266455-rbblg4pu	156	16	-	-	NN
cord-266455-rbblg4pu	156	17	escalation	escalation	NN
cord-266455-rbblg4pu	156	18	in	in	IN
cord-266455-rbblg4pu	156	19	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	156	20	in	in	IN
cord-266455-rbblg4pu	156	21	ICU	ICU	NNP
cord-266455-rbblg4pu	156	22	(	(	-LRB-
cord-266455-rbblg4pu	156	23	HAP	HAP	NNP
cord-266455-rbblg4pu	156	24	and	and	CC
cord-266455-rbblg4pu	156	25	VAP	VAP	NNP
cord-266455-rbblg4pu	156	26	only	only	RB
cord-266455-rbblg4pu	156	27	)	)	-RRB-
cord-266455-rbblg4pu	156	28	found	find	VBD
cord-266455-rbblg4pu	156	29	no	no	DT
cord-266455-rbblg4pu	156	30	difference	difference	NN
cord-266455-rbblg4pu	156	31	in	in	IN
cord-266455-rbblg4pu	156	32	mortality	mortality	NN
cord-266455-rbblg4pu	156	33	between	between	IN
cord-266455-rbblg4pu	156	34	those	those	DT
cord-266455-rbblg4pu	156	35	who	who	WP
cord-266455-rbblg4pu	156	36	were	be	VBD
cord-266455-rbblg4pu	156	37	de	de	JJ
cord-266455-rbblg4pu	156	38	-	-	VBN
cord-266455-rbblg4pu	156	39	escalated	escalate	VBN
cord-266455-rbblg4pu	156	40	according	accord	VBG
cord-266455-rbblg4pu	156	41	to	to	IN
cord-266455-rbblg4pu	156	42	culture	culture	NN
cord-266455-rbblg4pu	156	43	result	result	NN
cord-266455-rbblg4pu	156	44	and	and	CC
cord-266455-rbblg4pu	156	45	those	those	DT
cord-266455-rbblg4pu	156	46	that	that	WDT
cord-266455-rbblg4pu	156	47	were	be	VBD
cord-266455-rbblg4pu	156	48	n't	not	RB
cord-266455-rbblg4pu	156	49	.	.	.
cord-266455-rbblg4pu	157	1	In	in	IN
cord-266455-rbblg4pu	157	2	the	the	DT
cord-266455-rbblg4pu	157	3	context	context	NN
cord-266455-rbblg4pu	157	4	of	of	IN
cord-266455-rbblg4pu	157	5	CAP	CAP	NNP
cord-266455-rbblg4pu	157	6	,	,	,
cord-266455-rbblg4pu	157	7	both	both	CC
cord-266455-rbblg4pu	157	8	the	the	DT
cord-266455-rbblg4pu	157	9	IDSA	IDSA	NNP
cord-266455-rbblg4pu	157	10	51	51	CD
cord-266455-rbblg4pu	157	11	and	and	CC
cord-266455-rbblg4pu	157	12	NICE	NICE	NNP
cord-266455-rbblg4pu	157	13	/	/	SYM
cord-266455-rbblg4pu	157	14	BTS	BTS	NNP
cord-266455-rbblg4pu	157	15	46	46	CD
cord-266455-rbblg4pu	157	16	guidelines	guideline	NNS
cord-266455-rbblg4pu	157	17	recommend	recommend	VBP
cord-266455-rbblg4pu	157	18	organism	organism	NN
cord-266455-rbblg4pu	157	19	directed	direct	VBN
cord-266455-rbblg4pu	157	20	therapy	therapy	NN
cord-266455-rbblg4pu	157	21	when	when	WRB
cord-266455-rbblg4pu	157	22	a	a	DT
cord-266455-rbblg4pu	157	23	pathogen	pathogen	NN
cord-266455-rbblg4pu	157	24	has	have	VBZ
cord-266455-rbblg4pu	157	25	been	be	VBN
cord-266455-rbblg4pu	157	26	identified	identify	VBN
cord-266455-rbblg4pu	157	27	by	by	IN
cord-266455-rbblg4pu	157	28	culture	culture	NN
cord-266455-rbblg4pu	157	29	.	.	.
cord-266455-rbblg4pu	158	1	High	high	JJ
cord-266455-rbblg4pu	158	2	quality	quality	NN
cord-266455-rbblg4pu	158	3	data	data	NN
cord-266455-rbblg4pu	158	4	is	be	VBZ
cord-266455-rbblg4pu	158	5	lacking	lack	VBG
cord-266455-rbblg4pu	158	6	but	but	CC
cord-266455-rbblg4pu	158	7	observational	observational	JJ
cord-266455-rbblg4pu	158	8	data	datum	NNS
cord-266455-rbblg4pu	158	9	and	and	CC
cord-266455-rbblg4pu	158	10	limited	limited	JJ
cord-266455-rbblg4pu	158	11	interventional	interventional	JJ
cord-266455-rbblg4pu	158	12	data	data	NN
cord-266455-rbblg4pu	158	13	suggests	suggest	VBZ
cord-266455-rbblg4pu	158	14	this	this	DT
cord-266455-rbblg4pu	158	15	is	be	VBZ
cord-266455-rbblg4pu	158	16	safe	safe	JJ
cord-266455-rbblg4pu	158	17	[	[	-LRB-
cord-266455-rbblg4pu	158	18	52	52	CD
cord-266455-rbblg4pu	158	19	]	]	-RRB-
cord-266455-rbblg4pu	159	1	[	[	-LRB-
cord-266455-rbblg4pu	159	2	53	53	CD
cord-266455-rbblg4pu	159	3	]	]	-RRB-
cord-266455-rbblg4pu	159	4	[	[	-LRB-
cord-266455-rbblg4pu	159	5	54	54	CD
cord-266455-rbblg4pu	159	6	]	]	-RRB-
cord-266455-rbblg4pu	159	7	.	.	.
cord-266455-rbblg4pu	160	1	A	a	DT
cord-266455-rbblg4pu	160	2	systematic	systematic	JJ
cord-266455-rbblg4pu	160	3	review	review	NN
cord-266455-rbblg4pu	160	4	by	by	IN
cord-266455-rbblg4pu	160	5	Paul	Paul	NNP
cord-266455-rbblg4pu	160	6	et	et	NNP
cord-266455-rbblg4pu	160	7	al	al	NNP
cord-266455-rbblg4pu	160	8	55	55	CD
cord-266455-rbblg4pu	160	9	included	include	VBD
cord-266455-rbblg4pu	160	10	studies	study	NNS
cord-266455-rbblg4pu	160	11	with	with	IN
cord-266455-rbblg4pu	160	12	CAP	CAP	NNP
cord-266455-rbblg4pu	160	13	,	,	,
cord-266455-rbblg4pu	160	14	HAP	HAP	NNP
cord-266455-rbblg4pu	160	15	,	,	,
cord-266455-rbblg4pu	160	16	VAP	VAP	NNP
cord-266455-rbblg4pu	160	17	and	and	CC
cord-266455-rbblg4pu	160	18	Blood	Blood	NNP
cord-266455-rbblg4pu	160	19	stream	stream	NN
cord-266455-rbblg4pu	160	20	infection	infection	NN
cord-266455-rbblg4pu	160	21	.	.	.
cord-266455-rbblg4pu	161	1	The	the	DT
cord-266455-rbblg4pu	161	2	reviewers	reviewer	NNS
cord-266455-rbblg4pu	161	3	found	find	VBD
cord-266455-rbblg4pu	161	4	no	no	DT
cord-266455-rbblg4pu	161	5	association	association	NN
cord-266455-rbblg4pu	161	6	between	between	IN
cord-266455-rbblg4pu	161	7	de	de	NN
cord-266455-rbblg4pu	161	8	-	-	NN
cord-266455-rbblg4pu	161	9	escalation	escalation	NN
cord-266455-rbblg4pu	161	10	and	and	CC
cord-266455-rbblg4pu	161	11	survival	survival	NN
cord-266455-rbblg4pu	161	12	with	with	IN
cord-266455-rbblg4pu	161	13	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	161	14	(	(	-LRB-
cord-266455-rbblg4pu	161	15	OR	or	CC
cord-266455-rbblg4pu	161	16	0.97	0.97	CD
cord-266455-rbblg4pu	161	17	,	,	,
cord-266455-rbblg4pu	161	18	95	95	CD
cord-266455-rbblg4pu	161	19	%	%	NN
cord-266455-rbblg4pu	161	20	CI	CI	NNP
cord-266455-rbblg4pu	161	21	0.45	0.45	CD
cord-266455-rbblg4pu	161	22	-	-	HYPH
cord-266455-rbblg4pu	161	23	2.12	2.12	CD
cord-266455-rbblg4pu	161	24	)	)	-RRB-
cord-266455-rbblg4pu	161	25	.	.	.
cord-266455-rbblg4pu	162	1	Concern	concern	NN
cord-266455-rbblg4pu	162	2	has	have	VBZ
cord-266455-rbblg4pu	162	3	been	be	VBN
cord-266455-rbblg4pu	162	4	raised	raise	VBN
cord-266455-rbblg4pu	162	5	that	that	IN
cord-266455-rbblg4pu	162	6	the	the	DT
cord-266455-rbblg4pu	162	7	high	high	JJ
cord-266455-rbblg4pu	162	8	sensitivity	sensitivity	NN
cord-266455-rbblg4pu	162	9	of	of	IN
cord-266455-rbblg4pu	162	10	molecular	molecular	JJ
cord-266455-rbblg4pu	162	11	tests	test	NNS
cord-266455-rbblg4pu	162	12	will	will	MD
cord-266455-rbblg4pu	162	13	lead	lead	VB
cord-266455-rbblg4pu	162	14	to	to	IN
cord-266455-rbblg4pu	162	15	excessive	excessive	JJ
cord-266455-rbblg4pu	162	16	detection	detection	NN
cord-266455-rbblg4pu	162	17	of	of	IN
cord-266455-rbblg4pu	162	18	colonising	colonise	VBG
cord-266455-rbblg4pu	162	19	flora	flora	NNS
cord-266455-rbblg4pu	162	20	which	which	WDT
cord-266455-rbblg4pu	162	21	may	may	MD
cord-266455-rbblg4pu	162	22	paradoxically	paradoxically	RB
cord-266455-rbblg4pu	162	23	increase	increase	VB
cord-266455-rbblg4pu	162	24	unnecessary	unnecessary	JJ
cord-266455-rbblg4pu	162	25	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	162	26	use	use	NN
cord-266455-rbblg4pu	162	27	.	.	.
cord-266455-rbblg4pu	163	1	This	this	DT
cord-266455-rbblg4pu	163	2	is	be	VBZ
cord-266455-rbblg4pu	163	3	particularly	particularly	RB
cord-266455-rbblg4pu	163	4	pertinent	pertinent	JJ
cord-266455-rbblg4pu	163	5	in	in	IN
cord-266455-rbblg4pu	163	6	expectorated	expectorated	JJ
cord-266455-rbblg4pu	163	7	sputa	sputa	NN
cord-266455-rbblg4pu	163	8	where	where	WRB
cord-266455-rbblg4pu	163	9	small	small	JJ
cord-266455-rbblg4pu	163	10	numbers	number	NNS
cord-266455-rbblg4pu	163	11	of	of	IN
cord-266455-rbblg4pu	163	12	potentially	potentially	RB
cord-266455-rbblg4pu	163	13	pathogenic	pathogenic	JJ
cord-266455-rbblg4pu	163	14	bacteria	bacteria	NNS
cord-266455-rbblg4pu	163	15	can	can	MD
cord-266455-rbblg4pu	163	16	be	be	VB
cord-266455-rbblg4pu	163	17	present	present	JJ
cord-266455-rbblg4pu	163	18	in	in	IN
cord-266455-rbblg4pu	163	19	the	the	DT
cord-266455-rbblg4pu	163	20	absence	absence	NN
cord-266455-rbblg4pu	163	21	of	of	IN
cord-266455-rbblg4pu	163	22	disease	disease	NN
cord-266455-rbblg4pu	163	23	.	.	.
cord-266455-rbblg4pu	164	1	A	a	DT
cord-266455-rbblg4pu	164	2	potential	potential	JJ
cord-266455-rbblg4pu	164	3	solution	solution	NN
cord-266455-rbblg4pu	164	4	to	to	IN
cord-266455-rbblg4pu	164	5	this	this	DT
cord-266455-rbblg4pu	164	6	is	be	VBZ
cord-266455-rbblg4pu	164	7	the	the	DT
cord-266455-rbblg4pu	164	8	development	development	NN
cord-266455-rbblg4pu	164	9	of	of	IN
cord-266455-rbblg4pu	164	10	semi	semi	JJ
cord-266455-rbblg4pu	164	11	-	-	JJ
cord-266455-rbblg4pu	164	12	quantitative	quantitative	JJ
cord-266455-rbblg4pu	164	13	molecular	molecular	JJ
cord-266455-rbblg4pu	164	14	methods	method	NNS
cord-266455-rbblg4pu	164	15	such	such	JJ
cord-266455-rbblg4pu	164	16	as	as	IN
cord-266455-rbblg4pu	164	17	with	with	IN
cord-266455-rbblg4pu	164	18	the	the	DT
cord-266455-rbblg4pu	164	19	BioFire	BioFire	NNP
cord-266455-rbblg4pu	164	20	R	R	NNP
cord-266455-rbblg4pu	164	21	FilmArray	FilmArray	NNP
cord-266455-rbblg4pu	164	22	R	R	NNP
cord-266455-rbblg4pu	164	23	Pneumonia	pneumonia	NN
cord-266455-rbblg4pu	164	24	panel	panel	NN
cord-266455-rbblg4pu	164	25	.	.	.
cord-266455-rbblg4pu	165	1	This	this	DT
cord-266455-rbblg4pu	165	2	provides	provide	VBZ
cord-266455-rbblg4pu	165	3	a	a	DT
cord-266455-rbblg4pu	165	4	representation	representation	NN
cord-266455-rbblg4pu	165	5	of	of	IN
cord-266455-rbblg4pu	165	6	the	the	DT
cord-266455-rbblg4pu	165	7	amount	amount	NN
cord-266455-rbblg4pu	165	8	of	of	IN
cord-266455-rbblg4pu	165	9	bacterial	bacterial	JJ
cord-266455-rbblg4pu	165	10	DNA	dna	NN
cord-266455-rbblg4pu	165	11	present	present	NN
cord-266455-rbblg4pu	165	12	which	which	WDT
cord-266455-rbblg4pu	165	13	is	be	VBZ
cord-266455-rbblg4pu	165	14	highly	highly	RB
cord-266455-rbblg4pu	165	15	concordant	concordant	JJ
cord-266455-rbblg4pu	165	16	with	with	IN
cord-266455-rbblg4pu	165	17	reference	reference	NN
cord-266455-rbblg4pu	165	18	molecular	molecular	JJ
cord-266455-rbblg4pu	165	19	techniques	technique	NNS
cord-266455-rbblg4pu	165	20	.	.	.
cord-266455-rbblg4pu	166	1	As	as	IN
cord-266455-rbblg4pu	166	2	highlighted	highlight	VBN
cord-266455-rbblg4pu	166	3	by	by	IN
cord-266455-rbblg4pu	166	4	studies	study	NNS
cord-266455-rbblg4pu	166	5	using	use	VBG
cord-266455-rbblg4pu	166	6	the	the	DT
cord-266455-rbblg4pu	166	7	Unyvero	Unyvero	NNP
cord-266455-rbblg4pu	166	8	17	17	CD
cord-266455-rbblg4pu	166	9	,	,	,
cord-266455-rbblg4pu	166	10	39	39	CD
cord-266455-rbblg4pu	166	11	,	,	,
cord-266455-rbblg4pu	166	12	molecular	molecular	JJ
cord-266455-rbblg4pu	166	13	detection	detection	NN
cord-266455-rbblg4pu	166	14	of	of	IN
cord-266455-rbblg4pu	166	15	resistance	resistance	NN
cord-266455-rbblg4pu	166	16	genes	gene	NNS
cord-266455-rbblg4pu	166	17	may	may	MD
cord-266455-rbblg4pu	166	18	correlate	correlate	VB
cord-266455-rbblg4pu	166	19	poorly	poorly	RB
cord-266455-rbblg4pu	166	20	with	with	IN
cord-266455-rbblg4pu	166	21	phenotypic	phenotypic	JJ
cord-266455-rbblg4pu	166	22	sensitivity	sensitivity	NN
cord-266455-rbblg4pu	166	23	in	in	IN
cord-266455-rbblg4pu	166	24	its	-PRON-	PRP$
cord-266455-rbblg4pu	166	25	current	current	JJ
cord-266455-rbblg4pu	166	26	form	form	NN
cord-266455-rbblg4pu	166	27	.	.	.
cord-266455-rbblg4pu	167	1	Detection	detection	NN
cord-266455-rbblg4pu	167	2	of	of	IN
cord-266455-rbblg4pu	167	3	genes	gene	NNS
cord-266455-rbblg4pu	167	4	from	from	IN
cord-266455-rbblg4pu	167	5	'	'	``
cord-266455-rbblg4pu	167	6	off	off	IN
cord-266455-rbblg4pu	167	7	panel	panel	NN
cord-266455-rbblg4pu	167	8	'	'	''
cord-266455-rbblg4pu	167	9	organisms	organism	NNS
cord-266455-rbblg4pu	167	10	,	,	,
cord-266455-rbblg4pu	167	11	for	for	IN
cord-266455-rbblg4pu	167	12	example	example	NN
cord-266455-rbblg4pu	167	13	mec	mec	NNP
cord-266455-rbblg4pu	167	14	A	A	NNP
cord-266455-rbblg4pu	167	15	genes	gene	NNS
cord-266455-rbblg4pu	167	16	in	in	IN
cord-266455-rbblg4pu	167	17	colonising	colonise	VBG
cord-266455-rbblg4pu	167	18	coagulase	coagulase	NN
cord-266455-rbblg4pu	167	19	negative	negative	JJ
cord-266455-rbblg4pu	167	20	staphylococci	staphylococcus	NNS
cord-266455-rbblg4pu	167	21	,	,	,
cord-266455-rbblg4pu	167	22	may	may	MD
cord-266455-rbblg4pu	167	23	be	be	VB
cord-266455-rbblg4pu	167	24	incorrectly	incorrectly	RB
cord-266455-rbblg4pu	167	25	attributed	attribute	VBN
cord-266455-rbblg4pu	167	26	to	to	IN
cord-266455-rbblg4pu	167	27	those	those	DT
cord-266455-rbblg4pu	167	28	organisms	organism	NNS
cord-266455-rbblg4pu	167	29	which	which	WDT
cord-266455-rbblg4pu	167	30	are	be	VBP
cord-266455-rbblg4pu	167	31	on	on	IN
cord-266455-rbblg4pu	167	32	the	the	DT
cord-266455-rbblg4pu	167	33	panel	panel	NN
cord-266455-rbblg4pu	167	34	.	.	.
cord-266455-rbblg4pu	168	1	As	as	IN
cord-266455-rbblg4pu	168	2	such	such	JJ
cord-266455-rbblg4pu	168	3	,	,	,
cord-266455-rbblg4pu	168	4	clinicians	clinician	NNS
cord-266455-rbblg4pu	168	5	will	will	MD
cord-266455-rbblg4pu	168	6	need	need	VB
cord-266455-rbblg4pu	168	7	to	to	TO
cord-266455-rbblg4pu	168	8	be	be	VB
cord-266455-rbblg4pu	168	9	cautious	cautious	JJ
cord-266455-rbblg4pu	168	10	in	in	IN
cord-266455-rbblg4pu	168	11	interpreting	interpret	VBG
cord-266455-rbblg4pu	168	12	these	these	DT
cord-266455-rbblg4pu	168	13	results	result	NNS
cord-266455-rbblg4pu	168	14	.	.	.
cord-266455-rbblg4pu	169	1	As	as	RB
cord-266455-rbblg4pu	169	2	well	well	RB
cord-266455-rbblg4pu	169	3	as	as	IN
cord-266455-rbblg4pu	169	4	having	have	VBG
cord-266455-rbblg4pu	169	5	relatively	relatively	RB
cord-266455-rbblg4pu	169	6	quicker	quick	JJR
cord-266455-rbblg4pu	169	7	run	run	NN
cord-266455-rbblg4pu	169	8	times	time	NNS
cord-266455-rbblg4pu	169	9	,	,	,
cord-266455-rbblg4pu	169	10	syndromic	syndromic	NNP
cord-266455-rbblg4pu	169	11	multiplex	multiplex	NN
cord-266455-rbblg4pu	169	12	molecular	molecular	JJ
cord-266455-rbblg4pu	169	13	tests	test	NNS
cord-266455-rbblg4pu	169	14	could	could	MD
cord-266455-rbblg4pu	169	15	potentially	potentially	RB
cord-266455-rbblg4pu	169	16	be	be	VB
cord-266455-rbblg4pu	169	17	deployed	deploy	VBN
cord-266455-rbblg4pu	169	18	at	at	IN
cord-266455-rbblg4pu	169	19	the	the	DT
cord-266455-rbblg4pu	169	20	pointof	pointof	NN
cord-266455-rbblg4pu	169	21	-	-	HYPH
cord-266455-rbblg4pu	169	22	care	care	NN
cord-266455-rbblg4pu	169	23	.	.	.
cord-266455-rbblg4pu	170	1	The	the	DT
cord-266455-rbblg4pu	170	2	RespPOC	RespPOC	NNS
cord-266455-rbblg4pu	170	3	trial	trial	NN
cord-266455-rbblg4pu	170	4	by	by	IN
cord-266455-rbblg4pu	170	5	Brendish	Brendish	NNP
cord-266455-rbblg4pu	170	6	et	et	NNP
cord-266455-rbblg4pu	170	7	al	al	NNP
cord-266455-rbblg4pu	170	8	.	.	NNP
cord-266455-rbblg4pu	170	9	,	,	,
cord-266455-rbblg4pu	170	10	demonstrated	demonstrate	VBD
cord-266455-rbblg4pu	170	11	with	with	IN
cord-266455-rbblg4pu	170	12	a	a	DT
cord-266455-rbblg4pu	170	13	respiratory	respiratory	JJ
cord-266455-rbblg4pu	170	14	viral	viral	JJ
cord-266455-rbblg4pu	170	15	panel	panel	NN
cord-266455-rbblg4pu	170	16	that	that	IN
cord-266455-rbblg4pu	170	17	this	this	DT
cord-266455-rbblg4pu	170	18	was	be	VBD
cord-266455-rbblg4pu	170	19	logistically	logistically	RB
cord-266455-rbblg4pu	170	20	feasible	feasible	JJ
cord-266455-rbblg4pu	170	21	and	and	CC
cord-266455-rbblg4pu	170	22	associated	associate	VBN
cord-266455-rbblg4pu	170	23	with	with	IN
cord-266455-rbblg4pu	170	24	a	a	DT
cord-266455-rbblg4pu	170	25	number	number	NN
cord-266455-rbblg4pu	170	26	of	of	IN
cord-266455-rbblg4pu	170	27	clinical	clinical	JJ
cord-266455-rbblg4pu	170	28	benefits	benefit	NNS
cord-266455-rbblg4pu	170	29	compared	compare	VBN
cord-266455-rbblg4pu	170	30	to	to	IN
cord-266455-rbblg4pu	170	31	routine	routine	JJ
cord-266455-rbblg4pu	170	32	clinical	clinical	JJ
cord-266455-rbblg4pu	170	33	care	care	NN
cord-266455-rbblg4pu	170	34	24	24	CD
cord-266455-rbblg4pu	170	35	.	.	.
cord-266455-rbblg4pu	171	1	A	a	DT
cord-266455-rbblg4pu	171	2	post	post	FW
cord-266455-rbblg4pu	171	3	hoc	hoc	FW
cord-266455-rbblg4pu	171	4	analysis	analysis	NN
cord-266455-rbblg4pu	171	5	56	56	CD
cord-266455-rbblg4pu	171	6	of	of	IN
cord-266455-rbblg4pu	171	7	patients	patient	NNS
cord-266455-rbblg4pu	171	8	who	who	WP
cord-266455-rbblg4pu	171	9	tested	test	VBD
cord-266455-rbblg4pu	171	10	positive	positive	JJ
cord-266455-rbblg4pu	171	11	for	for	IN
cord-266455-rbblg4pu	171	12	respiratory	respiratory	JJ
cord-266455-rbblg4pu	171	13	viruses	virus	NNS
cord-266455-rbblg4pu	171	14	in	in	IN
cord-266455-rbblg4pu	171	15	the	the	DT
cord-266455-rbblg4pu	171	16	trial	trial	NN
cord-266455-rbblg4pu	171	17	highlighted	highlight	VBD
cord-266455-rbblg4pu	171	18	an	an	DT
cord-266455-rbblg4pu	171	19	association	association	NN
cord-266455-rbblg4pu	171	20	between	between	IN
cord-266455-rbblg4pu	171	21	rapid	rapid	JJ
cord-266455-rbblg4pu	171	22	turn	turn	NN
cord-266455-rbblg4pu	171	23	-	-	HYPH
cord-266455-rbblg4pu	171	24	around	around	RP
cord-266455-rbblg4pu	171	25	time	time	NN
cord-266455-rbblg4pu	171	26	(	(	-LRB-
cord-266455-rbblg4pu	171	27	defined	define	VBN
cord-266455-rbblg4pu	171	28	as	as	IN
cord-266455-rbblg4pu	171	29	<	<	NNP
cord-266455-rbblg4pu	171	30	1.6	1.6	CD
cord-266455-rbblg4pu	171	31	h	h	NNP
cord-266455-rbblg4pu	171	32	)	)	-RRB-
cord-266455-rbblg4pu	171	33	,	,	,
cord-266455-rbblg4pu	171	34	shorter	short	JJR
cord-266455-rbblg4pu	171	35	hospital	hospital	NN
cord-266455-rbblg4pu	171	36	admission	admission	NN
cord-266455-rbblg4pu	171	37	and	and	CC
cord-266455-rbblg4pu	171	38	shorter	short	JJR
cord-266455-rbblg4pu	171	39	durations	duration	NNS
cord-266455-rbblg4pu	171	40	of	of	IN
cord-266455-rbblg4pu	171	41	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	171	42	therapy	therapy	NN
cord-266455-rbblg4pu	171	43	.	.	.
cord-266455-rbblg4pu	172	1	It	-PRON-	PRP
cord-266455-rbblg4pu	172	2	is	be	VBZ
cord-266455-rbblg4pu	172	3	our	-PRON-	PRP$
cord-266455-rbblg4pu	172	4	belief	belief	NN
cord-266455-rbblg4pu	172	5	that	that	IN
cord-266455-rbblg4pu	172	6	point	point	NN
cord-266455-rbblg4pu	172	7	-	-	HYPH
cord-266455-rbblg4pu	172	8	of	of	IN
cord-266455-rbblg4pu	172	9	-	-	HYPH
cord-266455-rbblg4pu	172	10	care	care	NN
cord-266455-rbblg4pu	172	11	testing	testing	NN
cord-266455-rbblg4pu	172	12	represents	represent	VBZ
cord-266455-rbblg4pu	172	13	the	the	DT
cord-266455-rbblg4pu	172	14	ideal	ideal	JJ
cord-266455-rbblg4pu	172	15	strategy	strategy	NN
cord-266455-rbblg4pu	172	16	for	for	IN
cord-266455-rbblg4pu	172	17	new	new	JJ
cord-266455-rbblg4pu	172	18	,	,	,
cord-266455-rbblg4pu	172	19	rapid	rapid	JJ
cord-266455-rbblg4pu	172	20	diagnostic	diagnostic	JJ
cord-266455-rbblg4pu	172	21	test	test	NN
cord-266455-rbblg4pu	172	22	platforms	platform	NNS
cord-266455-rbblg4pu	172	23	allowing	allow	VBG
cord-266455-rbblg4pu	172	24	clinicians	clinician	NNS
cord-266455-rbblg4pu	172	25	to	to	TO
cord-266455-rbblg4pu	172	26	maximise	maximise	VB
cord-266455-rbblg4pu	172	27	the	the	DT
cord-266455-rbblg4pu	172	28	benefit	benefit	NN
cord-266455-rbblg4pu	172	29	from	from	IN
cord-266455-rbblg4pu	172	30	such	such	JJ
cord-266455-rbblg4pu	172	31	accurate	accurate	JJ
cord-266455-rbblg4pu	172	32	tests	test	NNS
cord-266455-rbblg4pu	172	33	early	early	RB
cord-266455-rbblg4pu	172	34	in	in	IN
cord-266455-rbblg4pu	172	35	the	the	DT
cord-266455-rbblg4pu	172	36	decision	decision	NN
cord-266455-rbblg4pu	172	37	-	-	HYPH
cord-266455-rbblg4pu	172	38	making	make	VBG
cord-266455-rbblg4pu	172	39	process	process	NN
cord-266455-rbblg4pu	172	40	.	.	.
cord-266455-rbblg4pu	173	1	Clearly	clearly	RB
cord-266455-rbblg4pu	173	2	,	,	,
cord-266455-rbblg4pu	173	3	rigorous	rigorous	JJ
cord-266455-rbblg4pu	173	4	quality	quality	NN
cord-266455-rbblg4pu	173	5	assurance	assurance	NN
cord-266455-rbblg4pu	173	6	is	be	VBZ
cord-266455-rbblg4pu	173	7	essential	essential	JJ
cord-266455-rbblg4pu	173	8	for	for	IN
cord-266455-rbblg4pu	173	9	any	any	DT
cord-266455-rbblg4pu	173	10	diagnostic	diagnostic	JJ
cord-266455-rbblg4pu	173	11	test	test	NN
cord-266455-rbblg4pu	173	12	irrespective	irrespective	RB
cord-266455-rbblg4pu	173	13	of	of	IN
cord-266455-rbblg4pu	173	14	the	the	DT
cord-266455-rbblg4pu	173	15	site	site	NN
cord-266455-rbblg4pu	173	16	of	of	IN
cord-266455-rbblg4pu	173	17	testing	testing	NN
cord-266455-rbblg4pu	173	18	.	.	.
cord-266455-rbblg4pu	174	1	It	-PRON-	PRP
cord-266455-rbblg4pu	174	2	should	should	MD
cord-266455-rbblg4pu	174	3	also	also	RB
cord-266455-rbblg4pu	174	4	be	be	VB
cord-266455-rbblg4pu	174	5	noted	note	VBN
cord-266455-rbblg4pu	174	6	that	that	IN
cord-266455-rbblg4pu	174	7	the	the	DT
cord-266455-rbblg4pu	174	8	tests	test	NNS
cord-266455-rbblg4pu	174	9	described	describe	VBN
cord-266455-rbblg4pu	174	10	in	in	IN
cord-266455-rbblg4pu	174	11	this	this	DT
cord-266455-rbblg4pu	174	12	article	article	NN
cord-266455-rbblg4pu	174	13	are	be	VBP
cord-266455-rbblg4pu	174	14	not	not	RB
cord-266455-rbblg4pu	174	15	currently	currently	RB
cord-266455-rbblg4pu	174	16	CLIA	CLIA	NNP
cord-266455-rbblg4pu	174	17	waivereda	waivereda	NN
cord-266455-rbblg4pu	174	18	requirement	requirement	NN
cord-266455-rbblg4pu	174	19	for	for	IN
cord-266455-rbblg4pu	174	20	use	use	NN
cord-266455-rbblg4pu	174	21	at	at	IN
cord-266455-rbblg4pu	174	22	the	the	DT
cord-266455-rbblg4pu	174	23	point	point	NN
cord-266455-rbblg4pu	174	24	-	-	HYPH
cord-266455-rbblg4pu	174	25	of	of	IN
cord-266455-rbblg4pu	174	26	-	-	HYPH
cord-266455-rbblg4pu	174	27	care	care	NN
cord-266455-rbblg4pu	174	28	in	in	IN
cord-266455-rbblg4pu	174	29	the	the	DT
cord-266455-rbblg4pu	174	30	US	US	NNP
cord-266455-rbblg4pu	174	31	.	.	.
cord-266455-rbblg4pu	175	1	Rapid	Rapid	NNP
cord-266455-rbblg4pu	175	2	syndromic	syndromic	JJ
cord-266455-rbblg4pu	175	3	molecular	molecular	JJ
cord-266455-rbblg4pu	175	4	tests	test	NNS
cord-266455-rbblg4pu	175	5	for	for	IN
cord-266455-rbblg4pu	175	6	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	175	7	have	have	VBP
cord-266455-rbblg4pu	175	8	improved	improve	VBN
cord-266455-rbblg4pu	175	9	diagnostic	diagnostic	JJ
cord-266455-rbblg4pu	175	10	accuracy	accuracy	NN
cord-266455-rbblg4pu	175	11	compared	compare	VBN
cord-266455-rbblg4pu	175	12	to	to	IN
cord-266455-rbblg4pu	175	13	the	the	DT
cord-266455-rbblg4pu	175	14	current	current	JJ
cord-266455-rbblg4pu	175	15	gold	gold	NN
cord-266455-rbblg4pu	175	16	standard	standard	NN
cord-266455-rbblg4pu	175	17	of	of	IN
cord-266455-rbblg4pu	175	18	culture	culture	NN
cord-266455-rbblg4pu	175	19	and	and	CC
cord-266455-rbblg4pu	175	20	can	can	MD
cord-266455-rbblg4pu	175	21	provide	provide	VB
cord-266455-rbblg4pu	175	22	results	result	NNS
cord-266455-rbblg4pu	175	23	in	in	IN
cord-266455-rbblg4pu	175	24	real	real	JJ
cord-266455-rbblg4pu	175	25	time	time	NN
cord-266455-rbblg4pu	175	26	.	.	.
cord-266455-rbblg4pu	176	1	In	in	IN
cord-266455-rbblg4pu	176	2	the	the	DT
cord-266455-rbblg4pu	176	3	era	era	NN
cord-266455-rbblg4pu	176	4	of	of	IN
cord-266455-rbblg4pu	176	5	widespread	widespread	JJ
cord-266455-rbblg4pu	176	6	AMR	AMR	NNP
cord-266455-rbblg4pu	176	7	their	-PRON-	PRP$
cord-266455-rbblg4pu	176	8	use	use	NN
cord-266455-rbblg4pu	176	9	has	have	VBZ
cord-266455-rbblg4pu	176	10	the	the	DT
cord-266455-rbblg4pu	176	11	potential	potential	NN
cord-266455-rbblg4pu	176	12	to	to	TO
cord-266455-rbblg4pu	176	13	dramatically	dramatically	RB
cord-266455-rbblg4pu	176	14	improve	improve	VB
cord-266455-rbblg4pu	176	15	the	the	DT
cord-266455-rbblg4pu	176	16	rational	rational	JJ
cord-266455-rbblg4pu	176	17	use	use	NN
cord-266455-rbblg4pu	176	18	of	of	IN
cord-266455-rbblg4pu	176	19	antibiotics	antibiotic	NNS
cord-266455-rbblg4pu	176	20	and	and	CC
cord-266455-rbblg4pu	176	21	to	to	TO
cord-266455-rbblg4pu	176	22	improve	improve	VB
cord-266455-rbblg4pu	176	23	clinical	clinical	JJ
cord-266455-rbblg4pu	176	24	outcomes	outcome	NNS
cord-266455-rbblg4pu	176	25	in	in	IN
cord-266455-rbblg4pu	176	26	patient	patient	NN
cord-266455-rbblg4pu	176	27	with	with	IN
cord-266455-rbblg4pu	176	28	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	176	29	.	.	.
cord-266455-rbblg4pu	177	1	High	high	JJ
cord-266455-rbblg4pu	177	2	quality	quality	NN
cord-266455-rbblg4pu	177	3	data	datum	NNS
cord-266455-rbblg4pu	177	4	from	from	IN
cord-266455-rbblg4pu	177	5	well	well	RB
cord-266455-rbblg4pu	177	6	conducted	conduct	VBN
cord-266455-rbblg4pu	177	7	randomised	randomised	JJ
cord-266455-rbblg4pu	177	8	controlled	control	VBN
cord-266455-rbblg4pu	177	9	trials	trial	NNS
cord-266455-rbblg4pu	177	10	are	be	VBP
cord-266455-rbblg4pu	177	11	now	now	RB
cord-266455-rbblg4pu	177	12	urgently	urgently	RB
cord-266455-rbblg4pu	177	13	needed	need	VBN
cord-266455-rbblg4pu	177	14	to	to	TO
cord-266455-rbblg4pu	177	15	assess	assess	VB
cord-266455-rbblg4pu	177	16	the	the	DT
cord-266455-rbblg4pu	177	17	impact	impact	NN
cord-266455-rbblg4pu	177	18	of	of	IN
cord-266455-rbblg4pu	177	19	these	these	DT
cord-266455-rbblg4pu	177	20	platforms	platform	NNS
cord-266455-rbblg4pu	177	21	on	on	IN
cord-266455-rbblg4pu	177	22	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	177	23	use	use	NN
cord-266455-rbblg4pu	177	24	and	and	CC
cord-266455-rbblg4pu	177	25	patient	patient	JJ
cord-266455-rbblg4pu	177	26	outcome	outcome	NN
cord-266455-rbblg4pu	177	27	.	.	.
cord-266455-rbblg4pu	178	1	Poole	Poole	NNP
cord-266455-rbblg4pu	178	2	,	,	,
cord-266455-rbblg4pu	178	3	S.	S.	NNP
cord-266455-rbblg4pu	178	4	-Declarations	-declaration	NNS
cord-266455-rbblg4pu	178	5	of	of	IN
cord-266455-rbblg4pu	178	6	interest	interest	NN
cord-266455-rbblg4pu	178	7	:	:	:
cord-266455-rbblg4pu	178	8	none	none	NN
cord-266455-rbblg4pu	178	9	.	.	.
cord-266455-rbblg4pu	179	1	Clark	Clark	NNP
cord-266455-rbblg4pu	179	2	,	,	,
cord-266455-rbblg4pu	179	3	T.W.	T.W.	NNP
cord-266455-rbblg4pu	179	4	has	have	VBZ
cord-266455-rbblg4pu	179	5	received	receive	VBN
cord-266455-rbblg4pu	179	6	speaker	speaker	NN
cord-266455-rbblg4pu	179	7	fees	fee	NNS
cord-266455-rbblg4pu	179	8	,	,	,
cord-266455-rbblg4pu	179	9	reimbursement	reimbursement	NN
cord-266455-rbblg4pu	179	10	for	for	IN
cord-266455-rbblg4pu	179	11	travel	travel	NN
cord-266455-rbblg4pu	179	12	and	and	CC
cord-266455-rbblg4pu	179	13	honoraria	honorarium	NNS
cord-266455-rbblg4pu	179	14	from	from	IN
cord-266455-rbblg4pu	179	15	Biofire	Biofire	NNP
cord-266455-rbblg4pu	179	16	LLC	LLC	NNP
cord-266455-rbblg4pu	179	17	and	and	CC
cord-266455-rbblg4pu	179	18	BioMerieux	BioMerieux	NNP
cord-266455-rbblg4pu	179	19	and	and	CC
cord-266455-rbblg4pu	179	20	has	have	VBZ
cord-266455-rbblg4pu	179	21	also	also	RB
cord-266455-rbblg4pu	179	22	received	receive	VBN
cord-266455-rbblg4pu	179	23	equipment	equipment	NN
cord-266455-rbblg4pu	179	24	and	and	CC
cord-266455-rbblg4pu	179	25	consumables	consumable	NNS
cord-266455-rbblg4pu	179	26	from	from	IN
cord-266455-rbblg4pu	179	27	these	these	DT
cord-266455-rbblg4pu	179	28	companies	company	NNS
cord-266455-rbblg4pu	179	29	for	for	IN
cord-266455-rbblg4pu	179	30	the	the	DT
cord-266455-rbblg4pu	179	31	purposes	purpose	NNS
cord-266455-rbblg4pu	179	32	of	of	IN
cord-266455-rbblg4pu	179	33	independent	independent	JJ
cord-266455-rbblg4pu	179	34	research	research	NN
cord-266455-rbblg4pu	179	35	.	.	.
cord-266455-rbblg4pu	180	1	No	no	DT
cord-266455-rbblg4pu	180	2	commercial	commercial	JJ
cord-266455-rbblg4pu	180	3	entities	entity	NNS
cord-266455-rbblg4pu	180	4	had	have	VBD
cord-266455-rbblg4pu	180	5	any	any	DT
cord-266455-rbblg4pu	180	6	input	input	NN
cord-266455-rbblg4pu	180	7	into	into	IN
cord-266455-rbblg4pu	180	8	this	this	DT
cord-266455-rbblg4pu	180	9	manuscript	manuscript	NN
cord-266455-rbblg4pu	180	10	.	.	.
cord-266455-rbblg4pu	181	1	This	this	DT
cord-266455-rbblg4pu	181	2	research	research	NN
cord-266455-rbblg4pu	181	3	did	do	VBD
cord-266455-rbblg4pu	181	4	not	not	RB
cord-266455-rbblg4pu	181	5	receive	receive	VB
cord-266455-rbblg4pu	181	6	any	any	DT
cord-266455-rbblg4pu	181	7	specific	specific	JJ
cord-266455-rbblg4pu	181	8	grant	grant	NN
cord-266455-rbblg4pu	181	9	from	from	IN
cord-266455-rbblg4pu	181	10	funding	fund	VBG
cord-266455-rbblg4pu	181	11	agencies	agency	NNS
cord-266455-rbblg4pu	181	12	in	in	IN
cord-266455-rbblg4pu	181	13	the	the	DT
cord-266455-rbblg4pu	181	14	public	public	NN
cord-266455-rbblg4pu	181	15	,	,	,
cord-266455-rbblg4pu	181	16	commercial	commercial	JJ
cord-266455-rbblg4pu	181	17	,	,	,
cord-266455-rbblg4pu	181	18	or	or	CC
cord-266455-rbblg4pu	181	19	not	not	RB
cord-266455-rbblg4pu	181	20	-	-	HYPH
cord-266455-rbblg4pu	181	21	for	for	IN
cord-266455-rbblg4pu	181	22	-	-	HYPH
cord-266455-rbblg4pu	181	23	profit	profit	NN
cord-266455-rbblg4pu	181	24	sectors	sector	NNS
cord-266455-rbblg4pu	181	25	.	.	.
cord-266455-rbblg4pu	182	1	Global	global	JJ
cord-266455-rbblg4pu	182	2	,	,	,
cord-266455-rbblg4pu	182	3	regional	regional	JJ
cord-266455-rbblg4pu	182	4	,	,	,
cord-266455-rbblg4pu	182	5	and	and	CC
cord-266455-rbblg4pu	182	6	national	national	JJ
cord-266455-rbblg4pu	182	7	life	life	NN
cord-266455-rbblg4pu	182	8	expectancy	expectancy	NN
cord-266455-rbblg4pu	182	9	,	,	,
cord-266455-rbblg4pu	182	10	all	all	DT
cord-266455-rbblg4pu	182	11	-	-	HYPH
cord-266455-rbblg4pu	182	12	cause	cause	NN
cord-266455-rbblg4pu	182	13	mortality	mortality	NN
cord-266455-rbblg4pu	182	14	,	,	,
cord-266455-rbblg4pu	182	15	and	and	CC
cord-266455-rbblg4pu	182	16	causespecific	causespecific	JJ
cord-266455-rbblg4pu	182	17	mortality	mortality	NN
cord-266455-rbblg4pu	182	18	for	for	IN
cord-266455-rbblg4pu	182	19	249	249	CD
cord-266455-rbblg4pu	182	20	causes	cause	NNS
cord-266455-rbblg4pu	182	21	of	of	IN
cord-266455-rbblg4pu	182	22	death	death	NN
cord-266455-rbblg4pu	182	23	,	,	,
cord-266455-rbblg4pu	182	24	1980	1980	CD
cord-266455-rbblg4pu	182	25	-	-	SYM
cord-266455-rbblg4pu	182	26	2015	2015	CD
cord-266455-rbblg4pu	182	27	:	:	:
cord-266455-rbblg4pu	182	28	a	a	DT
cord-266455-rbblg4pu	182	29	systematic	systematic	JJ
cord-266455-rbblg4pu	182	30	analysis	analysis	NN
cord-266455-rbblg4pu	182	31	for	for	IN
cord-266455-rbblg4pu	182	32	the	the	DT
cord-266455-rbblg4pu	182	33	global	global	JJ
cord-266455-rbblg4pu	182	34	burden	burden	NN
cord-266455-rbblg4pu	182	35	of	of	IN
cord-266455-rbblg4pu	182	36	disease	disease	NN
cord-266455-rbblg4pu	182	37	study	study	NN
cord-266455-rbblg4pu	182	38	2015	2015	CD
cord-266455-rbblg4pu	182	39	480	480	CD
cord-266455-rbblg4pu	182	40	-486	-486	NN
cord-266455-rbblg4pu	182	41	)	)	-RRB-
cord-266455-rbblg4pu	182	42	:	:	:
cord-266455-rbblg4pu	182	43	directly	directly	RB
cord-266455-rbblg4pu	182	44	standardised	standardised	JJ
cord-266455-rbblg4pu	182	45	rate	rate	NN
cord-266455-rbblg4pu	182	46	,	,	,
cord-266455-rbblg4pu	182	47	all	all	DT
cord-266455-rbblg4pu	182	48	ages	age	NNS
cord-266455-rbblg4pu	182	49	,	,	,
cord-266455-rbblg4pu	182	50	annual	annual	JJ
cord-266455-rbblg4pu	182	51	trend	trend	NN
cord-266455-rbblg4pu	182	52	:	:	:
cord-266455-rbblg4pu	182	53	NHS	NHS	NNP
cord-266455-rbblg4pu	182	54	digital	digital	JJ
cord-266455-rbblg4pu	182	55	Risk	risk	NN
cord-266455-rbblg4pu	182	56	factors	factor	NNS
cord-266455-rbblg4pu	182	57	for	for	IN
cord-266455-rbblg4pu	182	58	community	community	NN
cord-266455-rbblg4pu	182	59	-	-	HYPH
cord-266455-rbblg4pu	182	60	acquired	acquire	VBN
cord-266455-rbblg4pu	182	61	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	182	62	in	in	IN
cord-266455-rbblg4pu	182	63	adults	adult	NNS
cord-266455-rbblg4pu	182	64	in	in	IN
cord-266455-rbblg4pu	182	65	Europe	Europe	NNP
cord-266455-rbblg4pu	182	66	:	:	:
cord-266455-rbblg4pu	182	67	a	a	DT
cord-266455-rbblg4pu	182	68	literature	literature	NN
cord-266455-rbblg4pu	182	69	review	review	NN
cord-266455-rbblg4pu	182	70	Community	community	NN
cord-266455-rbblg4pu	182	71	-	-	HYPH
cord-266455-rbblg4pu	182	72	acquired	acquire	VBN
cord-266455-rbblg4pu	182	73	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	182	74	requiring	require	VBG
cord-266455-rbblg4pu	182	75	hospitalization	hospitalization	NN
cord-266455-rbblg4pu	182	76	among	among	IN
cord-266455-rbblg4pu	182	77	U.S.	U.S.	NNP
cord-266455-rbblg4pu	182	78	adults	adult	NNS
cord-266455-rbblg4pu	182	79	Changes	change	NNS
cord-266455-rbblg4pu	182	80	in	in	IN
cord-266455-rbblg4pu	182	81	prevalence	prevalence	NN
cord-266455-rbblg4pu	182	82	of	of	IN
cord-266455-rbblg4pu	182	83	health	health	NN
cord-266455-rbblg4pu	182	84	care	care	NN
cord-266455-rbblg4pu	182	85	-	-	HYPH
cord-266455-rbblg4pu	182	86	associated	associate	VBN
cord-266455-rbblg4pu	182	87	infections	infection	NNS
cord-266455-rbblg4pu	182	88	in	in	IN
cord-266455-rbblg4pu	182	89	U.S.	U.S.	NNP
cord-266455-rbblg4pu	182	90	hospitals	hospital	NNS
cord-266455-rbblg4pu	183	1	The	the	DT
cord-266455-rbblg4pu	183	2	epidemiology	epidemiology	NN
cord-266455-rbblg4pu	183	3	of	of	IN
cord-266455-rbblg4pu	183	4	nonventilator	nonventilator	NNP
cord-266455-rbblg4pu	183	5	hospital	hospital	NN
cord-266455-rbblg4pu	183	6	-	-	HYPH
cord-266455-rbblg4pu	183	7	acquired	acquire	VBN
cord-266455-rbblg4pu	183	8	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	183	9	in	in	IN
cord-266455-rbblg4pu	183	10	the	the	DT
cord-266455-rbblg4pu	183	11	United	United	NNP
cord-266455-rbblg4pu	183	12	States	States	NNP
cord-266455-rbblg4pu	183	13	National	National	NNP
cord-266455-rbblg4pu	183	14	trends	trend	NNS
cord-266455-rbblg4pu	183	15	in	in	IN
cord-266455-rbblg4pu	183	16	patient	patient	JJ
cord-266455-rbblg4pu	183	17	safety	safety	NN
cord-266455-rbblg4pu	183	18	for	for	IN
cord-266455-rbblg4pu	183	19	four	four	CD
cord-266455-rbblg4pu	183	20	common	common	JJ
cord-266455-rbblg4pu	183	21	conditions	condition	NNS
cord-266455-rbblg4pu	183	22	Attributable	attributable	JJ
cord-266455-rbblg4pu	183	23	mortality	mortality	NN
cord-266455-rbblg4pu	183	24	of	of	IN
cord-266455-rbblg4pu	183	25	ventilator	ventilator	NN
cord-266455-rbblg4pu	183	26	-	-	HYPH
cord-266455-rbblg4pu	183	27	associated	associate	VBN
cord-266455-rbblg4pu	183	28	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	183	29	:	:	:
cord-266455-rbblg4pu	183	30	respective	respective	JJ
cord-266455-rbblg4pu	183	31	impact	impact	NN
cord-266455-rbblg4pu	183	32	of	of	IN
cord-266455-rbblg4pu	183	33	main	main	JJ
cord-266455-rbblg4pu	183	34	characteristics	characteristic	NNS
cord-266455-rbblg4pu	183	35	at	at	IN
cord-266455-rbblg4pu	183	36	ICU	ICU	NNP
cord-266455-rbblg4pu	183	37	admission	admission	NN
cord-266455-rbblg4pu	183	38	and	and	CC
cord-266455-rbblg4pu	183	39	VAP	VAP	NNP
cord-266455-rbblg4pu	183	40	onset	onset	NN
cord-266455-rbblg4pu	183	41	using	use	VBG
cord-266455-rbblg4pu	183	42	conditional	conditional	JJ
cord-266455-rbblg4pu	183	43	logistic	logistic	JJ
cord-266455-rbblg4pu	183	44	regression	regression	NN
cord-266455-rbblg4pu	183	45	and	and	CC
cord-266455-rbblg4pu	183	46	multi	multi	JJ
cord-266455-rbblg4pu	183	47	-	-	JJ
cord-266455-rbblg4pu	183	48	state	state	JJ
cord-266455-rbblg4pu	183	49	models	model	NNS
cord-266455-rbblg4pu	183	50	Economic	economic	JJ
cord-266455-rbblg4pu	183	51	impact	impact	NN
cord-266455-rbblg4pu	183	52	of	of	IN
cord-266455-rbblg4pu	183	53	ventilator	ventilator	NN
cord-266455-rbblg4pu	183	54	-	-	HYPH
cord-266455-rbblg4pu	183	55	associated	associate	VBN
cord-266455-rbblg4pu	183	56	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	183	57	in	in	IN
cord-266455-rbblg4pu	183	58	a	a	DT
cord-266455-rbblg4pu	183	59	large	large	JJ
cord-266455-rbblg4pu	183	60	matched	match	VBN
cord-266455-rbblg4pu	183	61	cohort	cohort	NN
cord-266455-rbblg4pu	183	62	Tackling	tackle	VBG
cord-266455-rbblg4pu	183	63	drug	drug	NN
cord-266455-rbblg4pu	183	64	-	-	HYPH
cord-266455-rbblg4pu	183	65	resistant	resistant	JJ
cord-266455-rbblg4pu	183	66	infections	infection	NNS
cord-266455-rbblg4pu	183	67	globally	globally	RB
cord-266455-rbblg4pu	183	68	:	:	:
cord-266455-rbblg4pu	183	69	final	final	JJ
cord-266455-rbblg4pu	183	70	report	report	NN
cord-266455-rbblg4pu	183	71	and	and	CC
cord-266455-rbblg4pu	183	72	recommendations	recommendation	NNS
cord-266455-rbblg4pu	183	73	chaired	chair	VBN
cord-266455-rbblg4pu	183	74	by	by	IN
cord-266455-rbblg4pu	183	75	Jim	Jim	NNP
cord-266455-rbblg4pu	183	76	O'Neill	O'Neill	NNP
cord-266455-rbblg4pu	183	77	UK	UK	NNP
cord-266455-rbblg4pu	183	78	5-year	5-year	CD
cord-266455-rbblg4pu	183	79	action	action	NN
cord-266455-rbblg4pu	183	80	plan	plan	NN
cord-266455-rbblg4pu	183	81	for	for	IN
cord-266455-rbblg4pu	183	82	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	183	83	resistance	resistance	NN
cord-266455-rbblg4pu	183	84	2019	2019	CD
cord-266455-rbblg4pu	183	85	to	to	IN
cord-266455-rbblg4pu	183	86	2024	2024	CD
cord-266455-rbblg4pu	183	87	-GOV.uk	-GOV.uk	.
cord-266455-rbblg4pu	183	88	Surviving	survive	VBG
cord-266455-rbblg4pu	183	89	sepsis	sepsis	NN
cord-266455-rbblg4pu	183	90	campaign	campaign	NN
cord-266455-rbblg4pu	183	91	guidelines	guideline	NNS
cord-266455-rbblg4pu	183	92	for	for	IN
cord-266455-rbblg4pu	183	93	management	management	NN
cord-266455-rbblg4pu	183	94	of	of	IN
cord-266455-rbblg4pu	183	95	severe	severe	JJ
cord-266455-rbblg4pu	183	96	sepsis	sepsis	NN
cord-266455-rbblg4pu	183	97	and	and	CC
cord-266455-rbblg4pu	183	98	septic	septic	JJ
cord-266455-rbblg4pu	183	99	shock	shock	NN
cord-266455-rbblg4pu	183	100	Time	time	NN
cord-266455-rbblg4pu	183	101	to	to	IN
cord-266455-rbblg4pu	183	102	first	first	JJ
cord-266455-rbblg4pu	183	103	antibiotic	antibiotic	NN
cord-266455-rbblg4pu	183	104	and	and	CC
cord-266455-rbblg4pu	183	105	mortality	mortality	NN
cord-266455-rbblg4pu	183	106	in	in	IN
cord-266455-rbblg4pu	183	107	adults	adult	NNS
cord-266455-rbblg4pu	183	108	hospitalised	hospitalise	VBN
cord-266455-rbblg4pu	183	109	with	with	IN
cord-266455-rbblg4pu	183	110	community	community	NN
cord-266455-rbblg4pu	183	111	-	-	HYPH
cord-266455-rbblg4pu	183	112	acquired	acquire	VBN
cord-266455-rbblg4pu	183	113	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	183	114	:	:	:
cord-266455-rbblg4pu	183	115	a	a	DT
cord-266455-rbblg4pu	183	116	matched	match	VBN
cord-266455-rbblg4pu	183	117	-	-	HYPH
cord-266455-rbblg4pu	183	118	propensity	propensity	NN
cord-266455-rbblg4pu	183	119	analysis	analysis	NN
cord-266455-rbblg4pu	183	120	Epidemiology	epidemiology	NN
cord-266455-rbblg4pu	183	121	,	,	,
cord-266455-rbblg4pu	183	122	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	183	123	therapy	therapy	NN
cord-266455-rbblg4pu	183	124	,	,	,
cord-266455-rbblg4pu	183	125	and	and	CC
cord-266455-rbblg4pu	183	126	clinical	clinical	JJ
cord-266455-rbblg4pu	183	127	outcomes	outcome	NNS
cord-266455-rbblg4pu	183	128	in	in	IN
cord-266455-rbblg4pu	183	129	health	health	NN
cord-266455-rbblg4pu	183	130	careassociated	careassociated	NNP
cord-266455-rbblg4pu	183	131	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	183	132	:	:	:
cord-266455-rbblg4pu	183	133	a	a	DT
cord-266455-rbblg4pu	183	134	UK	UK	NNP
cord-266455-rbblg4pu	183	135	cohort	cohort	NN
cord-266455-rbblg4pu	183	136	study	study	NN
cord-266455-rbblg4pu	184	1	Can	Can	MD
cord-266455-rbblg4pu	184	2	an	an	DT
cord-266455-rbblg4pu	184	3	etiologic	etiologic	JJ
cord-266455-rbblg4pu	184	4	agent	agent	NN
cord-266455-rbblg4pu	184	5	be	be	VB
cord-266455-rbblg4pu	184	6	identified	identify	VBN
cord-266455-rbblg4pu	184	7	in	in	IN
cord-266455-rbblg4pu	184	8	adults	adult	NNS
cord-266455-rbblg4pu	184	9	who	who	WP
cord-266455-rbblg4pu	184	10	are	be	VBP
cord-266455-rbblg4pu	184	11	hospitalized	hospitalize	VBN
cord-266455-rbblg4pu	184	12	for	for	IN
cord-266455-rbblg4pu	184	13	community	community	NN
cord-266455-rbblg4pu	184	14	-	-	HYPH
cord-266455-rbblg4pu	184	15	acquired	acquire	VBN
cord-266455-rbblg4pu	184	16	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	184	17	:	:	:
cord-266455-rbblg4pu	185	1	results	result	NNS
cord-266455-rbblg4pu	185	2	of	of	IN
cord-266455-rbblg4pu	185	3	a	a	DT
cord-266455-rbblg4pu	185	4	one	one	CD
cord-266455-rbblg4pu	185	5	-	-	HYPH
cord-266455-rbblg4pu	185	6	year	year	NN
cord-266455-rbblg4pu	185	7	study	study	NN
cord-266455-rbblg4pu	185	8	Comprehensive	comprehensive	JJ
cord-266455-rbblg4pu	185	9	molecular	molecular	JJ
cord-266455-rbblg4pu	185	10	testing	testing	NN
cord-266455-rbblg4pu	185	11	for	for	IN
cord-266455-rbblg4pu	185	12	respiratory	respiratory	JJ
cord-266455-rbblg4pu	185	13	pathogens	pathogen	NNS
cord-266455-rbblg4pu	185	14	in	in	IN
cord-266455-rbblg4pu	185	15	community	community	NN
cord-266455-rbblg4pu	185	16	-	-	HYPH
cord-266455-rbblg4pu	185	17	acquired	acquire	VBN
cord-266455-rbblg4pu	185	18	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	186	1	The	the	DT
cord-266455-rbblg4pu	186	2	unyvero	unyvero	NNP
cord-266455-rbblg4pu	186	3	P55	P55	NNP
cord-266455-rbblg4pu	186	4	'	'	POS
cord-266455-rbblg4pu	186	5	sample	sample	NN
cord-266455-rbblg4pu	186	6	-	-	HYPH
cord-266455-rbblg4pu	186	7	in	in	RP
cord-266455-rbblg4pu	186	8	,	,	,
cord-266455-rbblg4pu	186	9	answer	answer	VB
cord-266455-rbblg4pu	186	10	-	-	HYPH
cord-266455-rbblg4pu	186	11	out	out	NN
cord-266455-rbblg4pu	186	12	'	'	''
cord-266455-rbblg4pu	186	13	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	186	14	assay	assay	NN
cord-266455-rbblg4pu	186	15	:	:	:
cord-266455-rbblg4pu	186	16	a	a	DT
cord-266455-rbblg4pu	186	17	performance	performance	NN
cord-266455-rbblg4pu	186	18	evaluation	evaluation	NN
cord-266455-rbblg4pu	186	19	Respiratory	respiratory	JJ
cord-266455-rbblg4pu	186	20	multiplex	multiplex	NN
cord-266455-rbblg4pu	186	21	polymerase	polymerase	NN
cord-266455-rbblg4pu	186	22	chain	chain	NN
cord-266455-rbblg4pu	186	23	reaction	reaction	NN
cord-266455-rbblg4pu	186	24	:	:	:
cord-266455-rbblg4pu	186	25	an	an	DT
cord-266455-rbblg4pu	186	26	important	important	JJ
cord-266455-rbblg4pu	186	27	diagnostic	diagnostic	JJ
cord-266455-rbblg4pu	186	28	tool	tool	NN
cord-266455-rbblg4pu	186	29	in	in	IN
cord-266455-rbblg4pu	186	30	immunocompromised	immunocompromised	JJ
cord-266455-rbblg4pu	186	31	patients	patient	NNS
cord-266455-rbblg4pu	186	32	Multiplex	Multiplex	NNP
cord-266455-rbblg4pu	186	33	PCR	PCR	NNP
cord-266455-rbblg4pu	186	34	performed	perform	VBN
cord-266455-rbblg4pu	186	35	of	of	IN
cord-266455-rbblg4pu	186	36	bronchoalveolar	bronchoalveolar	NNP
cord-266455-rbblg4pu	186	37	lavage	lavage	NNP
cord-266455-rbblg4pu	186	38	fluid	fluid	NN
cord-266455-rbblg4pu	186	39	increases	increase	VBZ
cord-266455-rbblg4pu	186	40	pathogen	pathogen	NN
cord-266455-rbblg4pu	186	41	identification	identification	NN
cord-266455-rbblg4pu	186	42	rate	rate	NN
cord-266455-rbblg4pu	186	43	in	in	IN
cord-266455-rbblg4pu	186	44	critically	critically	RB
cord-266455-rbblg4pu	186	45	ill	ill	JJ
cord-266455-rbblg4pu	186	46	patients	patient	NNS
cord-266455-rbblg4pu	186	47	with	with	IN
cord-266455-rbblg4pu	186	48	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	186	49	:	:	:
cord-266455-rbblg4pu	186	50	a	a	DT
cord-266455-rbblg4pu	186	51	pilot	pilot	NN
cord-266455-rbblg4pu	186	52	study	study	NN
cord-266455-rbblg4pu	186	53	Microbial	microbial	JJ
cord-266455-rbblg4pu	186	54	etiologies	etiology	NNS
cord-266455-rbblg4pu	186	55	of	of	IN
cord-266455-rbblg4pu	186	56	hospital	hospital	NN
cord-266455-rbblg4pu	186	57	-	-	HYPH
cord-266455-rbblg4pu	186	58	acquired	acquire	VBN
cord-266455-rbblg4pu	186	59	bacterial	bacterial	JJ
cord-266455-rbblg4pu	186	60	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	186	61	and	and	CC
cord-266455-rbblg4pu	186	62	ventilator	ventilator	NN
cord-266455-rbblg4pu	186	63	-	-	HYPH
cord-266455-rbblg4pu	186	64	associated	associate	VBN
cord-266455-rbblg4pu	186	65	bacterial	bacterial	JJ
cord-266455-rbblg4pu	186	66	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	186	67	Geographical	Geographical	NNP
cord-266455-rbblg4pu	186	68	and	and	CC
cord-266455-rbblg4pu	186	69	temporal	temporal	JJ
cord-266455-rbblg4pu	186	70	variation	variation	NN
cord-266455-rbblg4pu	186	71	in	in	IN
cord-266455-rbblg4pu	186	72	the	the	DT
cord-266455-rbblg4pu	186	73	frequency	frequency	NN
cord-266455-rbblg4pu	186	74	and	and	CC
cord-266455-rbblg4pu	186	75	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	186	76	susceptibility	susceptibility	NN
cord-266455-rbblg4pu	186	77	of	of	IN
cord-266455-rbblg4pu	186	78	bacteria	bacteria	NNS
cord-266455-rbblg4pu	186	79	isolated	isolate	VBN
cord-266455-rbblg4pu	186	80	from	from	IN
cord-266455-rbblg4pu	186	81	patients	patient	NNS
cord-266455-rbblg4pu	186	82	hospitalized	hospitalize	VBN
cord-266455-rbblg4pu	186	83	with	with	IN
cord-266455-rbblg4pu	186	84	bacterial	bacterial	JJ
cord-266455-rbblg4pu	186	85	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	186	86	:	:	:
cord-266455-rbblg4pu	186	87	results	result	NNS
cord-266455-rbblg4pu	186	88	from	from	IN
cord-266455-rbblg4pu	186	89	20	20	CD
cord-266455-rbblg4pu	186	90	years	year	NNS
cord-266455-rbblg4pu	186	91	of	of	IN
cord-266455-rbblg4pu	186	92	the	the	DT
cord-266455-rbblg4pu	186	93	sentry	sentry	NNP
cord-266455-rbblg4pu	186	94	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	186	95	surveillance	surveillance	NN
cord-266455-rbblg4pu	186	96	program	program	NN
cord-266455-rbblg4pu	186	97	Viral	viral	JJ
cord-266455-rbblg4pu	186	98	infection	infection	NN
cord-266455-rbblg4pu	186	99	in	in	IN
cord-266455-rbblg4pu	186	100	patients	patient	NNS
cord-266455-rbblg4pu	186	101	with	with	IN
cord-266455-rbblg4pu	186	102	severe	severe	JJ
cord-266455-rbblg4pu	186	103	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	186	104	requiring	require	VBG
cord-266455-rbblg4pu	186	105	intensive	intensive	JJ
cord-266455-rbblg4pu	186	106	care	care	NN
cord-266455-rbblg4pu	186	107	unit	unit	NN
cord-266455-rbblg4pu	186	108	admission	admission	NN
cord-266455-rbblg4pu	186	109	Routine	routine	JJ
cord-266455-rbblg4pu	186	110	molecular	molecular	JJ
cord-266455-rbblg4pu	186	111	point	point	NN
cord-266455-rbblg4pu	186	112	-	-	HYPH
cord-266455-rbblg4pu	186	113	of	of	IN
cord-266455-rbblg4pu	186	114	-	-	HYPH
cord-266455-rbblg4pu	186	115	care	care	NN
cord-266455-rbblg4pu	186	116	testing	testing	NN
cord-266455-rbblg4pu	186	117	for	for	IN
cord-266455-rbblg4pu	186	118	respiratory	respiratory	JJ
cord-266455-rbblg4pu	186	119	viruses	virus	NNS
cord-266455-rbblg4pu	186	120	in	in	IN
cord-266455-rbblg4pu	186	121	adults	adult	NNS
cord-266455-rbblg4pu	186	122	presenting	present	VBG
cord-266455-rbblg4pu	186	123	to	to	IN
cord-266455-rbblg4pu	186	124	hospital	hospital	NN
cord-266455-rbblg4pu	186	125	with	with	IN
cord-266455-rbblg4pu	186	126	acute	acute	JJ
cord-266455-rbblg4pu	186	127	respiratory	respiratory	JJ
cord-266455-rbblg4pu	186	128	illness	illness	NN
cord-266455-rbblg4pu	186	129	(	(	-LRB-
cord-266455-rbblg4pu	186	130	Re	re	NN
cord-266455-rbblg4pu	186	131	-	-	NN
cord-266455-rbblg4pu	186	132	sPOC	spoc	JJ
cord-266455-rbblg4pu	186	133	)	)	-RRB-
cord-266455-rbblg4pu	186	134	:	:	:
cord-266455-rbblg4pu	186	135	a	a	DT
cord-266455-rbblg4pu	186	136	pragmatic	pragmatic	JJ
cord-266455-rbblg4pu	186	137	,	,	,
cord-266455-rbblg4pu	186	138	open	open	JJ
cord-266455-rbblg4pu	186	139	-	-	HYPH
cord-266455-rbblg4pu	186	140	label	label	NN
cord-266455-rbblg4pu	186	141	,	,	,
cord-266455-rbblg4pu	186	142	randomised	randomised	JJ
cord-266455-rbblg4pu	186	143	controlled	control	VBN
cord-266455-rbblg4pu	186	144	trial	trial	NN
cord-266455-rbblg4pu	186	145	Effectiveness	Effectiveness	NNP
cord-266455-rbblg4pu	186	146	of	of	IN
cord-266455-rbblg4pu	186	147	neuraminidase	neuraminidase	NN
cord-266455-rbblg4pu	186	148	inhibitors	inhibitor	NNS
cord-266455-rbblg4pu	186	149	in	in	IN
cord-266455-rbblg4pu	186	150	reducing	reduce	VBG
cord-266455-rbblg4pu	186	151	mortality	mortality	NN
cord-266455-rbblg4pu	186	152	in	in	IN
cord-266455-rbblg4pu	186	153	patients	patient	NNS
cord-266455-rbblg4pu	186	154	admitted	admit	VBN
cord-266455-rbblg4pu	186	155	to	to	IN
cord-266455-rbblg4pu	186	156	hospital	hospital	NN
cord-266455-rbblg4pu	186	157	with	with	IN
cord-266455-rbblg4pu	186	158	influenza	influenza	NN
cord-266455-rbblg4pu	186	159	a	a	DT
cord-266455-rbblg4pu	186	160	H1N1pdm09	H1N1pdm09	NNP
cord-266455-rbblg4pu	186	161	virus	virus	NN
cord-266455-rbblg4pu	186	162	infection	infection	NN
cord-266455-rbblg4pu	186	163	:	:	:
cord-266455-rbblg4pu	186	164	a	a	DT
cord-266455-rbblg4pu	186	165	meta	meta	NN
cord-266455-rbblg4pu	186	166	-	-	HYPH
cord-266455-rbblg4pu	186	167	analysis	analysis	NN
cord-266455-rbblg4pu	186	168	of	of	IN
cord-266455-rbblg4pu	186	169	individual	individual	JJ
cord-266455-rbblg4pu	186	170	participant	participant	NN
cord-266455-rbblg4pu	186	171	data	datum	NNS
cord-266455-rbblg4pu	186	172	Early	early	JJ
cord-266455-rbblg4pu	186	173	oseltamivir	oseltamivir	NN
cord-266455-rbblg4pu	186	174	after	after	IN
cord-266455-rbblg4pu	186	175	hospital	hospital	NN
cord-266455-rbblg4pu	186	176	admission	admission	NN
cord-266455-rbblg4pu	186	177	is	be	VBZ
cord-266455-rbblg4pu	186	178	associated	associate	VBN
cord-266455-rbblg4pu	186	179	with	with	IN
cord-266455-rbblg4pu	186	180	shortened	shorten	VBN
cord-266455-rbblg4pu	186	181	hospitalization	hospitalization	NN
cord-266455-rbblg4pu	186	182	:	:	:
cord-266455-rbblg4pu	186	183	a	a	DT
cord-266455-rbblg4pu	186	184	5-Year	5-year	CD
cord-266455-rbblg4pu	186	185	analysis	analysis	NN
cord-266455-rbblg4pu	186	186	of	of	IN
cord-266455-rbblg4pu	186	187	oseltamivir	oseltamivir	JJ
cord-266455-rbblg4pu	186	188	timing	timing	NN
cord-266455-rbblg4pu	186	189	and	and	CC
cord-266455-rbblg4pu	186	190	clinical	clinical	JJ
cord-266455-rbblg4pu	186	191	outcomes	outcome	NNS
cord-266455-rbblg4pu	186	192	National	national	JJ
cord-266455-rbblg4pu	186	193	surveillance	surveillance	NN
cord-266455-rbblg4pu	186	194	scheme	scheme	NN
cord-266455-rbblg4pu	186	195	for	for	IN
cord-266455-rbblg4pu	186	196	Legionnaires	Legionnaires	NNPS
cord-266455-rbblg4pu	186	197	'	'	POS
cord-266455-rbblg4pu	186	198	disease	disease	NN
cord-266455-rbblg4pu	186	199	in	in	IN
cord-266455-rbblg4pu	186	200	residents	resident	NNS
cord-266455-rbblg4pu	186	201	of	of	IN
cord-266455-rbblg4pu	186	202	England	England	NNP
cord-266455-rbblg4pu	186	203	and	and	CC
cord-266455-rbblg4pu	186	204	Wales	Wales	NNP
cord-266455-rbblg4pu	186	205	ReSyn	ReSyn	NNP
cord-266455-rbblg4pu	186	206	-	-	HYPH
cord-266455-rbblg4pu	186	207	Plex	Plex	NNP
cord-266455-rbblg4pu	186	208	:	:	:
cord-266455-rbblg4pu	186	209	respiratory	respiratory	JJ
cord-266455-rbblg4pu	186	210	syndrome	syndrome	NN
cord-266455-rbblg4pu	186	211	linked	link	VBN
cord-266455-rbblg4pu	186	212	pathogens	pathogen	NNS
cord-266455-rbblg4pu	186	213	multiplex	multiplex	JJ
cord-266455-rbblg4pu	186	214	detection	detection	NN
cord-266455-rbblg4pu	186	215	and	and	CC
cord-266455-rbblg4pu	186	216	characterization	characterization	NN
cord-266455-rbblg4pu	187	1	Biofire	Biofire	NNP
cord-266455-rbblg4pu	187	2	diagnostics	diagnostic	NNS
cord-266455-rbblg4pu	187	3	-FilmArray	-FilmArray	.
cord-266455-rbblg4pu	188	1	Pneumonia	pneumonia	NN
cord-266455-rbblg4pu	188	2	panel	panel	NN
cord-266455-rbblg4pu	188	3	Evaluation	Evaluation	NNP
cord-266455-rbblg4pu	188	4	of	of	IN
cord-266455-rbblg4pu	188	5	the	the	DT
cord-266455-rbblg4pu	188	6	biofire	biofire	NN
cord-266455-rbblg4pu	188	7	R	r	NN
cord-266455-rbblg4pu	188	8	filmarray	filmarray	NNP
cord-266455-rbblg4pu	188	9	R	R	NNP
cord-266455-rbblg4pu	188	10	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	188	11	panel	panel	NN
cord-266455-rbblg4pu	188	12	in	in	IN
cord-266455-rbblg4pu	188	13	icu	icu	NNP
cord-266455-rbblg4pu	188	14	patients	patient	NNS
cord-266455-rbblg4pu	188	15	with	with	IN
cord-266455-rbblg4pu	188	16	suspected	suspect	VBN
cord-266455-rbblg4pu	188	17	ventilator	ventilator	NN
cord-266455-rbblg4pu	188	18	-	-	HYPH
cord-266455-rbblg4pu	188	19	associated	associate	VBN
cord-266455-rbblg4pu	188	20	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	188	21	n.d	n.d	NNP
cord-266455-rbblg4pu	188	22	Clinical	clinical	JJ
cord-266455-rbblg4pu	188	23	evaluation	evaluation	NN
cord-266455-rbblg4pu	188	24	and	and	CC
cord-266455-rbblg4pu	188	25	potential	potential	JJ
cord-266455-rbblg4pu	188	26	impact	impact	NN
cord-266455-rbblg4pu	188	27	of	of	IN
cord-266455-rbblg4pu	188	28	a	a	DT
cord-266455-rbblg4pu	188	29	semi	semi	JJ
cord-266455-rbblg4pu	188	30	-	-	JJ
cord-266455-rbblg4pu	188	31	quantitative	quantitative	JJ
cord-266455-rbblg4pu	188	32	multiplex	multiplex	JJ
cord-266455-rbblg4pu	188	33	molecular	molecular	JJ
cord-266455-rbblg4pu	188	34	assay	assay	NN
cord-266455-rbblg4pu	188	35	for	for	IN
cord-266455-rbblg4pu	188	36	the	the	DT
cord-266455-rbblg4pu	188	37	identification	identification	NN
cord-266455-rbblg4pu	188	38	of	of	IN
cord-266455-rbblg4pu	188	39	pathogenic	pathogenic	JJ
cord-266455-rbblg4pu	188	40	bacteria	bacteria	NNS
cord-266455-rbblg4pu	188	41	and	and	CC
cord-266455-rbblg4pu	188	42	viruses	virus	NNS
cord-266455-rbblg4pu	188	43	in	in	IN
cord-266455-rbblg4pu	188	44	lower	low	JJR
cord-266455-rbblg4pu	188	45	respiratory	respiratory	JJ
cord-266455-rbblg4pu	188	46	specimens	specimen	NNS
cord-266455-rbblg4pu	188	47	Clinical	clinical	JJ
cord-266455-rbblg4pu	188	48	evaluation	evaluation	NN
cord-266455-rbblg4pu	188	49	of	of	IN
cord-266455-rbblg4pu	188	50	the	the	DT
cord-266455-rbblg4pu	188	51	biofire	biofire	NNP
cord-266455-rbblg4pu	188	52	filmarray	filmarray	NNP
cord-266455-rbblg4pu	188	53	pneumonia	pneumonia	NNP
cord-266455-rbblg4pu	188	54	panel	panel	NN
cord-266455-rbblg4pu	188	55	plus	plus	CC
cord-266455-rbblg4pu	188	56	Precision	Precision	NNP
cord-266455-rbblg4pu	188	57	of	of	IN
cord-266455-rbblg4pu	188	58	the	the	DT
cord-266455-rbblg4pu	188	59	filmarray	filmarray	NNP
cord-266455-rbblg4pu	188	60	R	R	NNP
cord-266455-rbblg4pu	188	61	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	188	62	panel	panel	NN
cord-266455-rbblg4pu	188	63	considerations	consideration	NNS
cord-266455-rbblg4pu	188	64	for	for	IN
cord-266455-rbblg4pu	188	65	interpreting	interpret	VBG
cord-266455-rbblg4pu	188	66	relative	relative	JJ
cord-266455-rbblg4pu	188	67	abundance	abundance	NN
cord-266455-rbblg4pu	188	68	of	of	IN
cord-266455-rbblg4pu	188	69	bacterial	bacterial	JJ
cord-266455-rbblg4pu	188	70	nucleic	nucleic	JJ
cord-266455-rbblg4pu	188	71	acids	acid	NNS
cord-266455-rbblg4pu	188	72	in	in	IN
cord-266455-rbblg4pu	188	73	lower	low	JJR
cord-266455-rbblg4pu	188	74	respiratory	respiratory	JJ
cord-266455-rbblg4pu	188	75	specimens	specimen	NNS
cord-266455-rbblg4pu	188	76	Buc	Buc	NNP
cord-266455-rbblg4pu	188	77	BW	BW	NNP
cord-266455-rbblg4pu	188	78	Potential	potential	JJ
cord-266455-rbblg4pu	188	79	clinical	clinical	JJ
cord-266455-rbblg4pu	188	80	impact	impact	NN
cord-266455-rbblg4pu	188	81	of	of	IN
cord-266455-rbblg4pu	188	82	a	a	DT
cord-266455-rbblg4pu	188	83	semi	semi	JJ
cord-266455-rbblg4pu	188	84	-	-	JJ
cord-266455-rbblg4pu	188	85	quantitative	quantitative	JJ
cord-266455-rbblg4pu	188	86	multiplex	multiplex	JJ
cord-266455-rbblg4pu	188	87	molecular	molecular	JJ
cord-266455-rbblg4pu	188	88	assay	assay	NN
cord-266455-rbblg4pu	188	89	for	for	IN
cord-266455-rbblg4pu	188	90	the	the	DT
cord-266455-rbblg4pu	188	91	identification	identification	NN
cord-266455-rbblg4pu	188	92	of	of	IN
cord-266455-rbblg4pu	188	93	bacteria	bacteria	NNS
cord-266455-rbblg4pu	188	94	,	,	,
cord-266455-rbblg4pu	188	95	viruses	virus	NNS
cord-266455-rbblg4pu	188	96	,	,	,
cord-266455-rbblg4pu	188	97	and	and	CC
cord-266455-rbblg4pu	188	98	fungi	fungus	NNS
cord-266455-rbblg4pu	188	99	in	in	IN
cord-266455-rbblg4pu	188	100	lower	low	JJR
cord-266455-rbblg4pu	188	101	respiratory	respiratory	JJ
cord-266455-rbblg4pu	188	102	specimens	specimen	NNS
cord-266455-rbblg4pu	188	103	Available	available	JJ
cord-266455-rbblg4pu	188	104	at	at	IN
cord-266455-rbblg4pu	188	105	https://	https://	NNP
cord-266455-rbblg4pu	188	106	curetis.com/wp-content/uploads/00255	curetis.com/wp-content/uploads/00255	NNP
cord-266455-rbblg4pu	189	1	_	_	NNP
cord-266455-rbblg4pu	189	2	HPN	HPN	NNP
cord-266455-rbblg4pu	190	1	_	_	NNP
cord-266455-rbblg4pu	191	1	ApplicationManual	ApplicationManual	NNP
cord-266455-rbblg4pu	192	1	_	_	NN
cord-266455-rbblg4pu	192	2	Rev6-EN.pdf	Rev6-EN.pdf	NNP
cord-266455-rbblg4pu	192	3	an	an	DT
cord-266455-rbblg4pu	192	4	observational	observational	JJ
cord-266455-rbblg4pu	192	5	study	study	NN
cord-266455-rbblg4pu	192	6	comparing	compare	VBG
cord-266455-rbblg4pu	192	7	the	the	DT
cord-266455-rbblg4pu	192	8	performance	performance	NN
cord-266455-rbblg4pu	192	9	of	of	IN
cord-266455-rbblg4pu	192	10	two	two	CD
cord-266455-rbblg4pu	192	11	multiplex	multiplex	NN
cord-266455-rbblg4pu	192	12	PCR	pcr	NN
cord-266455-rbblg4pu	192	13	platforms	platform	NNS
cord-266455-rbblg4pu	192	14	against	against	IN
cord-266455-rbblg4pu	192	15	routine	routine	JJ
cord-266455-rbblg4pu	192	16	microbiology	microbiology	NN
cord-266455-rbblg4pu	192	17	for	for	IN
cord-266455-rbblg4pu	192	18	the	the	DT
cord-266455-rbblg4pu	192	19	detection	detection	NN
cord-266455-rbblg4pu	192	20	of	of	IN
cord-266455-rbblg4pu	192	21	potential	potential	JJ
cord-266455-rbblg4pu	192	22	pathogens	pathogen	NNS
cord-266455-rbblg4pu	192	23	in	in	IN
cord-266455-rbblg4pu	192	24	patients	patient	NNS
cord-266455-rbblg4pu	192	25	with	with	IN
cord-266455-rbblg4pu	192	26	suspected	suspect	VBN
cord-266455-rbblg4pu	192	27	hospital	hospital	NN
cord-266455-rbblg4pu	192	28	acquired	acquire	VBN
cord-266455-rbblg4pu	192	29	/	/	SYM
cord-266455-rbblg4pu	192	30	ventilator	ventilator	NN
cord-266455-rbblg4pu	192	31	associated	associate	VBN
cord-266455-rbblg4pu	192	32	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	192	33	(	(	-LRB-
cord-266455-rbblg4pu	192	34	HAP	HAP	NNP
cord-266455-rbblg4pu	192	35	/	/	SYM
cord-266455-rbblg4pu	192	36	VAP	VAP	NNP
cord-266455-rbblg4pu	192	37	)	)	-RRB-
cord-266455-rbblg4pu	192	38	across	across	IN
cord-266455-rbblg4pu	192	39	Performance	Performance	NNP
cord-266455-rbblg4pu	192	40	du	du	NNP
cord-266455-rbblg4pu	192	41	test	test	NN
cord-266455-rbblg4pu	192	42	unyvero	unyvero	NNP
cord-266455-rbblg4pu	192	43	HPN	HPN	NNP
cord-266455-rbblg4pu	192	44	chez	chez	NNP
cord-266455-rbblg4pu	192	45	des	des	FW
cord-266455-rbblg4pu	192	46	patients	patient	NNS
cord-266455-rbblg4pu	192	47	de	de	IN
cord-266455-rbblg4pu	192	48	réanimation	réanimation	NN
cord-266455-rbblg4pu	192	49	avec	avec	FW
cord-266455-rbblg4pu	192	50	une	une	FW
cord-266455-rbblg4pu	192	51	pneumopathie	pneumopathie	NNP
cord-266455-rbblg4pu	192	52	acquise	acquise	NNP
cord-266455-rbblg4pu	192	53	sous	sous	NNP
cord-266455-rbblg4pu	192	54	ventilation	ventilation	NN
cord-266455-rbblg4pu	193	1	mécanique	mécanique	NNP
cord-266455-rbblg4pu	194	1	ou	ou	NNP
cord-266455-rbblg4pu	194	2	une	une	NNP
cord-266455-rbblg4pu	194	3	pneumopathie	pneumopathie	NNP
cord-266455-rbblg4pu	194	4	nosocomiale	nosocomiale	NNP
cord-266455-rbblg4pu	194	5	sévère	sévère	NNP
cord-266455-rbblg4pu	194	6	Impact	Impact	NNP
cord-266455-rbblg4pu	194	7	of	of	IN
cord-266455-rbblg4pu	194	8	the	the	DT
cord-266455-rbblg4pu	194	9	unyvero	unyvero	NNP
cord-266455-rbblg4pu	194	10	HPN	HPN	NNP
cord-266455-rbblg4pu	194	11	test	test	NN
cord-266455-rbblg4pu	194	12	in	in	IN
cord-266455-rbblg4pu	194	13	ICU	ICU	NNP
cord-266455-rbblg4pu	194	14	patients	patient	NNS
cord-266455-rbblg4pu	194	15	with	with	IN
cord-266455-rbblg4pu	194	16	ventilator	ventilator	NN
cord-266455-rbblg4pu	194	17	-	-	HYPH
cord-266455-rbblg4pu	194	18	associated	associate	VBN
cord-266455-rbblg4pu	194	19	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	194	20	(	(	-LRB-
cord-266455-rbblg4pu	194	21	VAP	VAP	NNP
cord-266455-rbblg4pu	194	22	)	)	-RRB-
cord-266455-rbblg4pu	194	23	or	or	CC
cord-266455-rbblg4pu	195	1	severe	severe	JJ
cord-266455-rbblg4pu	195	2	hospital	hospital	NN
cord-266455-rbblg4pu	195	3	-	-	HYPH
cord-266455-rbblg4pu	195	4	acquired	acquire	VBN
cord-266455-rbblg4pu	195	5	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	195	6	(	(	-LRB-
cord-266455-rbblg4pu	195	7	HAP	HAP	NNP
cord-266455-rbblg4pu	195	8	)	)	-RRB-
cord-266455-rbblg4pu	195	9	Comparison	Comparison	NNP
cord-266455-rbblg4pu	195	10	of	of	IN
cord-266455-rbblg4pu	195	11	unyvero	unyvero	NNP
cord-266455-rbblg4pu	195	12	P55	P55	NNP
cord-266455-rbblg4pu	195	13	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	195	14	cartridge	cartridge	NN
cord-266455-rbblg4pu	195	15	,	,	,
cord-266455-rbblg4pu	195	16	inhouse	inhouse	NN
cord-266455-rbblg4pu	195	17	PCR	pcr	NN
cord-266455-rbblg4pu	195	18	and	and	CC
cord-266455-rbblg4pu	195	19	culture	culture	NN
cord-266455-rbblg4pu	195	20	for	for	IN
cord-266455-rbblg4pu	195	21	the	the	DT
cord-266455-rbblg4pu	195	22	identification	identification	NN
cord-266455-rbblg4pu	195	23	of	of	IN
cord-266455-rbblg4pu	195	24	respiratory	respiratory	JJ
cord-266455-rbblg4pu	195	25	pathogens	pathogen	NNS
cord-266455-rbblg4pu	195	26	and	and	CC
cord-266455-rbblg4pu	195	27	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	195	28	resistance	resistance	NN
cord-266455-rbblg4pu	195	29	in	in	IN
cord-266455-rbblg4pu	195	30	bronchoalveolar	bronchoalveolar	NNP
cord-266455-rbblg4pu	195	31	lavage	lavage	NN
cord-266455-rbblg4pu	195	32	fluids	fluid	NNS
cord-266455-rbblg4pu	195	33	in	in	IN
cord-266455-rbblg4pu	195	34	the	the	DT
cord-266455-rbblg4pu	195	35	critical	critical	JJ
cord-266455-rbblg4pu	195	36	care	care	NN
cord-266455-rbblg4pu	195	37	setting	set	VBG
cord-266455-rbblg4pu	195	38	n	n	NNP
cord-266455-rbblg4pu	195	39	Sample	Sample	NNP
cord-266455-rbblg4pu	195	40	-	-	HYPH
cord-266455-rbblg4pu	195	41	in	in	RP
cord-266455-rbblg4pu	195	42	,	,	,
cord-266455-rbblg4pu	195	43	answer	answer	NN
cord-266455-rbblg4pu	195	44	-	-	HYPH
cord-266455-rbblg4pu	195	45	out	out	NN
cord-266455-rbblg4pu	195	46	'	'	''
cord-266455-rbblg4pu	195	47	?	?	.
cord-266455-rbblg4pu	196	1	Evaluation	evaluation	NN
cord-266455-rbblg4pu	196	2	and	and	CC
cord-266455-rbblg4pu	196	3	comprehensive	comprehensive	JJ
cord-266455-rbblg4pu	196	4	analysis	analysis	NN
cord-266455-rbblg4pu	196	5	of	of	IN
cord-266455-rbblg4pu	196	6	the	the	DT
cord-266455-rbblg4pu	196	7	unyvero	unyvero	NNP
cord-266455-rbblg4pu	196	8	P50	P50	NNP
cord-266455-rbblg4pu	196	9	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	196	10	assay	assay	NN
cord-266455-rbblg4pu	196	11	Assessment	Assessment	NNP
cord-266455-rbblg4pu	196	12	of	of	IN
cord-266455-rbblg4pu	196	13	the	the	DT
cord-266455-rbblg4pu	196	14	multiplex	multiplex	NN
cord-266455-rbblg4pu	196	15	PCR	pcr	NN
cord-266455-rbblg4pu	196	16	-	-	HYPH
cord-266455-rbblg4pu	196	17	based	base	VBN
cord-266455-rbblg4pu	196	18	assay	assay	NN
cord-266455-rbblg4pu	196	19	unyvero	unyvero	NNP
cord-266455-rbblg4pu	196	20	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	196	21	application	application	NN
cord-266455-rbblg4pu	196	22	for	for	IN
cord-266455-rbblg4pu	196	23	detection	detection	NN
cord-266455-rbblg4pu	196	24	of	of	IN
cord-266455-rbblg4pu	196	25	bacterial	bacterial	JJ
cord-266455-rbblg4pu	196	26	pathogens	pathogen	NNS
cord-266455-rbblg4pu	196	27	and	and	CC
cord-266455-rbblg4pu	196	28	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	196	29	resistance	resistance	NN
cord-266455-rbblg4pu	196	30	genes	gene	NNS
cord-266455-rbblg4pu	196	31	in	in	IN
cord-266455-rbblg4pu	196	32	children	child	NNS
cord-266455-rbblg4pu	196	33	and	and	CC
cord-266455-rbblg4pu	196	34	Evaluation	Evaluation	NNP
cord-266455-rbblg4pu	196	35	of	of	IN
cord-266455-rbblg4pu	196	36	Curetis	Curetis	NNP
cord-266455-rbblg4pu	196	37	unyvero	unyvero	NNP
cord-266455-rbblg4pu	196	38	,	,	,
cord-266455-rbblg4pu	196	39	a	a	DT
cord-266455-rbblg4pu	196	40	multiplex	multiplex	JJ
cord-266455-rbblg4pu	196	41	PCR	pcr	NN
cord-266455-rbblg4pu	196	42	-	-	HYPH
cord-266455-rbblg4pu	196	43	based	base	VBN
cord-266455-rbblg4pu	196	44	testing	testing	NN
cord-266455-rbblg4pu	196	45	system	system	NN
cord-266455-rbblg4pu	196	46	,	,	,
cord-266455-rbblg4pu	196	47	for	for	IN
cord-266455-rbblg4pu	196	48	rapid	rapid	JJ
cord-266455-rbblg4pu	196	49	detection	detection	NN
cord-266455-rbblg4pu	196	50	of	of	IN
cord-266455-rbblg4pu	196	51	bacteria	bacteria	NNS
cord-266455-rbblg4pu	196	52	and	and	CC
cord-266455-rbblg4pu	196	53	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	196	54	resistance	resistance	NN
cord-266455-rbblg4pu	196	55	and	and	CC
cord-266455-rbblg4pu	196	56	impact	impact	NN
cord-266455-rbblg4pu	196	57	of	of	IN
cord-266455-rbblg4pu	196	58	the	the	DT
cord-266455-rbblg4pu	196	59	assay	assay	NN
cord-266455-rbblg4pu	196	60	on	on	IN
cord-266455-rbblg4pu	196	61	management	management	NN
cord-266455-rbblg4pu	196	62	of	of	IN
cord-266455-rbblg4pu	196	63	severe	severe	JJ
cord-266455-rbblg4pu	196	64	nosocomial	nosocomial	JJ
cord-266455-rbblg4pu	196	65	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	196	66	Sample	sample	NN
cord-266455-rbblg4pu	196	67	-	-	HYPH
cord-266455-rbblg4pu	196	68	in	in	RP
cord-266455-rbblg4pu	196	69	,	,	,
cord-266455-rbblg4pu	196	70	answer	answer	NN
cord-266455-rbblg4pu	196	71	-	-	HYPH
cord-266455-rbblg4pu	196	72	out	out	NN
cord-266455-rbblg4pu	196	73	'	'	''
cord-266455-rbblg4pu	196	74	?	?	.
cord-266455-rbblg4pu	197	1	Evaluation	evaluation	NN
cord-266455-rbblg4pu	197	2	and	and	CC
cord-266455-rbblg4pu	197	3	comprehensive	comprehensive	JJ
cord-266455-rbblg4pu	197	4	analysis	analysis	NN
cord-266455-rbblg4pu	197	5	of	of	IN
cord-266455-rbblg4pu	197	6	the	the	DT
cord-266455-rbblg4pu	197	7	unyvero	unyvero	NNP
cord-266455-rbblg4pu	197	8	P50	P50	NNP
cord-266455-rbblg4pu	197	9	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	197	10	assay	assay	NN
cord-266455-rbblg4pu	198	1	A	a	DT
cord-266455-rbblg4pu	198	2	review	review	NN
cord-266455-rbblg4pu	198	3	of	of	IN
cord-266455-rbblg4pu	198	4	novel	novel	JJ
cord-266455-rbblg4pu	198	5	technologies	technology	NNS
cord-266455-rbblg4pu	198	6	and	and	CC
cord-266455-rbblg4pu	198	7	techniques	technique	NNS
cord-266455-rbblg4pu	198	8	associated	associate	VBN
cord-266455-rbblg4pu	198	9	with	with	IN
cord-266455-rbblg4pu	198	10	identification	identification	NN
cord-266455-rbblg4pu	198	11	of	of	IN
cord-266455-rbblg4pu	198	12	bloodstream	bloodstream	NN
cord-266455-rbblg4pu	198	13	infection	infection	NN
cord-266455-rbblg4pu	198	14	etiologies	etiology	NNS
cord-266455-rbblg4pu	198	15	and	and	CC
cord-266455-rbblg4pu	198	16	rapid	rapid	JJ
cord-266455-rbblg4pu	198	17	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	198	18	genotypic	genotypic	JJ
cord-266455-rbblg4pu	198	19	and	and	CC
cord-266455-rbblg4pu	198	20	quantitative	quantitative	JJ
cord-266455-rbblg4pu	198	21	phenotypic	phenotypic	JJ
cord-266455-rbblg4pu	198	22	determination	determination	NN
cord-266455-rbblg4pu	198	23	Diagnosis	diagnosis	NN
cord-266455-rbblg4pu	198	24	and	and	CC
cord-266455-rbblg4pu	198	25	management	management	NN
cord-266455-rbblg4pu	198	26	of	of	IN
cord-266455-rbblg4pu	198	27	community	community	NN
cord-266455-rbblg4pu	198	28	-	-	HYPH
cord-266455-rbblg4pu	198	29	and	and	CC
cord-266455-rbblg4pu	198	30	hospital	hospital	NN
cord-266455-rbblg4pu	198	31	-	-	HYPH
cord-266455-rbblg4pu	198	32	acquired	acquire	VBN
cord-266455-rbblg4pu	198	33	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	198	34	in	in	IN
cord-266455-rbblg4pu	198	35	adults	adult	NNS
cord-266455-rbblg4pu	198	36	.	.	.
cord-266455-rbblg4pu	199	1	Nice	nice	JJ
cord-266455-rbblg4pu	199	2	clinical	clinical	JJ
cord-266455-rbblg4pu	199	3	guideline	guideline	NN
cord-266455-rbblg4pu	199	4	191	191	CD
cord-266455-rbblg4pu	199	5	.	.	.
cord-266455-rbblg4pu	200	1	Nice	nice	JJ
cord-266455-rbblg4pu	200	2	,	,	,
cord-266455-rbblg4pu	200	3	National	National	NNP
cord-266455-rbblg4pu	200	4	Clinical	Clinical	NNP
cord-266455-rbblg4pu	200	5	Guidelines	Guidelines	NNPS
cord-266455-rbblg4pu	200	6	Centre	Centre	NNP
cord-266455-rbblg4pu	200	7	Management	Management	NNP
cord-266455-rbblg4pu	200	8	of	of	IN
cord-266455-rbblg4pu	200	9	adults	adult	NNS
cord-266455-rbblg4pu	200	10	with	with	IN
cord-266455-rbblg4pu	200	11	hospital	hospital	NN
cord-266455-rbblg4pu	200	12	-	-	HYPH
cord-266455-rbblg4pu	200	13	acquired	acquire	VBN
cord-266455-rbblg4pu	200	14	and	and	CC
cord-266455-rbblg4pu	200	15	ventilatorassociated	ventilatorassociate	VBD
cord-266455-rbblg4pu	200	16	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	200	17	:	:	:
cord-266455-rbblg4pu	201	1	2016	2016	CD
cord-266455-rbblg4pu	201	2	clinical	clinical	JJ
cord-266455-rbblg4pu	201	3	practice	practice	NN
cord-266455-rbblg4pu	201	4	guidelines	guideline	NNS
cord-266455-rbblg4pu	201	5	by	by	IN
cord-266455-rbblg4pu	201	6	the	the	DT
cord-266455-rbblg4pu	201	7	infectious	infectious	JJ
cord-266455-rbblg4pu	201	8	diseases	disease	NNS
cord-266455-rbblg4pu	201	9	society	society	NN
cord-266455-rbblg4pu	201	10	of	of	IN
cord-266455-rbblg4pu	201	11	America	America	NNP
cord-266455-rbblg4pu	201	12	and	and	CC
cord-266455-rbblg4pu	201	13	the	the	DT
cord-266455-rbblg4pu	201	14	American	american	JJ
cord-266455-rbblg4pu	201	15	thoracic	thoracic	JJ
cord-266455-rbblg4pu	201	16	society	society	NN
cord-266455-rbblg4pu	202	1	Early	early	JJ
cord-266455-rbblg4pu	202	2	use	use	NN
cord-266455-rbblg4pu	202	3	of	of	IN
cord-266455-rbblg4pu	202	4	imipenem	imipenem	NNP
cord-266455-rbblg4pu	202	5	/	/	SYM
cord-266455-rbblg4pu	202	6	cilastatin	cilastatin	NNP
cord-266455-rbblg4pu	202	7	and	and	CC
cord-266455-rbblg4pu	202	8	vancomycin	vancomycin	NNS
cord-266455-rbblg4pu	202	9	followed	follow	VBN
cord-266455-rbblg4pu	202	10	by	by	IN
cord-266455-rbblg4pu	202	11	de	de	NN
cord-266455-rbblg4pu	202	12	-	-	NN
cord-266455-rbblg4pu	202	13	escalation	escalation	NN
cord-266455-rbblg4pu	202	14	versus	versus	IN
cord-266455-rbblg4pu	202	15	conventional	conventional	JJ
cord-266455-rbblg4pu	202	16	antimicrobials	antimicrobial	NNS
cord-266455-rbblg4pu	202	17	without	without	IN
cord-266455-rbblg4pu	202	18	de	de	NN
cord-266455-rbblg4pu	202	19	-	-	NN
cord-266455-rbblg4pu	202	20	escalation	escalation	NN
cord-266455-rbblg4pu	202	21	for	for	IN
cord-266455-rbblg4pu	202	22	patients	patient	NNS
cord-266455-rbblg4pu	202	23	with	with	IN
cord-266455-rbblg4pu	202	24	hospitalacquired	hospitalacquired	JJ
cord-266455-rbblg4pu	202	25	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	202	26	in	in	IN
cord-266455-rbblg4pu	202	27	a	a	DT
cord-266455-rbblg4pu	202	28	medical	medical	JJ
cord-266455-rbblg4pu	202	29	ICU	ICU	NNP
cord-266455-rbblg4pu	202	30	:	:	:
cord-266455-rbblg4pu	202	31	a	a	DT
cord-266455-rbblg4pu	202	32	randomized	randomized	JJ
cord-266455-rbblg4pu	202	33	clinical	clinical	JJ
cord-266455-rbblg4pu	202	34	trial	trial	NN
cord-266455-rbblg4pu	202	35	De	de	NN
cord-266455-rbblg4pu	202	36	-	-	HYPH
cord-266455-rbblg4pu	202	37	escalation	escalation	NN
cord-266455-rbblg4pu	202	38	versus	versus	IN
cord-266455-rbblg4pu	202	39	continuation	continuation	NN
cord-266455-rbblg4pu	202	40	of	of	IN
cord-266455-rbblg4pu	202	41	empirical	empirical	JJ
cord-266455-rbblg4pu	202	42	antimicrobial	antimicrobial	JJ
cord-266455-rbblg4pu	202	43	treatment	treatment	NN
cord-266455-rbblg4pu	202	44	in	in	IN
cord-266455-rbblg4pu	202	45	severe	severe	JJ
cord-266455-rbblg4pu	202	46	sepsis	sepsis	NN
cord-266455-rbblg4pu	202	47	:	:	:
cord-266455-rbblg4pu	202	48	a	a	DT
cord-266455-rbblg4pu	202	49	multicenter	multicenter	JJ
cord-266455-rbblg4pu	202	50	non	non	JJ
cord-266455-rbblg4pu	202	51	-	-	JJ
cord-266455-rbblg4pu	202	52	blinded	blinded	JJ
cord-266455-rbblg4pu	202	53	randomized	randomized	JJ
cord-266455-rbblg4pu	202	54	noninferiority	noninferiority	NN
cord-266455-rbblg4pu	202	55	trial	trial	NN
cord-266455-rbblg4pu	202	56	Antibiotic	Antibiotic	NNP
cord-266455-rbblg4pu	202	57	de	de	NN
cord-266455-rbblg4pu	202	58	-	-	NN
cord-266455-rbblg4pu	202	59	escalation	escalation	NN
cord-266455-rbblg4pu	202	60	in	in	IN
cord-266455-rbblg4pu	202	61	patients	patient	NNS
cord-266455-rbblg4pu	202	62	with	with	IN
cord-266455-rbblg4pu	202	63	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	202	64	in	in	IN
cord-266455-rbblg4pu	202	65	the	the	DT
cord-266455-rbblg4pu	202	66	intensive	intensive	JJ
cord-266455-rbblg4pu	202	67	care	care	NN
cord-266455-rbblg4pu	202	68	unit	unit	NN
cord-266455-rbblg4pu	202	69	:	:	:
cord-266455-rbblg4pu	202	70	a	a	DT
cord-266455-rbblg4pu	202	71	systematic	systematic	JJ
cord-266455-rbblg4pu	202	72	review	review	NN
cord-266455-rbblg4pu	202	73	and	and	CC
cord-266455-rbblg4pu	202	74	meta	meta	NNP
cord-266455-rbblg4pu	202	75	-	-	HYPH
cord-266455-rbblg4pu	202	76	analysis	analysis	NN
cord-266455-rbblg4pu	202	77	infectious	infectious	JJ
cord-266455-rbblg4pu	202	78	diseases	disease	NNS
cord-266455-rbblg4pu	202	79	society	society	NN
cord-266455-rbblg4pu	202	80	of	of	IN
cord-266455-rbblg4pu	202	81	america	america	NNP
cord-266455-rbblg4pu	202	82	/	/	SYM
cord-266455-rbblg4pu	202	83	american	american	NNP
cord-266455-rbblg4pu	202	84	thoracic	thoracic	NNP
cord-266455-rbblg4pu	202	85	society	society	NNP
cord-266455-rbblg4pu	202	86	consensus	consensus	NN
cord-266455-rbblg4pu	202	87	guidelines	guideline	NNS
cord-266455-rbblg4pu	202	88	on	on	IN
cord-266455-rbblg4pu	202	89	the	the	DT
cord-266455-rbblg4pu	202	90	management	management	NN
cord-266455-rbblg4pu	202	91	of	of	IN
cord-266455-rbblg4pu	202	92	communityacquired	communityacquired	JJ
cord-266455-rbblg4pu	202	93	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	202	94	in	in	IN
cord-266455-rbblg4pu	202	95	adults	adult	NNS
cord-266455-rbblg4pu	203	1	Prospective	prospective	JJ
cord-266455-rbblg4pu	203	2	,	,	,
cord-266455-rbblg4pu	203	3	randomised	randomised	JJ
cord-266455-rbblg4pu	203	4	study	study	NN
cord-266455-rbblg4pu	203	5	to	to	TO
cord-266455-rbblg4pu	203	6	compare	compare	VB
cord-266455-rbblg4pu	203	7	empirical	empirical	JJ
cord-266455-rbblg4pu	203	8	treatment	treatment	NN
cord-266455-rbblg4pu	203	9	versus	versus	IN
cord-266455-rbblg4pu	203	10	targeted	target	VBN
cord-266455-rbblg4pu	203	11	treatment	treatment	NN
cord-266455-rbblg4pu	203	12	on	on	IN
cord-266455-rbblg4pu	203	13	the	the	DT
cord-266455-rbblg4pu	203	14	basis	basis	NN
cord-266455-rbblg4pu	203	15	of	of	IN
cord-266455-rbblg4pu	203	16	the	the	DT
cord-266455-rbblg4pu	203	17	urine	urine	NN
cord-266455-rbblg4pu	203	18	antigen	antigen	NN
cord-266455-rbblg4pu	203	19	results	result	NNS
cord-266455-rbblg4pu	203	20	in	in	IN
cord-266455-rbblg4pu	203	21	hospitalised	hospitalise	VBN
cord-266455-rbblg4pu	203	22	patients	patient	NNS
cord-266455-rbblg4pu	203	23	with	with	IN
cord-266455-rbblg4pu	203	24	community	community	NN
cord-266455-rbblg4pu	203	25	-	-	HYPH
cord-266455-rbblg4pu	203	26	acquired	acquire	VBN
cord-266455-rbblg4pu	203	27	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	203	28	Comparison	comparison	NN
cord-266455-rbblg4pu	203	29	between	between	IN
cord-266455-rbblg4pu	203	30	pathogen	pathogen	NN
cord-266455-rbblg4pu	203	31	directed	direct	VBD
cord-266455-rbblg4pu	203	32	antibiotic	antibiotic	JJ
cord-266455-rbblg4pu	203	33	treatment	treatment	NN
cord-266455-rbblg4pu	203	34	and	and	CC
cord-266455-rbblg4pu	203	35	empirical	empirical	JJ
cord-266455-rbblg4pu	203	36	broad	broad	JJ
cord-266455-rbblg4pu	203	37	spectrum	spectrum	NN
cord-266455-rbblg4pu	203	38	antibiotic	antibiotic	NN
cord-266455-rbblg4pu	203	39	treatment	treatment	NN
cord-266455-rbblg4pu	203	40	in	in	IN
cord-266455-rbblg4pu	203	41	patients	patient	NNS
cord-266455-rbblg4pu	203	42	with	with	IN
cord-266455-rbblg4pu	203	43	community	community	NN
cord-266455-rbblg4pu	203	44	acquired	acquire	VBD
cord-266455-rbblg4pu	203	45	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	203	46	:	:	:
cord-266455-rbblg4pu	203	47	a	a	DT
cord-266455-rbblg4pu	203	48	prospective	prospective	JJ
cord-266455-rbblg4pu	203	49	randomised	randomised	JJ
cord-266455-rbblg4pu	203	50	study	study	NN
cord-266455-rbblg4pu	203	51	Antibiotic	Antibiotic	NNP
cord-266455-rbblg4pu	203	52	de	de	NN
cord-266455-rbblg4pu	203	53	-	-	NN
cord-266455-rbblg4pu	203	54	escalation	escalation	NN
cord-266455-rbblg4pu	203	55	for	for	IN
cord-266455-rbblg4pu	203	56	bloodstream	bloodstream	NN
cord-266455-rbblg4pu	203	57	infections	infection	NNS
cord-266455-rbblg4pu	203	58	and	and	CC
cord-266455-rbblg4pu	203	59	pneumonia	pneumonia	NN
cord-266455-rbblg4pu	203	60	:	:	:
cord-266455-rbblg4pu	203	61	systematic	systematic	JJ
cord-266455-rbblg4pu	203	62	review	review	NN
cord-266455-rbblg4pu	203	63	and	and	CC
cord-266455-rbblg4pu	203	64	meta	meta	NNP
cord-266455-rbblg4pu	203	65	-	-	HYPH
cord-266455-rbblg4pu	203	66	analysis	analysis	NN
cord-266455-rbblg4pu	203	67	Impact	Impact	NNP
cord-266455-rbblg4pu	203	68	of	of	IN
cord-266455-rbblg4pu	203	69	turnaround	turnaround	NN
cord-266455-rbblg4pu	203	70	time	time	NN
cord-266455-rbblg4pu	203	71	on	on	IN
cord-266455-rbblg4pu	203	72	outcome	outcome	NN
cord-266455-rbblg4pu	203	73	with	with	IN
cord-266455-rbblg4pu	203	74	point	point	NN
cord-266455-rbblg4pu	203	75	-	-	HYPH
cord-266455-rbblg4pu	203	76	of	of	IN
cord-266455-rbblg4pu	203	77	-	-	HYPH
cord-266455-rbblg4pu	203	78	care	care	NN
cord-266455-rbblg4pu	203	79	testing	testing	NN
cord-266455-rbblg4pu	203	80	for	for	IN
cord-266455-rbblg4pu	203	81	respiratory	respiratory	JJ
cord-266455-rbblg4pu	203	82	viruses	virus	NNS
cord-266455-rbblg4pu	203	83	:	:	:
cord-266455-rbblg4pu	203	84	a	a	DT
cord-266455-rbblg4pu	203	85	post	post	FW
cord-266455-rbblg4pu	203	86	hoc	hoc	FW
cord-266455-rbblg4pu	203	87	analysis	analysis	NN
cord-266455-rbblg4pu	203	88	from	from	IN
cord-266455-rbblg4pu	203	89	a	a	DT
cord-266455-rbblg4pu	203	90	randomised	randomised	JJ
cord-266455-rbblg4pu	203	91	controlled	control	VBN
cord-266455-rbblg4pu	203	92	trial	trial	NN
cord-266455-rbblg4pu	203	93	The	the	DT
cord-266455-rbblg4pu	203	94	authors	author	NNS
cord-266455-rbblg4pu	203	95	would	would	MD
cord-266455-rbblg4pu	203	96	like	like	VB
cord-266455-rbblg4pu	203	97	to	to	TO
cord-266455-rbblg4pu	203	98	thank	thank	VB
cord-266455-rbblg4pu	203	99	Paula	Paula	NNP
cord-266455-rbblg4pu	203	100	Sands	Sands	NNPS
cord-266455-rbblg4pu	203	101	,	,	,
cord-266455-rbblg4pu	203	102	Research	Research	NNP
cord-266455-rbblg4pu	203	103	engagement	engagement	NN
cord-266455-rbblg4pu	203	104	Librarian	librarian	NN
cord-266455-rbblg4pu	203	105	at	at	IN
cord-266455-rbblg4pu	203	106	the	the	DT
cord-266455-rbblg4pu	203	107	Southampton	Southampton	NNP
cord-266455-rbblg4pu	203	108	General	General	NNP
cord-266455-rbblg4pu	203	109	Hospital	Hospital	NNP
cord-266455-rbblg4pu	203	110	Healthcare	Healthcare	NNP
cord-266455-rbblg4pu	203	111	library	library	NN
cord-266455-rbblg4pu	203	112	for	for	IN
cord-266455-rbblg4pu	203	113	her	-PRON-	PRP$
cord-266455-rbblg4pu	203	114	help	help	NN
cord-266455-rbblg4pu	203	115	and	and	CC
cord-266455-rbblg4pu	203	116	expertise	expertise	VB
cord-266455-rbblg4pu	203	117	in	in	IN
cord-266455-rbblg4pu	203	118	constructing	construct	VBG
cord-266455-rbblg4pu	203	119	search	search	NN
cord-266455-rbblg4pu	203	120	terms	term	NNS
cord-266455-rbblg4pu	203	121	for	for	IN
cord-266455-rbblg4pu	203	122	literature	literature	NN
cord-266455-rbblg4pu	203	123	review	review	NN
cord-266455-rbblg4pu	203	124	.	.	.